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ABSTRACT 
Diffuse idiopathic skeletal hyperostosis (DISH) is a common skeletal disorder 
characterized by the presence of new bone formation in ligaments and entheses. DISH 
can co-exist with Chondrocalcinosis (CC) and it has been suggested that both diseases 
share the same pathogenic mechanism. To date, two genes, COL6A1 and FGF2, have 
been shown to have a weak positive association with DISH susceptibility. The main 
objective of this thesis was to investigate the genetic basis of the DISH/CC disease, 
making use of Next Generation Sequencing technology, association and expression 
studies, in a group of DISH/CC samples from the Azores biobank. Two regulatory 
variants in the RSPO4 gene were significantly more frequent in controls than in DISH/CC 
patients. These may protect against the DISH/CC phenotype, possibly by altering gene 
expression of the RSPO4 gene. Using whole exome sequencing we identified a significant 
association between the DISH/CC disease and a genetic variant in BMP4 (rs17563), a 
gene involved in endochondral bone formation. Another of the candidate genes associated 
with DISH/CC was ABCC6 that is of relevance in ectopic calcification disorders. 
Although inconclusive, the expression studies performed in human cartilage tissue 
indicated overexpression of ABCC6 in DISH and CC patients relative to the controls, 
raising the hypothesis that this gene may be involved in calcium pyrophosphate formation 
in DISH and CC. A comparative approach using teleosts revealed that the abcc6 gene is 
expressed in skin but was not associated with ectopic calcification of the scales. 
Furthermore, comparative genomics revealed the abcc6 has only been retained in the 
genome of bony vertebrates. In summary, I identify for the first time potential gene 
variants that protect (RSPO4) or predispose (BMP4) to DISH/CC. The relevance of the 
ABCC6 gene in this phenotype remains to be proven. It is unlikely that one major gene is 
responsible for DISH/CC and instead it appears to be a polygenic disease. 
Keywords: Chondrocalcinosis, DISH, WES, BMP4, ABCC6, RSPO4.
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RESUMO 
A hiperostose idiopática difusa do esqueleto (DISH) é uma doença musculoesquelética 
comum caracterizada pela formação óssea de novo em ligamentos e enteses. A DISH 
pode coexistir com a condrocalcinose e por isso tem sido sugerido que ambas partilham o 
mesmo mecanismo patogénico. COL6A1 e FGF2 são os dois genes de suscetibilidade 
conhecidos com uma ligação genética fraca à DISH. 
O objetivo principal desta tese foi investigar a genética da DISH/CC, utilizando a 
sequenciação de nova geração e estudos de associação e expressão, num grupo de 
amostras de doentes com DISH/CC do AZORBIO. 
Duas variantes na região reguladora do gene RSPO4 são significativamente mais 
frequentes nos controlos do que nos doentes DISH/CC. Estas variantes podem afetar a 
expressão do gene, conferindo proteção à doença. Utilizando a sequenciação exómica 
identificamos uma associação significativa entre a DISH/CC e a variante genética 
rs17563 no gene BMP4, um gene diretamente envolvido na formação óssea endocondral.  
Outro gene candidato estudado foi o ABCC6, que parece ser relevante em doenças 
caracterizadas por calcificações ectópicas. Embora inconclusivos, os estudos de expressão 
em tecidos de cartilagem humana mostraram que o gene ABCC6 apresenta expressão 
superior nos doentes DISH e CC em relação a um doente controlo, levantando a hipótese 
de que este aumento de expressão poderá estar envolvido com a deposição de cristais de 
pirofosfato de cálcio nestes doentes. Uma abordagem comparativa utilizando teleósteos 
revelou que o gene abcc6 está expresso na pele dos peixes, mas não está associado com a 
calcificação ectópica das escamas. Além disso, nos resultados da genómica comparativa o 
gene abcc6 só foi encontrado no genoma de vertebrados ósseos, indicando que este gene 
poderá estar envolvido em inovações específicas dos vertebrados. 
Concluindo, foi identificado pela primeira vez potenciais variantes genéticas que 
protegem (RSPO4) ou predispõem (BMP4) à DISH/CC. A relevância do gene ABCC6 
neste fenótipo necessita de ser provada. É pouco provável que um único gene esteja 
envolvido no aparecimento de DISH/CC, e por isso a doença parece ser poligénica. 
Palavras-chave: Condrocalcinose, DISH, WES, BMP4, ABCC6, RSPO4. 
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RESUMO ALARGADO 
A hiperostose idiopática difusa do esqueleto (DISH, MIM 106400) é uma doença 
musculoesquelética comum caracterizada pela calcificação progressiva e ossificação de 
tecidos moles, em particular ligamentos e enteses [1, 2]. Em alguns casos a deposição 
óssea pode levar a alterações biomecânicas do sistema músculo-esquelético e/ou a 
formação de massas cervicais obstrutivas [3, 4]. Desconhece-se a prevalência e a 
incidência exata da DISH, porém sabe-se que é mais frequente no sexo masculino e que a 
sua prevalência aumenta com a idade, afetando principalmente os indivíduos com mais de 
40 anos [5]. Várias evidências sugerem que fatores genéticos estão envolvidos na 
etiologia da DISH, como a existência de casos familiares com início precoce (na terceira 
ou quarta década de vida) [29], e a maior frequência da DISH em uma raça específica de 
cães, a raça boxer [30, 31]. Variantes de suscetibilidade para a DISH foram encontradas 
nos genes COL6A1 e FGF2, no entanto estas estão localizadas em regiões não 
codificantes da proteína e são consideradas variantes comuns na população em geral, o 
que sugere um efeito menor ou não patogénico. Embora os genes COL6A1 e FGF2 
pareçam estar envolvidos na suscetibilidade da DISH, a genética da DISH é ainda 
desconhecida. 
A DISH pode coexistir com um grande número de outras doenças reumáticas, sendo 
exemplos destas a ossificação do ligamento lateral posterior (OPLL, MIM 602475) [6], 
Ossificação do ligamento flavum [8], Espondilite anquilosante (AS) (MIM 106300) [7-
21] e Condrocalcinose (CC) [22, 23]. A coexistência da DISH com CC é muito comum 
na ilha Terceira (Açores) e parece ser uma manifestação endémica. Estudos anteriores, 
conduzidos pelo nosso grupo, levaram à identificação e caracterização de doze famílias 
com início precoce de DISH e/ou CC levando o grupo a sugerir que ambas as doenças, 
designadas como fenótipo DISH/CC, poderiam partilhar o mesmo mecanismo 
patogénico. Estas famílias parecem apresentar um tipo familiar precoce, autossómica 
dominante, com um fenótipo que inclui calcificações entesopáticas periféricas e axiais 
[24]. Um fenótipo similar foi relatado em outros estudos no passado [25, 26]. Estes 
doentes têm a sua qualidade de vida gravemente comprometida devido ao início precoce e 
ao fenótipo exuberante.  
Este estudo foi realizado nos Açores, um arquipelago português localizado no meio do 
Oceano Atlântico, numa pequena ilha com apenas 56.467 habitantes, Ilha Terceira 
(Census, 2011). Em populações isoladas ou com mobilidade reduzida, como é o caso da 
 xiv 
 
Ilha Terceira, existe uma elevada taxa de casamentos consanguíneos e uma alta 
probabilidade de ancestralidade comum que é particularmente valiosa no mapeamento de 
genes envolvidos em doenças monogénicas mendelianas e, portanto, investigar o fenótipo 
DISH/CC nessa população aumenta a probabilidade de identificar o gene causador desta 
patologia. Na ilha Terceira Açores foi estabelecido um biobanco com produtos biológicos 
e dados associados para a população da Ilha Terceira. Os Biobancos são essenciais na 
investigação, por conterem coleções de amostras e dados armazenados de forma 
organizada. Actualmente, o biobanco dos Açores (AZORBIO) do Serviço Especializado 
de Epidemiologia e Biologia Molecular (SEEBMO) tem uma colecção de material 
biológico e dados associados de doentes açorianos de diferentes patologias [27]. 
O objetivo principal desta tese foi investigar doentes e famílias afetadas com o fenótipo 
DISH/CC para determinar a sua base genética. Para atingir esse objetivo, foram utilizados 
diferentes estudos que se encontram divididos ao longo dos capítulos desta tese. 
No capítulo 2 foi realizada uma revisão da literatura sobre a genética da ossificação dos 
ligamentos da coluna vertebral (OSL). Com base na sua análise verifica-se que a 
contribuição genética para o desenvolvimento destas ossificações parece ser inegável. A 
existência de casos familiares com início precoce (terceira/quarta década de vida) [1], a 
existência de modelos animais [2, 3], e a existência de uma grande variedade de genes 
com associação positiva, essencialmente na OPLL, são evidências que reforçam ainda 
mais esta predisposição genética. É provável que esta contribuição genética não seja 
causada por um único gene com grande efeito (padrão de herança mendeliana), mas sim 
por uma variedade de variantes em diversos genes. Para além disso existem também 
múltiplos fatores exógenos que podem estar envolvidos na patogénese da doença, mas 
provavelmente em indivíduos suscetíveis. Portanto, a OSL parece ser genética e 
multifatorial. A presença de OSL tem também sido associada com inúmeros distúrbios 
metabólicos de diferentes etiologias. A coexistência de ossificação dos ligamentos da 
coluna espinhal com alguns transtornos monogénicos tem sido relatada na literatura e 
estes normalmente estão associados a uma perturbação na homeostasia do cálcio e 
fosfato, levando-nos acreditar que os genes envolvidos nestes processos são bons 
candidatos para a etiologia da OSL. 
No capítulo 3 são apresentados os materiais e métodos utilizados ao longo de todo o 
trabalho. No capítulo 4, encontra-se descrito um caso de CC associado à síndrome de 
Gitelman. A CC é caracterizada pela deposição de sais de cálcio na cartilagem articular, 
membranas sinoviais e, em alguns casos, nos tecidos moles periarticulares [28]. Os sais 
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depositados são normalmente compostos por pirofosfato de cálcio desidratado (CPP), 
embora outros sais de cálcio, como a hidroxiapatite, também possam ser encontrados 
[28]. Sabe-se que mutações no gene ANKH, em algumas famílias, são a causa 
monogénica de CC articular familiar (CCAL2, MIM 118600). Esse gene está relacionado 
com o metabolismo do pirofosfato inorgânico (PPi) sendo responsável pelo transporte 
deste pela membrana. A CC pode ocorrer sob 3 formas: 1) hereditária, 2) esporádica, e 3) 
associada a doenças metabólicas como hiperparatiroidismo, hemacromatose, doença de 
Wilson, Síndrome de Gitelman entre outras. A síndrome de Gitelman é uma doença 
genética renal autossómica recessiva, causada por uma mutação no gene SLC12A3, o qual 
codifica o transportador NCCT (thiazide-sensitive sodium-chloride cotransporter) 
expresso no túbulo contornado distal do rim. A síndrome é caracterizada por alcalose 
metabólica, hipocalemia, hipocalciúria e hipomagnesiémia. A hipomagnesiémia está 
associada a uma redução na concentração de magnésio celular e pertence à lista de causas 
de CC secundária associada a síndromes metabólicos. A hipomagnesiémia parece 
favorecer a CC através da elevação intra-articular dos níveis de PPi extracelular e/ou 
através da redução da solubilidade dos cristais de CPP [4]. Neste estudo foi identificado 
um caso de CC associada a hipomagnesiémia causada por uma mutação patogénica 
homozigótica no gene SLC12A3. Alguns familiares deste doente são portadores da 
mutação heterozigótica e apresentavam CC.  
No capítulo 5 foi realizado um estudo de sequenciação de dois genes candidatos ao 
fenótipo DISH/CC, o gene LEMD3 e o gene RSPO4 para verificar uma possível 
associação com o fenótipo em estudo. Foram identificadas várias variantes no gene 
RSPO4, no entanto não foram observadas diferenças estatisticamente significativas na 
ocorrência destas variantes genéticas no fenótipo DISH/CC relativamente ao grupo 
controlo. Duas variantes na região reguladora do gene RSPO4 (rs146447064 e 
rs14915407) são significativamente mais frequentes em controlos do que em doentes 
DISH/CC, indicando que estas podem eventualmente afetar a expressão do gene, 
conferindo proteção à doença. A variante estudada no gene LEMD3 é extremamente rara 
e parece não estar envolvida com o fenótipo em estudo. 
No capítulo 6 desta tese descreve-se o estudo de sequenciação exómica realizado em 
quatro indivíduos das 12 famílias anteriormente referidas com o objetivo de determinar o 
possivel gene envolvido no fenótipo DISH/CC, aparentemente autossómico dominante. A 
sequenciação completa do exoma é uma técnica capaz de identificar rapidamente todas as 
variantes codificantes no genoma de um individuo. Esta técnica tem sido uma ferramenta 
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essencial para a deteção de variantes patogénicas causadoras de doenças. Das filtragens 
efetuadas surgiram vinte e uma variantes genéticas relevantes, em dezassete genes que 
estão direta ou indiretamente relacionados com a mineralização e/ou ossificação. 
Identificamos uma associação significativa entre a doença DISH/CC e a variante genética 
rs17563 no gene BMP4, um gene diretamente envolvido na formação óssea endocondral 
(p = 0,009, OR = 2,331). 
No capítulo 7 descreve-se o estudo do gene ABCC6, um gene que surgiu das filtragens da 
sequenciação exómica. Este gene contém 31 exões e está localizado no cromossoma 16, 
assim como os seus dois pequenos pseudogenes ABCC6P1 e ABCC6P2. O gene codifica 
o transportador MRP6 que pertence à família de transportadores da membrana 
dependentes de ATP. Pensa-se que está envolvido no transporte de adenosinas trifosfato. 
O MRP6 é composto por 1503 aminoácidos, três segmentos membranares, consistindo 
em 17 hélices hidrofóbicas e dois domínios de ligação a nucleótidos. A proteína apresenta 
expressão ubiquitária no entanto é principalmente no fígado e rins que esta se expressa 
mais. Alterações neste gene e também no gene ENPP1, já anteriormente designado como 
associado à OPLL, estão associadas ao Pseudoxantoma Elasticum (PXE, MIM 264800) e 
à calcificação arterial generalizada da infância (GACI2, MIM 614473). A PXE é 
caracterizada por calcificações das fibras elásticas na pele, artérias, trato gastrointestinal e 
retina. A PXE é geralmente autossómica recessiva podendo ser esporádica ou dominante 
com penetrância variável. A GACI, doença autossómica recessiva, é caracterizada por 
calcificações na lâmina elástica interna das artérias musculares e estenose. O gene 
ABCC6 foi considerado um candidato ideal porque: 1) mutações genéticas neste gene são 
a maior causa da PXE, e em alguns casos podem causar GACI, doenças que tal como a 
DISH/CC causam calcificações ectópicas; 2) a maioria dos casos de GACI são devidos a 
mutações no gene ENPP1, levando-nos a pensar que os dois genes podem ter processos 
fisiológicos comuns e, para além disso, o gene ENPP1 foi anteriormente estudado por nós 
e por outros grupos por poder estar associado à CC; 3) recentemente foi estudado a 
associação de um transportador de adenosinas - ENT1- com a DISH; como o gene 
ABCC6 pode também ser um transportador de adenosinas, leva-nos também a pensar que 
pode haver algum mecanismo fisiológico comum entre os dois transportadores. A 
variante rara não sinónima rs41278174 no gene ABCC6 foi encontrada num doente. A 
variante é altamente conservada entre mamíferos, e de acordo com os algoritmos 
utilizados (SIFT e PolyPhen) pode afetar a proteína. Verificámos que esta variante é 
frequente na ilha Terceira- Açores nomeadamente em controlos masculinos quando 
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comparados com doentes do sexo masculino (DISH/CC e AS). Esta variante está 
localizada no domínio transmembranar da proteína MRP6, um domínio essencial na 
especificidade do substrato de transportadores ABC [25]. Mutações no domínio 
transmembranar também podem afetar a integração da proteína na membrana celular 
levando a uma perda de função [26]. A variante rs41278174 poderá alterar a 
especificidade do transportador MRP6 nos homens, conferindo um efeito protetor através 
de um mecanismo desconhecido. Foram encontradas outras variantes neste gene mas de 
acordo com o estudo de associação não apresentam associação positiva com a DISH/CC. 
Os estudos de expressão por qPCR mostraram que os transcritos de ABCC6 são pouco 
expressos em tecidos de cartilagem humana, no entanto verificou-se que nos doentes 
DISH e CC o gene apresentava expressão superior em relação a um doente controlo. Este 
aumento de expressão poderá estar envolvido com a formação de cristais de CPP em 
doentes DISH e CC. 
No capítulo 8 foi realizado uma abordagem comparativa utilizando teleósteos, que 
revelou que o gene abcc6 está expresso na pele mas não está associado com a calcificação 
ectópica das escamas. Além disso, na genómica comparativa o gene abcc6 só foi 
encontrado no genoma de vertebrados ósseos, indicando que este gene poderá estar 
envolvido com inovações específicas dos vertebrados. 
Os resultados deste trabalho sugerem que vários genes parecem estar envolvidos na 
etiologia do fenótipo DISH/CC. A associação positiva encontrada para o gene BMP4 
deverá ser reproduzida com um maior número de doentes para verificar a sua veracidade. 
A expressão aumentada do gene ABCC6 encontrada nos doentes DISH e CC deverá 
também ser confirmada com mais amostras de cartilagem a fim de esclarecer e confirmar 
se este gene está mesmo envolvido na formação de deposição de CPP nos doentes com 
DISH e CC. 
Palavras-chave: Condrocalcinose, DISH, WES, BMP4, ABCC6, RSPO4, calcificações 
ectópicas, variantes genéticas, genes, Açores, PPi, CPP. 
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LIST OF ABBREVIATURES 
 
A 
A- Affected 
A1- allele1 
A2- allele 2 
AA- Amino acids 
A-Allelic test 
ABC- ATP binding cassete 
ABCC6,1,3 - ATP-binding cassete subfamily 
C, member 6, 1,3 
ABCC6P1- ATP-binding cassette subfamily C, 
member 6 pseudogene 1 
ABCC6P2- ATP-binding cassette subfamily C, 
member 6 pseudogene 2 
ABCG2- ATP Binding Cassette Subfamily G 
Member 2 
ABI-SOLiD- Applied Biosystems Sequencing 
by Oligonucleotide Ligation and Detection  
Aca- Anolis carolinensis 
ACE- Angiotensin I Converting Enzyme 
ACVR1- Activin A receptor, type I 
AD- Autosomal dominant 
Aga- Anopheles gambiae 
AHSG: Alpha 2-Heremans-Schmid 
glycoprotein 
AIP- Aryl hydrocarbon receptor-interacting 
protein 
Ala- alanine 
ALPL- Alkaline Phosphatase, 
Liver/Bone/Kidney 
AMDH- Acromesomelic dysplasia, Hunter-
Thompson 
Ame- Astyanax mexicanus 
Amel- Apis mellifera 
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1. INTRODUCTION 
1.1 Background of the study 
The starting point of this thesis was the identification of many families, from Terceira 
Island, Azores, that may represent an early onset, autosomal dominant, familial type of 
pyrophosphate arthropathy, with a phenotype that includes peripheral and axial 
enthesopathic calcifications. A detailed radiological analysis of these families showed a 
high level of ectopic calcification especially in elbows (82.9%) and spine (81.4%).  The 
concurrence of spinal ossifications, resembling Diffuse Idiopathic Skeletal Hyperostosis 
(DISH), and CPPD Chondrocalcinosis (CC), in many of those patients, suggested a 
shared pathogenic mechanism [24]. For a number of years the possible major gene 
involved in the aethiopathogenesis, of the then designated DISH/CC phenotype, has been 
investigated using different strategies, including whole exome linkage and an Identity-by-
state study, and two zones, in chromosomes 12 and 20, seemed relevant for further 
investigation [29]. For this purpose a biobank with biological products and associated 
data was established for the population from the Terceira Island in the Azores. Biobanks 
are essential in research, by having collections of samples and data stored in an organized 
manner. At the moment the biobank Azores (AZORBIO) of the Specialized Service of 
Epidemiology and Molecular Biology (SEEBMO) has a collection of biological material 
and associated data of Azorean patients with different pathologies [27]. The Azores 
archipelago (Portugal) is located in the middle of the Atlantic Ocean, 1500 km from the 
European mainland and is formed by nine islands of volcanic origin. The islands are 
grouped according to their geographic positions: Eastern (São Miguel and Santa Maria), 
Central (Terceira, Faial, Pico, Graciosa and São Jorge) and Western (Flores and Corvo) 
[24, 30] (Figure 1-1). The Azores were officially populated in 1439 and have 
approximately 246,746 inhabitants distributed in a very asymmetric way among islands. 
Terceira is a relatively small island with only 56.467 inhabitants (Census, 2011). Isolated 
populations or populations with reduced mobility, as is the case of Terceira Island, have 
proven particularly valuable for the purposes of mapping genes involved in Mendelian 
monogenic disorders and thus, investigating this phenotype in this population it was 
reasoned would increase the likelihood of identifying the causative gene mutation.  
 
Chapter I 
 
 
4 
 
 
Figure 1-1. Geographic location of the Azores. The islands are grouped according to their 
geographic positions in Eastern, Central and Western. Taken from Santos et al, 2009 [30]. 
 
 
1.2 Objectives of the thesis 
The main objective of this thesis was to proceed with the investigation of the genetic 
basis of the DISH/CC phenotype making use of Next Generation Sequencing technology, 
together with association and expression studies.  
The studies presented in this thesis were guided by the following objectives: 
• Investigate the association of CC with the metabolic disorder- Gitelman 
Syndrome; 
• Investigate the candidate genes RSPO4 and LEMD3 genes, derived from a 
previous analysis of identity-by-descent sharing across four families with CC; 
• Select the best candidate genes in WES results from 4 unrelated DISH/CC 
patients; 
• Perform case/control and expression studies on the best candidate genes; 
• Characterize the candidate gene in terms of origin and evolution. 
On completion of this thesis I expect to contribute to the identification of genetic factors 
involved in the DISH/CC phenotype. 
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1.3 Thesis outline 
The Chapter 2 introduces the basic knowledge of what is known about the genetics of 
ossification of spinal ligaments- DISH, OPLL and OLF, and focusses on the main 
disorder investigated in this thesis: DISH. Chapter 3 provides a detailed presentation of 
the material and methods used in the thesis. The association of CC with Gitelman 
Syndrome through the genetic analysis of the SLC12A3 gene is presented in chapter 4. 
Chapter 5 covers the possible role of RSPO4 and LEMD3 genetic variants in the 
aetiology of DISH/CC. The whole exome sequencing study performed in order to detect 
genetic variants that are expected to have a potentially damaging effect on proteins with 
functions related to calcification and/or ossification is reported in chapter 6. In chapter 7 
the candidate gene ABCC6 is investigated using case/control and expression studies to 
verify the association with the phenotype under study. Finally, the characterization and 
comparison of the ABCC6 gene in metazoans including humans using “in silico” 
methodologies is presented in chapter 8. The chapter 9 presents the general discussion 
and conclusions of this thesis. The final chapter contains the bibliography, followed by 
appendix with an article publication. 
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2.  LITERATURE REVIEW 
2.1 Introduction 
The spine is a columnar structure in the center of the body composed by spinal bones 
(vertebrae) and inter-vertebral discs. It is supported by spinal ligaments (flexible band-
like structures), which include the anterior and posterior longitudinal ligaments, ligament 
nuchae and the yellow ligament (ligamentum flavum) of the spine [31]. There is a group 
of diseases characterized by the ossification of spinal ligaments (OSL); the anterolateral 
spinal ligament [Diffuse Idiopathic Skeletal Hyperostosis (DISH; MIM 106400)], the 
posterior longitudinal ligament [Ossification of the Posterior Longitudinal Ligament 
(OPLL; MIM 602475)] and the ligament flavum [Ossification of Ligamentum Flavum 
(OLF)]. In some cases OPLL, DISH and OLF co-occur in the same patient [32] 
suggesting possible common aetiopathogenic factors. Genetic links in OPLL, DISH and 
OLF have been investigated and several papers cite or allude to genetic factors as playing 
a role in the aetiology of this diseases [33-35]. There are reports in the literature that 
describe familial cases of DISH and OPLL which further strengthen this genetic 
association. Although the evidence of a genetic predisposition in all the three diseases 
have been described, very few studies in DISH and OLF appear in the literature, only 
OPLL has been extensively investigated. However, the studies that have looked at the 
possible genetic links are still inconclusive and the aetiology of these diseases remains 
unknown. The main objective of this study is to investigate genetic variants associated 
with DISH susceptibility. Therefore, in this thesis, the genetic mechanisms already 
involved in OPLL and OLF aetiology will be explored in detail since they can give 
insights into the pathogenesis of DISH. 
2.2 Diagnosis  
DISH (DISH; MIM 106400) is the current terminology for a systemic non inflammatory 
disorder reported in 1925 by Knaggs [36] and later described by Forestier and Routes-
Querol in 1950 [37]. This disorder has had a variety of denominations in the literature 
throughout the years, due to the diverse phenotypes encountered. It is a common 
condition amongst the elderly characterized by calcification and ossification of the 
anterior longitudinal ligament affecting, in particular, the right side of the spine with 
preservation of the intervertebral disc space. Whilst spinal involvement in DISH is nearly 
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universal, extraspinal sites, such as the elbow, shoulder, hip, knee and heel are very 
common [1, 5, 22, 23, 38]. The diagnosis of DISH is established using radiographies. 
There are two main diagnostic criteria sets to identify definite, probable or possible DISH 
(Table 2-1). Resnick [39] defined the first set of criteria that were, some years later, 
revised by Utsinger [5] for epidemiological purposes. Criteria are indicated in the 
following table: 
 
Table 2-1. DISH diagnostic criteria. 
 Resnick Criteria [39] Utsinger Criteria [5] 
D
ef
in
it
e 
1 
Presence of flowing calcification and 
ossification along the anterolateral aspect of at 
least four contiguous vertebral bodies with or 
without associated localized pointed 
excrescences at the intervening vertebral body-
intervertebral disc junctions. 
Continuous ossification along the anterolateral 
aspect of at least four contiguous vertebral bodies, 
primarily in the thoracolumbar spine. Ossification 
begins as a fine ribbon-like wave of bone but 
commonly develops into a broad, bumpy, 
buttress-like band of bone. 
P
ro
b
a
b
le
 
P
o
ss
ib
le
 
2 
The presence of relative preservation of 
intervertebral disc height in the involved 
vertebral segment and the absence of extensive 
radiographic changes of “degenerative” disc 
disease, including vacuum phenomena and 
vertebral body marginal sclerosis. 
Continuous ossification along the anterolateral 
aspect of at least two contiguous vertebral bodies. 
P
o
ss
ib
le
 
3 
The absence of apophyseal joint bony ankylosis 
and sacroiliac joint erosion, sclerosis or 
intraarticular osseous fusion. 
Symmetrical and peripheral enthesopathy 
involving the posterior heel, superior patella or 
olecranon, with the entheseal new bone having a 
well-defined cortical margin. 
 
According to the criteria, the probability of DISH is as follows: ‘definite’ if criterion 1 is 
present, ‘probable’ if criteria 2 and 3 are present and ‘possible’ if criterion 2 or 3 is 
present; particularly if calcaneal spurs occur together with olecranon or patellar spurs. 
Exclusion criteria include: abnormal disc space height in the involved areas and/or 
apophyseal joint ankylosis. Resnick criteria number 3 has an exclusion factor based on 
the erosions, sclerosis or fusion of sacroiliac joints. This helps to exclude patients with 
Ankylosing Spondylitis (AS), a disease that can be confused with DISH. The third factor 
for exclusion of DISH diagnosis was withdrawn by Utsinger because differentiation of 
these two disorders should be possible with lateral and antero posterior axial x-rays.  
Recently efforts have been made to revise the definition of DISH in order to incorporate 
the current knowledge about DISH, however a new definition of DISH is still under 
debate [40]. Despite the need for a new definition of DISH, the criteria proposed by 
Utsinger are still universally accepted and widely used in the literature and will be used in 
this thesis. 
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OPLL (OPLL; MIM 602475) is characterized by ectopic hyperostosis and calcification of 
the posterior longitudinal ligament at the cervical, thoracic and lumbar spine [41]. In 
OPLL patients, the cervical spine (70%) is the most commonly affected, followed by the 
thoracic (15%) and lumbar (15%) spine [42, 43]. Some patients present myelopathy 
and/or radiculopathy due to chronic compression of the spinal cord and nerve roots. 
Symptoms of myelopathy are more severe in thoracic OPLL than in cervical OPLL due to 
the narrow canal, rigidity of the thoracic spine, tenuous blood supply, and inability of the 
spinal cord to resist much compression [42]. OPLL is diagnosed on lateral plain 
radiographs as an abnormal radiopacity along the posterior  of the vertebral bodies [44], 
however because of overlying osseous structures, it is important to obtain magnetic 
resonance images to successfully diagnose OPLL [45]. OPLL is classified in four 
ossification types: continuous, segmental, mixed and localized or other [44, 46, 47]. The 
segmental is the most common and involves the ossification behind each vertebral body; 
the continuous type is an ossified mass that spans several vertebral bodies; the mixed type 
is a mixture of both continuous and segmental types and the localized or other type the 
ossification is localized to the intervertebral disk space without involvement of the 
vertebral body [44].  
OLF, also known as ossification of the yellow ligament, is associated with serious 
neurologic symptoms including thoracic myelopathy and spinal stenosis [48]. The 
calcification is confined to the ligamentum flavum (LF) and does not extend to the closed 
spinal bony arch  [49]. CPP and hydroxyapatite have been positively identified and are 
the main players in the calcification of LF [50, 51]. According to Mwaka and 
collaborators [52] CPP in the cervical LF seems to progress with reduction in elastic 
fibers, increase in collagen fibrils in the matrix, and migration of metaplastic hypertrophic 
chondrocytes. The lower thoracic spine is the most affected region, however several cases 
of cervical, upper thoracic, and lumbar areas have been reported [53, 54]. Cervical 
radiography, tomography, and computed tomography are useful for diagnosis, however 
histological examination of the calcified mass using light microscopy, scanning electron 
microscopy, and x-ray diffraction analysis are essential for the definitive diagnosis [49]. 
2.3 Epidemiology  
The reported epidemiology of DISH differs in the literature. Cassin et al [55] assessed 
1000 African blacks aged older than 40 years and reported that the DISH prevalence was 
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3.8% in males and 4.2% in females. Another study analysed the data from two large 
American Midwest metropolitan hospital populations with 1363 individuals and reported 
a prevalence of DISH of 25% in males and 15% in females over 50 years of age and 35% 
in males and 26% in females over 70 years of age [56]. Holton et al [57] postulated that 
the prevalence of DISH was 42% in a group of 298 males aged over 65 from the general 
population. A recent study of 558 Japanese found that the prevalence of DISH was 17.6% 
using x-ray and 27,2% using computed tomography [58]. The exact prevalence and 
incidence of DISH is actually unknown, and a reliable estimate of the prevalence of the 
disease in the general population is difficult due to the benign nature of the condition. The 
affected individuals do not seek medical care and normally are diagnosed during the 
examination of other medical conditions [57]. However, it is well known that DISH is 
more frequent in males and its prevalence increases with age, affecting mainly subjects 
over the age of 40 [5]. Furthermore DISH seems to have a higher prevalence in developed 
countries [59], although this predominance might be due to the more frequent use of 
advanced radiological examinations in developed countries than in undeveloped 
countries. 
OPLL can be found in any population however it is more common in Asian populations, 
in particular amongst Japanese with a prevalence of 2 to 4% as compared with 0.01 to 2% 
in non-Asian populations [60]. Men are 2.5 times more likely to develop OPLL than 
women [41] and the age of onset may be in the fifth decade of life [61], although in some 
studies no association between age and the presence of OPLL was found [41]. This lack 
of consensus can be explained by the fact that the study which didn’t find any association 
probably used a group of patients with asymptomatic OPLL, while the other study only 
involved patients with symptomatic OPLL, already diagnosed. 
OLF affects populations worldwide but there is a higher prevalence in east Asian ethnic 
groups, especially the Japanese, with the incidence of 12% in thoracic OLF (15% in men 
and 7.7% in women) [62]. OLF is common in the 6th to 7th decades [46]. 
2.4 Evidences for a genetic aetiology 
Genetic links in OPLL, DISH and OLF have been investigated and several papers cite or 
allude to genetic factors as playing a role in the aetiology of these diseases [33-35].  The 
  Chapter II 
 
13 
 
reports in the literature that describe familial cases of DISH and OPLL and the existence 
of animal models further strengthen this genetic association. 
2.4.1 Familial cases 
The genetic predisposition to OPLL and DISH is supported by several reports of familial 
incidence of DISH, and by studies relating a relative recurrence risk of up to 26.1% in 
parents of OPLL patients and 28.9% in siblings [63]. 
Reports of familial DISH are uncommon in the literature. One report, dating from 1969, 
describes a family of Greek Cypriot ancestry with eight individuals showing signs of 
Ankylosing Vertebral Hyperostosis (AVH) by the third decade. Only three of them had 
backache as symptoms. All the individuals affected with AVH also shown tylosis 
(punctuate hyperkeratosis) and the mean age of individuals affected was 31 years old. Six 
members of this family were affected only with tylosis. Axial skeleton X-ray examination 
of the eight affected family members showed ossification of paraspinal ligaments, 
especially in lower thoracic region. There were also large osteophytes with preservation 
of disk space and marginal sclerosis of the sacroiliac joint. Laboratory results were all 
normal, the authors mention normal calcium and carbohydrate metabolism and glucose 
tolerance tests. Obesity was present in most individuals. Weight, in the opinion of the 
authors, could not account for all the x-ray changes since there was one affected 
individual with normal build. There was one other case of an individual with tylosis, 
normal spine and gross obesity. Beardwell et al suggested that the co-existence of tylosis 
with AVH could indicate a possible genetic link between these two disorders [64]. This 
link was never confirmed being this association an occasional finding. Another report of 
familial DISH was published in 1985 by Abiteboul et al [65], where the authors describe 
two families, one of French Canadian origin and another of Italian origin. French 
Canadian family is composed of 3 brothers and one sister definitely affected by AVH 
developing radiological changes by the 4th decade of age. Two other are probably affected 
with AVH. None of the individuals had diabetes. Italian family was first identified after a 
coxofemoral surgery of a 71 years old woman. Her sister was submitted to the same 
surgery when she was 82 years old. Former patient had five daughters, all of them 
observed by the authors of this study. Two of them showed radiological manifestations of 
the AVH. Other 2 sisters had more modest phenotypes being classified as probable AVH. 
None of these individuals was HLA-B*27, was obese or had diabetes. There is another 
report relating a family with striking cervical disease without extensive dorsal 
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involvement and normal sacroiliac joints. Inflammatory markers were all normal and 
none of the individuals of this family was HLA-B*27 positive. The authors denote the 
unusual phenotype and refer to the difficulty of classifying this condition as DISH [66].  
In 2006, Bruges-Armas et al [23] reported twelve familial cases identified on the island of 
Terceira (Azores, Portugal), multiply affected with DISH and/or chondrocalcinosis (CC). 
These families may represent a familial type of pyrophosphate arthropathy with a 
phenotype that includes peripheral and axial enthesopathic calcifications. These findings, 
according to the authors’ suggestion, support the hypothesis that both disorders may share 
common aetiopathogenic factors. One hundred and three individuals from the twelve 
unrelated families were assessed. Radiographs were taken of all the individuals including 
x-rays of the dorsolumbar, pelvis, knees, elbows and wrists, and all cases were screened 
for known associations of CC.  Ectopic calcifications were identified in seventy patients. 
Axial, elbow, knee and metacarpophalangeal (MCP) pain and/or swelling, deformity and 
radiographic enthesopathic changes were the most frequent findings/symptoms. Elbow 
and MCP periarticular calcifications were observed in 35 and 5 patients respectively, and 
CC was identified in 12 patients. Fifteen patients had sacroiliac disease on computed 
tomography - ankylosis or sclerosis. 52 patients could be classified as definite (17%), 
probable (26%), or possible (31%) DISH. Concomitant DISH and CC was diagnosed in 
12 patients. Pyrophosphate crystals were identified from knee effusions in 13 patients. 
The pattern of disease transmission was compatible with an autosomal dominant 
monogenic disease and the mean age for to develop the disease was 38 years. A recent 
paleopathological study mentions the co-existence of gout and DISH in the medici Grand 
Dukes Cosimo I and Ferdinand I [67]. Studies on these families would be very useful and 
would surely sum up important information related to DISH aetiopathogenesis. 
 
Reports of familial OPLL are scarce but they also occur in the literature. The prevalence 
of OPLL is much greater among family members of patients with OPLL than in the 
general population [63, 68], which indicates a strong familial predisposition to OPLL. 
Familial aggregation of OPLL was first demonstrated by Terayama et al in 1989 [63] in a 
study assessing 1030 relatives of probands with cervical OPLL in 347 families. The 
authors found that OPLL was observed in 26.15% of the parents and 28.89% of the 
siblings of the probands. In this study, the relative risk of first degree relatives developing 
OPLL are greater than five times that of the expected incidence in the general population. 
Another study looking to 100 patients and family members with OPLL found a 
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prevalence of 27% with a relative risk seven times that of the general population [69]. 
Because the segregation rate in the siblings is higher and the higher prevalence of 
OPLL in the parents, both authors suggested that OPLL is possibly controlled by 
autosomal dominant inheritance.  In contrast, Hamanishi et al [68] reported one OPLL 
family with a suspected autosomal recessive trait, but indicated that it was not possible to 
exclude that it was a dominant trait.  
Altogether, familial studies suggest there is a genetic predisposition, however the mode of 
inheritance for OPLL is not well defined, since the segregation analysis in families 
support both autosomal dominant and autosomal recessive patterns of inheritance. 
According to Koga et al [70] the mode of inheritance is obscured by a lack of large 
families, the late onset of the disease, a sex difference, and environmental effects. Other 
OPLL familial cases exist in the literature, although they do not indicate the mode of 
inheritance.  Tanabe et al [71] in 2002 report a case of familial thoracic OPLL in 
Caucasian siblings and Kim et al [72] used OPLL families to find genetic association 
between BMP-2 and COL6A1 polymorphisms.  
As far as we known, there are no reports in the literature that describe familial cases of 
OLF. 
2.4.2 Animal models 
Several genes have been associated in the regulation of the biomineralization process. In 
this section genes involved in the pathological mineralization of the axial skeleton in 
animal models are presented. In recent years, the use of animal models has permitted 
specific genes to be manipulated and is a powerful tool for the identification of genetic 
determinants in ectopic calcification disorders. The improvement of strategies to study 
genetic mutations affecting the skeleton have made it possible the precisely evaluate the 
role of many different genes and proteins. 
2.4.2.1 Animal models for DISH  
1) Natural cases 
Some naturally cases of DISH disease have been observed in some animals [73-76]. 
Spinal hyperostosis similar to DISH has been described in canine cases [77, 78] and are 
more frequent in boxer breed. As in human cases, the disease is more common in older 
male animals [73]. Similar cases of DISH were reported by Ghazanfar et al [79] in a 
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fighting Bulldog and by Kornmayer et al [80] in a Weimaraner breed. However, DISH 
can also occur in smaller breed dogs, and was identified in a 5 year-old, female Shih-
tzu [81]. The high prevalence of a specific disease in a certain dog breed and its absence 
in other breeds, is suggestive of a genetic mechanism [82], and thus these breeds may 
serve as an animal model for DISH. A recent study identified DISH in a nine years old cat 
which shows contiguous smooth new bone formation ventral and lateral to the vertebral 
extending from the cranial thoracic area to the lumbosacral junction, and appearing 
similar to canine DISH [75]. 
2) ENT1-/- mice 
Warraich et al [83] reported that mice ENT1-/-, lacking ENT1 exhibit progressive ectopic 
mineralization of the upper thoracic and cervical spinal cord resembling human DISH. 
Furthermore these mice had a significant reduction in the expression of Enpp1, Ank and 
Alpl genes in intervertebral discs. Another study [84] using ENT1-/- mice focused on the 
lower portion of the spine and femur, demonstrated that these mice exhibited reduced 
bone density in the lower half of the spinal column as well as in the midshaft of the 
femur. Furthermore these authors confirmed the previous findings of Warraich et al [83] 
that ENT1-/- mice have osteoid formations in the upper portion of the spinal column 
(thoracic and cervical spinal cord). 
In humans ENT1 gene, also known as solute carrier family 29 member 1 (SLC29A1), is 
one of the four members of equilibrative nucleoside transporters that maps on 
chromosome 6 (6p21.1). The gene encodes a transmembrane glycoprotein, which 
transfers hydrophilic nucleosides, such as adenosine, across the plasma membrane 
(equilibrative transport) [85]. The protein is ubiquitously expressed and involved in 
purine metabolism transporting the majority of adenosine transport across the plasma 
membrane. Recently adenosine signaling has been shown to regulate bone remodeling 
[86]. A search in Ensembl database (http://www.ensembl.org/index.html) reveals that 
several genetic variants in this gene exist, although none are associated with a human 
phenotype or disease, with the exception of a mutation (T647C) described by Kim et al 
[87] that is involved in the development of alcoholism with increased risk of alcohol 
withdrawal-induced seizures.  
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2.4.2.2 Animal models for OPLL 
1) tiptoe-walking-Yoshimura (twy) mouse 
The spinal hyperostotic twy mouse is a naturally occurring mutant that exhibits OSL 
similar to human OPLL [88], which served as a model for human OPLL disease [89]. 
Ossification occurs not only in the spinal ligaments but also in various soft tissues such as 
joint capsules, tendon enthesis, chondral tissues, and peripheral ligaments [89]. The 
accelerated bone formation characteristic of ttw mice is caused by a nonsense mutation in 
the Enpp1 gene that causes deficiency in its expression and protein activity. It was 
thought that the dysfunction of Npps, which has a predicted truncation of the gene 
product, resulting in the loss of more than one-third of the native protein [89]. The  
Enpp1-/- knock-out mouse has diminished bone density with calcification of joints and 
vertebrae [90].   
ENPP1 (also known as NPPS or PC-1) is one of the seven members of the ectonucleotide 
pyrophosphate\phosphodiesterase family that maps to chromosome 6  (6q22-q23) [91]. 
The gene encodes a membrane bound glycoprotein (NPP1) [92], that regulates bone 
mineralization by hydrolyzing extracellular nucleotide triphosphates (ATP) to produce 
pyrophosphate [93]. Since NPP1 generates pyrophosphate it serves at least in part as a 
physiological inhibitor of calcification. The protein occurs in a large variety of tissues, 
including bone and cartilage, where it occurs in osteoblasts and chondrocytes respectively 
[94, 95]. In humans, mutations in the ENPP1 gene are responsible for Generalized arterial 
calcification of infancy (GACI; MIM #208000), a severe disease characterized by 
progressive calcification of the internal elastic lamina of muscular arteries and stenosis 
due to myointimal proliferation [96]. More recently GACI disease has been related to 
pseudoxanthoma elasticum (PXE; MIM #264800), since in some GACI cases, mutations 
in ENPP1 can also cause typical pseudoxanthomatous skin lesions and angioid streaks of 
the retina [97]. A mouse model for GACI disease, the spontaneous asj-2J mutant mouse 
with the V246D missense mutation in the Enpp1 gene, has some similarities with ttw 
mouse. In the asj-2J mutant mouse the mutant Enpp1 protein is absent from the liver, and 
this causes reduced PPi levels in the plasma, and consequently extensive mineralization 
of a number of tissues, including blood vessels [98]. Mutations in the ENPP1 gene also 
causes hypophosphatemic rickets [99] and Cole disease [100].  
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2) ZFR mouse  
The ZFR (Zucker fatty rat) is a murine model originally used for studies of obesity, 
hyperinsulinemia, hypercholesterolemia and hyperlipidemia. This mice had ossified 
spinal ligaments, mainly in the thoracic spine and the ossification is histopathologically 
similar to human OPLL [101]. A molecular variant in the leptin receptor (LEPR) gene is 
the genetic cause in ZFR rats [102].  
LEP gene maps on chromosome 7 (7q32.1) and is closely related to bone metabolism, 
since leptin is a powerful inhibitor of bone turnover in vivo [103]. According to Elefteriou 
et al, leptin is an adipocyte product both necessary and sufficient to control bone mass, 
since increasing serum leptin levels, reduced bone mass. Conversely, reducing serum-free 
leptin levels by overexpressing the soluble receptor for leptin increased bone mass [103]. 
According to Liu et al [104] leptin promoted differentiation of vascular smooth muscle 
cells from female mice into osteoblasts by increasing RANKL expression. In humans, 
mutations in this gene cause severe obesity, and morbid obesity with hypogonadism 
[105].  
2.4.2.3 Other animal models with OSL 
The ank mice shows generalized arthritis associated with extensive hydroxyapatite 
deposition in articular cartilage and synovial fluid; they also present spinal, peripheral 
joint, and ligament bony ankylosis and calcification of arteries [106, 107]. The ANKH 
gene maps on chromosome 5 (5p15.1) and encodes a multipass transmembrane protein 
ANK (492 aminoacids) that transports intracellular inorganic pyrophosphate (PPi) to the 
extracellular milieu [106], where it acts as a potent inhibitor of mineralization [108]. The 
Expression Atlas (https://www.ebi.ac.uk/gxa/home) reveals that this protein is expressed 
in more than 30 different tissues and cells including the eye, brain, lung, kidney, skin and 
cartilage. 
In humans, mutations in this gene have been associated with autossomal dominant 
craniometaphyseal dysplasia (CMD; MIM#123000) [109] and chondrocalcinosis 
(CCAL2; MIM #118600) [110].  
Zebrafish have been used to study vertebrate mineralization since they share many of the 
basic features of chondrogenesis and osteogenesis with higher vertebrates [111-118]. In 
common with humans and mouse, the enpp1 mutant zebrafish (dragonfish) develops 
ectopic calcifications in a variety of soft tissues including skin, eye, cartilaginous 
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elements, the heart, intracranial space and the notochord sheet [114]. Two other zebrafish 
mutants that display defective skeletal biomineralization, caused by changes in 
phosphate/pyrophosphate homeostasis in the embryos include nob (no bone, 
mineralization fails) and dragonfish (dgf), that has ectopic mineralization of the axial 
skeleton with apparent fusion of the mineralized vertebral centra and bone nodules at 
characteristic positions of the cleithrum [119]. The nob phenotype is caused by a mutation 
in the ectonucleotidase entpd5 gene, which has a crucial role in providing sufficient levels 
of phosphate through hydrolyzing nucleoside triphosphates and diphosphates [119], Dgf, 
in turn, encodes Enpp1 [120]. According to Huitema et all [119], a stringently controlled 
balance between Entpd5 and Enpp1 activities determines the level of mineralization 
through controlling the ratio of inorganic phosphate (Pi) to pyrophosphate in the 
microenviroment of osteoblasts.  
Mutations in the zebrafish orthologue abcc6a (ATP binding cassete subfamily C, member 
6a) gene results in extensive hypermineralisation of the axial skeleton [113]. The ablation 
of abcc6a gene interfered with normal fish development with pericardial edema and a 
curled tail and was associated with fish death [111]. Another zebrafish mutant, gräte (grt; 
abcc6ahu4958) had a mutation in abcc6a gene, which has been associated with the 
regulation of tissue calcification [113]. The gräte mutant has excessive mineralisation in 
the craniofacial and axial skeleton [113]. In zebrafish the abcc6a gene is strongly 
expressed at the site of mineralisation and secretes ATP from cells increasing PPi locally, 
in contrast with the hepatically derived PPi in mammals. The authors suggested that 
zebrafish Abcc6a is one of several sources of nucleotides for ENPP1. In humans, the 
ABCC6 gene maps on chromosome 16 (16p13.1) and encodes multidrug resistance 
protein-6 (MRP-6), a transmembrane protein involved in transport of molecules between 
the extra-cellular space and the inside of the cell. The physiological role of MRP6 and its 
substrate specificity is unclear, although recently multiple sources of evidence indicate 
involvement in the regulation of human tissue calcification [121, 122].  MRP6 has a 
widespread tissue distribution but is highly expressed in the basolateral membrane of 
hepatocytes and proximal kidney tubules [123, 124]. In humans, mutations in ABCC6 
gene cause PXE [125-127] and in some cases, mutations in ABCC6 were also associated 
with GACI, a disorder associated with ENPP1 mutations [96]. The abcc6-/- mouse model 
was negative for expression of Mrp6 in the liver and has profound mineralization of 
several tissues including skin, arterial blood vessels and retina [128], which resembles the 
human PXE phenotype. Furthermore these mice display a 40% reduction in plasma PPi 
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levels [129]. According to Jansen and collaborators [129], PXE is not caused by a lack of 
functional MRP6 in the affected tissues, but rather by the absence of PPi that is normally 
provided to the circulation by an MRP6 mechanism. Recently it has been proposed [130] 
that polymorphisms in genes known to regulate cellular pyrophosphate metabolism, such 
as ALPL, ENPP1 and ANKH, are genetic risk factors contributing to PXE. 
2.4.3 Genetic variants associated  
2.4.3.1 Genetic studies on DISH 
The variation in the prevalence of DISH throughout the world [2],  the existence of 
familial cases with early onset (in the third decade of life) [64] and the higher frequency 
of DISH in specific dog breeds [77, 78] suggests that genetic factors might play a part in 
its aetiology. So far, however, no single gene has been conclusively associated with the 
disease and very few genetic studies on DISH have been published to date. Some of the 
first genetic studies in DISH were performed on Major Histocompatibility Complex 
(MHC) genes (Human Leukocyte Antigens, HLA), due to the similarity of radiographic 
patterns shared with AS, a spondyloarthropathy with a well-known association with the 
HLA-B*27 allele [131, 132]. The first study, performed by Shapiro et al [133], reported a 
positive association between HLA-B27 and DISH, since 16 out of the 47 studied patients 
were HLA-B27 positive (34%). The authors hypothesized that this gene could be 
involved in new bone formation due to the association with two disorders such as AS and 
DISH, where bone proliferation is an essential feature [134]. This study was followed by 
many more that rejected the hypothesis and the association of HLA alleles and DISH was 
discarded [135]. Conflicting results were reported in relation to HLA alleles [136-141] 
and associations of HLA-B8 [142] and HLA-B5 [143] to DISH were proposed but has 
never been proven. In a relatively small study, 65 individuals affected with DISH and 
2352 controls, Vitamin D Receptor (VDR), collagen Type Iα1 (COL1A1) polymorphisms 
were investigated. These genes are involved in bone density; COL1A1 is involved in 
determination of bone density and the interaction of both COL1A1 and VDR with calcium 
intake regulate changes of bone density over time [144]. Despite the importance of VDR 
and COL1A1 in bone homeostasis, the authors conclude that neither of these genes seem 
to contribute to DISH aetiology [145]. 
Another study investigated the influence of polymorphisms in collagen 6A1 gene 
(COL6A1) in 97 Japanese DISH patients (298 Japanese controls) and 96 Czech DISH 
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patients (96 Czech controls). One polymorphism (Intron 32; -23) was associated with 
DISH in Japanese patients but was not associated with DISH in Czech patients. Even so, 
the authors suggested that COL6A1 could be responsible for the hyperostotic state leading 
to ectopic bone formation in spinal ligaments [34]. COL6A1 encodes an extracellular 
matrix protein that may serve as a scaffold for osteoblast or pre-osteoblast cells or 
chondrocytes that subsequently contribute to membranous or endochondral ossification 
[34]. The COL6A1 gene is also strongly associated to OPLL [33, 146], and 
polymorphisms in this gene are considered helpful markers of OPLL disease [6].  
A whole genome linkage analysis followed by an “identity-by-state/descent” was 
performed in DISH/CC Azorean families to clarify the genetic basis of these pathologies 
in these families, and two zones in chromosome 12 and 20 were found [29]. Another 
attempt to find genetic associations was undertaken by Jun et all [147], who found that 
two SNPs (rs1476217 and rs3747676) in the FGF2 gene were associated with DISH and, 
one of these (rs1476217), was also associated with OLF. The FGF2 gene is involved in 
FGF signalling, which controls bone formation by regulating the expression of various 
genes involved in osteoblast differentiation and apoptosis [148].  
Only two genes have been shown to have a positive association with DISH susceptibility; 
COL6A1 [34]  and FGF2 [147] (Table 2-2). However, all the gene variants that showed 
significant association were located in non-coding regions and were common variants 
within the general population, which suggests that these variants have a minor effect on 
DISH susceptibility. In conclusion, the genetic aetiology of DISH is still unknown since 
the studies that have looked at the possible genetic association with DISH are still 
inconclusive since none of the studied genes have been shown to be pathogenetically 
relevant for DISH patients. 
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Table 2-2. Genetic variants associated with DISH. 
Gene Chr Physiological function 
Study type 
No Subjects 
[case/control] 
SNP- significantly 
associated 
Ref 
COL6A1 21 
Involved in membranous or 
endochondral ossification. 
Association study 
[97/298] (Japanese) and 
[96/96] (Czech) 
(Assessed 7 SNPs in 
COL6A1 gene). 
Intron 32 (-29) (only in 
Japanese) (chi2 = 9.33; p = 
0.0022), but not with the 
Czech DISH patients. 
[34] 
FGF2 4 
Involved in bone formation by 
regulating the expression of 
various genes involved in 
osteoblast differentiation and 
apoptosis. 
Association study with 
154 OPLL, 3 OPLL 
with DISH and 222 
controls. 
rs1476217 (p=0.03) 
rs3747676 (p=0.01)  
[147] 
Abbreviations: SNP- Single nucleotide polymorphism, Chr: chromosome, p: p-value, Ref: References. 
2.4.3.2 Genetic studies on OPLL 
As in many other diseases, the genetic basis of OPLL is now being uncovered with the 
help of rapidly advancing genome science and technology. The aetiology of OPLL has 
been extensively investigated from many perspectives and despite the existence of 
conflicting results, a great number of genetic variants have been associated with 
susceptibility and severity of OPLL along the years (Table 2-3). 
As with DISH, some of the first genetic studies in OPLL were performed on HLA, and 
this putative association has been extensively discussed in the literature. Koga et al [70] 
in 1998 provided a genetic linkage study of 91 affected sib pairs and they identified a 
predisposition locus for OPLL on 6p, close to the HLA complex. Based on this study 
several other studies were performed in this region [149-151], however the association 
between HLA alleles and OPLL have not been clarified and this association  does not 
appear to imply causation [152].  
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Table 2-3. Genetic variants associated with OPLL. The physiological functions of proteins are also indicated (obtained from GeneCards). 
Gene Chr Physiological function 
Study type 
No Subjects [case/control] 
SNP- significantly associated Ref 
IL-1β 2 
Stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation and 
fibroblast growth factor activity. 
Case-control association study 
[120 (43F) /306 (140F)] (Japanese) 
(Assessed 5 candidate genes; 5 SNPs) 
IL1B AbaI polymorphism (gender specific – female) (p=0.001) 
[153] 
ESR1 6 
Essential for sexual development and reproductive function, but also play a role in tissues such as 
bone. 
ER (XbaI) gender specific (female) (p=0.007) 
Large Scale Case-control study [711/896] (Japanese) 
(Assessed 35 candidate genes; 109 SNPs) 
rs9340799 (p=0.017) no correction 
rs2228480 (p=0.034) no correction 
[154] AHSG 3 
Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows 
affinity for calcium and barium ions. 
rs2077119 (p=0.0011) 
TGFB3 14 Involved in embryogenesis and cell differentiation. 
rs2268624 (p=0.00040 / p=0.044 after Bonferoni Correction) 
rs2284792 (p=0.037) no correction 
ACE 17 Plays a key role in the renin-angiotensin system. 
Case control association study [95/274] (Korean) 
(Assessed I/D polymorphism in ACE) 
rs4646994 
(genotype DD p<0.001; 
D allele p=0.009) 
[155] 
BMP2 
 
20 
 
Induce bone and cartilage formation; member of TGFβ superfamily. 
Case control study [192/304] 
(Assessed 2 SNPs in Exon 3 of BMP2) 
rs3178250 
(p=0.003 gender specific – males) 
[156] 
Case control study  [57/135] 
(Assessed 2 SNPs in exon 2 of BMP2) 
rs2273073 (p<0.001) susceptibility to OPLL 
rs1049007 (p=<0.001) severity of OPLL 
[157] 
Case control study [420/506] 
(Assessed all coding sequencing of BMP2) 
rs2273073( p<0.001) 
rs235768 (p=0.005) 
[158] 
BMP4 14 Induce bone and cartilage formation. 
Nonparametric linkage study with 126 affected sib-pairs using 
microsatellite markers in 88 candidate genes 
Only BMP4 gene reached criteria of suggestive evidence of linkage (NPL=2.23; 
p=0.035) 
[159] 
Case control association study [179/298] (Chinese). 
(Assessed 2 polymorphisms in BMP4) 
rs17563 (genotype: p=0.039; Allele: p=0.014) [160] 
Case control association study (450/550) (Chinese) 
(Assessed complete genomic BMP4 coding) 
rs17563 
rs76335800 
[161] 
BMP9 10 Could be involved in bone formation. 
Case control association study [450/550] (Chinese) 
(Assessed complete genomic BMP9 coding) 
rs75024165 (p<0.001) 
rs34379100  (p<0.001) 
[162] 
COL11A2 6 
Plays an important role in fibrillogenesis. May contribute to the formation of ectopic bone by 
enhancing endochondral ossification. 
Genetic Linkage, association and haplotype analysis study of 
91 affected sib pairs from 53 Japanese families 
Promoter (-182) (p=0.02); rs1799907  (p=0.0004); rs1799910 (p=0.02); 
rs1799911 (p=0.03) Haplotypes 
[70] 
Haplotype association [161/163] 
rs1799907 (p=0.0003) 
(haplotype with 4 SNPs) male association 
[61] 
COL17A1 10 
Plays a role in the integrity of hemidesmosome and the attachment of basal keratinocytes to the 
underlying basement membrane. WES and association studies [28/100] (Chinese) 
rs805698 (p=0.00023) 
rs4918079 (p=0.003) 
[163] 
PTCH1 9 Functions as a tumor supressor. p.P1232L; p.T265S [163] 
COL6A1 21 A cell binding protein and may lead to increased bone mass. 
Genomewide linkage study followed by fine mapping and 
haplotype analysis of 142 affected sib pairs 
intron 32 (-29) (p=0.000003) 
rs2236485 (p=0.0002)(MAF 0.13) 
rs2236486 (P=0.00005)(MAF 0.39) 
rs2236487 (p=0.00006) (MAF 0.37) 
[33, 146] 
Case control association study [90/155] (Chinese) 
Promoter (-572) (p=0.000215) 
Intron 32 (-29) rs2236486 (p=0.00483) 
[33] 
ENPP1 6 Functions in bone mineralization and soft tissue calcification by regulating pyrophosphate levels. 
ttw mouse studies Gly568stop [89] 
Association study [323/332] 
(Assessed all coding sequencing of ENPP1 gene) 
IVS20-11delT (p=0.0029) [164] 
Case-control association study [180/265] IVS15-14T --> C (p<0.0001) [165] 
Association study [95/90] (Chinese) 
(Assessed 4 SNPs in ENPP1) 
C973T (p<0.001) 
IVS15-14T-C (p=0.026) 
[166] 
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Gene Chr Physiological function 
Study type 
No Subjects [case/control] 
SNP - significantly associated Ref 
HLA 6 Involved in the presentation of foreign antigens to the immune system. 
Family based association study with 33 families of patients 
with OPLL 
 [151] 
Family based association study with families of 24 patients 
with OPLL 
 [150] 
IL-15RA 10 Enhance cell proliferation and expression of opoptosis inhibitor. 
A case control study [235/250] (Chinese) rs2228059 [167] 
Association study [166/230] (Korean) rs2228059 [168] 
RUNX2 6 Involved in osteoblastic differentiation and skeletal morphogenesis. 
Case control study (Sequenom system) 
[82/118] (Chinese) 
(Assessed 19 SNPs in 4 candidate genes) 
rs1321075 (p=0.043) 
rs12333172 (p=0.034) 
[35] 
RXRB 6 
A member of retinoid receptor family regulating a wide variety of biological processes including 
development, differentiation, and cellular metabolism. 
Association study and haplotype analysis 
[134/158] (Japanese) 
3’UTR (+140) (p=0.0028) 
3’UTR (+561) (p=0.034) 
[169] 
TGFB1 19 Mediates bone development and metabolism. A case control [46/273] T869-->C [170] 
VDR 12 Plays a central role in calcium homeostasis. Case-control study [63/126] VDR FF genotype [171] 
RSPH9 6 Play a role in the membranous ossification process.  
Genome Wide association study 
[1130/7135] (Japanese) 
followed by an 
Association study (for replication) 
[548/6469] (Japanese) 
 
rs927485 (p=9.4x10 -9) 
[172] 
STK38L 12 Play a role in the membranous ossification process. rs11045000 (p=2.95x10 -11) 
RSPO2 8 
Implicated in the endochondral ossification process. 
rs374810 (p=1.88x10 -13) 
rs13279799 (p=1.28x10 -10) 
CCDC91 12 rs1979679 (p=4.34x10 -12) 
HOA1 20 Implicated in the endochondral ossification process. rs2423294 (p=1.10x10 -13) 
FGFR1 8 
Plays an essential role in the regulation of embryonic development, cell proliferation, differentiation 
and migration. 
Association study [157/222] 
(Assessed 9 SNPs in 3 genes) 
rs13317 (p=0.02) [147] 
BID 22 Has a role in opoptosis signaling. 
Association study [157/209] (Korean) 
(Assessed 2 coding SNPs in BID) 
rs8190315 (p=0.0052) 
rs2072392 (p=0.0052) 
[173] 
TGFBR2 3 Regulate the transcription of a subset of genes related to cell proliferation. Association study [21/42] 
rs11466512  (p=0.007) 
rs56105708 (p=0.024) 
[174] 
VKORC1 16 Involved in vitamin K metabolism. Association study [98/200] (Korean) rs9923231 (p=0.004) (female) [175] 
IFNG 12 It is a potent activator of macrophages. Association study [135/222] 
rs2430561 
rs3138557 
[176] 
Abbreviations: SNP- Single nucleotide polymorphism, NA: Not applicable, Ref: References, ACE: Angiotensin I Converting Enzyme; BMP2: Bone Morphogenetic Protein 2; BMP4: Bone Morphogenetic Protein 4; BMP9: Bone Morphogenetic Protein 9; 
COL11A2: Collagen Type XI Alpha 2; COL17A1: Collagen Type XVII Alpha 1; COL6A1: Collagen Type VI Alpha 1; ENPP1: Ectonucleotide Pyrophosphatase/Phosphodiesterase 1; ESR1: Estrogen Receptor 1; HLA: Human Leukocyte antigen; IL-15RA: 
Interleukin 15 Receptor Alpha; IL-1β: Interleukin 1 Beta; PTCH1: Patched 1; RUNX2: Run-Related Transcription Factor 2; RXRB: Retinoid X Receptor Beta; TGFβ1: Transforming Growth factor Beta 1; TGFβ3: Transforming Growth factor Beta 3; AHSG: 
Alpha 2-Heremans-Schmid glycoprotein; VDR: Vitamin D Receptor; RSPH9: radial spoke head 9 homolog; STK38L: serine/threonine kinase 38 like; RSPO2: R-spontin 2; CCDC91: Coiled-coil domain containing 91 ; HOA1: Hydroxyacid oxidase 1; FGFR1: 
Fibroblast Growth Factor Receptor 1; BID: BH3 Interacting Domain Death Agonist. TGFBR2: Transforming Growth Factor, Beta Receptor II. VKORC1: Vitamin K epoxide reductase complex subunit 1; IFNG: Interferon, Gamma. 
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Along the years several other genes located on chromosome 6 have been investigated. 
COL11A2, located at 6p21.3 was analyzed by Koga et al  [70] for the presence of 
molecular variants associated with OPLL and 4 variants (promoter -182, rs1799907, 
rs1799910 and rs1799911) showed strong statistical association with OPLL (Table 2-3). 
On the other hand, according to Maeda [177] the rs1799907 polymorphism, previously 
associated with OPLL [70], might act as a protective allele in the development of OPLL, 
since the polymorphism is more frequently observed in controls than in OPLL patients. 
Interestingly, the authors found that rs1799907 resulted in altered splicing in the region 
containing exons 6 through 8 with preservation of exon 7. The protective effect is 
proposed to be due to the higher frequency of the rs1799907 allele in white populations, 
in whom a low frequency of OPLL has been reported. Maeda et al [61] in another study 
found a male-specific association of a COL11A2 haplotype with OPLL. Other genes 
located in chromosome 6 such as RXRβ [169], ESR1, RSPH9 and RUNX2 were also 
investigated and in all of them SNPs associated with OPLL were identified (Table 2-3). 
Based on the initial findings, that a nonsense mutation in the Npps gene  
(ENPP1; MIM*173335) in the naturally occurring mutant ttw mouse causes ectopic 
ossification of the spinal ligaments that resembles OPLL [89], several studies have tried 
to associate this gene  to OPLL. ENPP1 is the main enzyme that generates PPi (a known 
inhibitor of calcification), in osteoblasts and chondrocytes, regulating bone mineralization 
by decreasing hydroxyapatite crystal deposition [178]. Nakamura et al [164] in an 
association study found that ENPP1 is involved in OPLL by revealing an allelic 
association with an intron 20 polymorphism (denoted as IVS20-11delT). This 
polymorphism was significantly higher in OPLL patients than in controls, indicating that 
individuals with this variation may be more susceptible to abnormal ossification of the 
spinal ligaments. This variant is considered a risk factor for diabetes mellitus type 2 and 
obesity [179]. In another study the same variant - IVS20-11delT- in ENPP1 and the 
A861G variant of the leptin receptor gene were more frequent in patients with OPLL in 
the thoracic spine relative to those with OPLL restricted to the cervical spine, leading the 
authors to suggest that both variants are associated with more extensive OPLL, but not 
with the frequency with which it occurs [180]. Other studies, however, reported that 
IVS20-11delT was unassociated with OPLL [154, 165] and other associated variants such 
as IVS15-14T [165] was associated with susceptibility and severity of OPLL. Other 
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authors showed that the polymorphism TT genotype of C973T and IVS15-14T in the 
same gene were associated with more severe disease [166].  
In addition, COL11A2, COL6A1 that map to chromosome 21 and COL17A1 that maps to 
chromosome 10 have also been studied in OPLL susceptibility. The COL6A1 gene [33, 
146, 181], is strongly associated with OPLL and polymorphisms of this gene are 
considered helpful markers of OPLL disease. However, this association has not been 
confirmed by some authors [35, 72, 159]. Polymorphisms of this gene are also related to 
DISH in a Japanese population [34] and this suggests that COL6A1 may not only play a 
role in OPLL, but in pathological ectopic ossification in general. A whole exome 
sequencing study revealed that COL17A1 was associated with OPLL and two SNPs in 
this gene rs805698 and rs4918079 were significantly associated with OPLL [163]. 
Bone morphogenic proteins (BMP2, BMP4 and BMP9) and TGFβ superfamily proteins 
also play a role in OPLL pathogenesis. A positive association to OPLL was found with 
the following SNPs: rs3178250 [156], rs2273073 [157, 158] and rs1949007 [157] in the 
BMP2 gene. Furthermore Yan in 2013 [158], showed that the rs2273073 variant in the 
BMP2 gene was positively associated with the level of Smad4 protein expression and the 
activity of alkaline phosphatase. Activation of Smads causes their translocation from the 
cell cytoplasm to the nucleus where they control gene expression [182], and alkaline 
phosphatase is the first functional gene expressed in the process of calcification and is 
secreted by osteoblasts in the process of osteogenic differentiation [183]. On the other 
hand, Kim et al [72] showed that SNPs rs2273073 and rs1949007 in BMP2 gene may not 
influence the OPLL in Korean patients. Other study elaborated by Liu et al [35] also 
failed to show the association of BMP2 gene to OPLL in the Chinese Han population.  
The BMP4 protein is another candidate gene for OPLL and two SNPs rs17563 [160, 161], 
rs76335800 and a specific haplotype, TGGGCTT [161], were demonstrated to contribute 
to the risk of developing OPLL in a Chinese population. The association of BMP-4 with 
OPLL was also confirmed by Furushima et al [159] in a large scale screening study for 
candidate genes in OPLL, in which only the BMP-4 gene reached the criteria for 
suggestive evidence of linkage. In the BMP9 gene two SNPs have been associated with 
OPLL: rs75024165 and rs34379100 [162]. 
Another interesting gene with conflicting results is TGFβ1, that, according to Kamiya et 
al [170], is  genetically determinant in predisposition for the condition (869T>C; 
rs1982073 ). However Han et al [184] showed that the SNP previously associated with 
OPLL (869T>C; rs1982073) and  the promoter (-509C>T; rs1800469) were not 
  Chapter II 
 
27 
 
associated with OPLL in a Korean population. Similarly, in one study that assessed 109 
polymorphisms of 35 candidate genes in 711 patients with OPLL and 896 controls failed 
to confirm the positive association of OPLL with TGFβ1 gene. Interestingly, in the 
ossified matrix and chondrocytes of adjacent cartilaginous areas of OPLL, TGF-beta1 is 
overexpressed, and one study examined if there is an association between the SNP 
869T>C; rs1982073 and the radiological appearance of OPLL. Although a T-C transition 
in TGF-beta1 did not predict a difference in the radiographic appearance of the ossified 
segment of posterior longitudinal ligament, it was associated with the location of OPLL 
within the spinal column. According to the authors TGFβ1 polymorphisms are not related 
to the onset of OPLL, but rather to the area of the ossified lesion. The "C" allele might be 
a risk factor for patients with OPLL in other areas in addition to the cervical lesion [185]. 
Association of TGFβ3, which plays an important role in regulating chondrogenic 
differentiation of mesenchymal stem cells in humans [186] has also been described [154] 
and an intronic SNP rs2268624 has a significant association with OPLL. 
Other genes from large scale studies have recently emerged as promising targets for 
future investigation, including AHSG, STK38L, RSPO2, CCDC91 and HOA1. In a 
Genome wide linkage study [187] with 214 affected sib-pairs the D20S894 marker on 
chromosome 20p12 was associated with OPLL. The linkage region contained 25 known 
genes and two genes located in this linkage region may be good candidate genes for 
OPLL, one example is Jagged 1 (JAG1) because of its potential involvement in the 
endochondral bone formation [188] and BMP2 already studied and an already established 
important regulator of bone metabolism. Very recently 8 potentially pathogenic missense 
variants in 4 genes, including 3 in COL6A1, 2 in COL11A2, 2 in FGFR1 and 1 in BMP-2 
were identified in a target exome sequencing study with 11 OPLL candidate genes using 
55 Chinese patients with OPLL [181]. Although the authors suggested that these missense 
variants were involved in pathogenicity of OPLL, further confirmation is required. 
A large number of genes have already been associated with OPLL, nonetheless it is 
probable that many other potential genes are involved in inheritance of the disease. OPLL 
does not appear to follow a simple, single gene Mendelian inheritance pattern and it is 
most likely multifactorial and develops in individuals with a genetic predisposition due to 
a variety of different mutations in various genes on various chromosomes. 
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2.4.4 Genetic studies on OLF 
As far as we known, there are few studies in the literature that investigate a disease 
causing gene in OLF. Kong and collaborators [33] investigated the frequency of 4 SNPs 
in COL6A1 gene, a well-known OPLL susceptibility gene for OLF and OPLL, in 183 
patients (61 with OLF) and 155 controls and suggest that  COL6A1 may be a common 
susceptibility gene for OLF in Chinese population (Table 2-4). Another study [35] 
investigates the possible association of four genes, that may be related to ossification of 
spinal ligaments (RUNX2; BMP2; COL6A1 and VDR), and the authors found that RUNX2 
(rs1321075 and rs12333172 polymorphisms) could be responsible for ectopic bone 
formation in the spinal ligament in a Chinese population. Jun et all [147] investigated the 
association between FGF2 (Fibroblast Growth Factor), FGFR1 (Fibroblast Growth Factor 
Receptor 1) and FGFR2 (Fibroblast Growth Factor Receptor 2) polymorphisms with OLF 
and OPLL and found a positive association of the SNP rs1476217 in FGF2 gene (Table 
2-4). 
 
Table 2-4. Genetic variants associated with OLF. 
Gene Chr Physiological function 
Study type 
No Subjects 
[case/control] 
SNP- 
significantly 
associated 
Ref 
COL6A1 21 
Collagen VI is a major structural component 
of microfibrils. Mutations in the genes that 
code for the collagen VI subunits result in the 
autosomal dominant disorder, Bethlem 
myopathy. 
Case control association 
study with 61 OLF 
patients and 155 Chinese 
controls. Assessed 4 
SNPs in COL6A1 
rs17551710 
(p=0.0005) 
[33] 
RUNX2 6 
RUNX2 is a transcription factor that encodes 
a nuclear protein with a Runt DNA-binding 
domain. This protein is essential for 
osteoblastic differentiation and skeletal 
morphogenesis and acts as a scaffold for 
nucleic acids and regulatory factors involved 
in skeletal gene expression. Mutations in this 
gene have been associated with the bone 
development disorder cleidocranial dysplasia. 
Case control association 
study with 36 Chinese 
patients (12 with OLF 
and 22 with OLF and 
OPLL) and 118 controls 
rs1321075 
(p=0.034) 
rs12333172 
(p=0.043) 
[35] 
FGF2 4 
The protein encoded by this gene is a member 
of the FGF family. This protein has been 
implicated in diverse biological processes, 
including limb and nervous system 
development. 
Case control association 
study of 157 OPLL 
patients (29 with OLF) 
and 222 controls 
rs1476217 
(p=0.01) 
[147] 
Abbreviations: SNP: Single nucleotide polymorphism, Chr: chromosome, p: p-value, Ref: references, 
COL6A1: Collagen Type VI Alpha 1 Chain, FGF2: fibroblast growth factor 2, RUNX2: Runt-related 
transcription factor 2. 
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2.5 Association with other diseases 
 
The presence of OSL has been reported in association with numerous disorders of 
different etiologies. 
2.5.1 Monogenic disorders 
Case reports of patients with monogenic metabolic disorders with co-occurrence of both 
DISH and OPLL have been reported in literature (Table 2-5). All of the disorders 
presented in table 2-5 are directly involved in calcium and phosphate homeostasis, with 
the exception of alkaptonuria, a disorder of tyrosine metabolism characterized by the 
accumulation of homogentisic acid, ochronosis, and destruction of connective tissue 
resulting in degenerative spondylosis and arthritis [189]. In ochronosis, calcification of 
intervertebral disks due to calcium hydroxyapatite and marked sclerosis including 
sacroiliac joint can also be observed. Genes involved in Hypophosphatemic rickets and 
Hypophosphatasia are, as expected, directly involved in phosphate homeostasis. 
Analysing the genes present in table 2-5 the FGF23 gene inhibits phosphate uptake and 
mineralization in vivo by suppressing expression of type IIc (SLC34A1) 
sodium/phosphate cotransporters in the brush border membranes of proximal tubes  [190]. 
SLC34A1 contributes to the maintenance of inorganic phosphate concentration in the 
kidney [191]. DMP1 gene encodes the Dentin matrix acidic phosphoprotein 1, which 
plays a role in controlling osteocyte formation and phosphate homeostasis [192]. 
Proteolytic degradation of DMP1 leads to the release of the “Acidic serine- and aspartate-
rich MEPE-associated motif” (ASARM) peptides, which are potent inhibitors of 
mineralization (minhibins) [193]. The ASARM peptide inhibits mineralization directly by 
binding to hydroxyapatite crystals and decreasing expression of PHEX, whereas 
phosphaturic effects are mediated by renal accumulation of ASARM peptides and 
inhibition of Pi reabsorption. PHEX, a Type II, zinc dependent, transmembrane 
endopeptidase is involved in bone and dentin mineralization as well as in renal phosphate 
reabsorption [14]. CLCN5 is a renal chloride channel gene highly expressed in proximal 
tubules of the kidney that play an important role in renal tubular function [194]. 
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Table 2-5. Monogenic disorders previously associated with OSL, type of inheritance, 
number of Mendelian Inheritance in Man database (MIM) and gene involved. Lack of 
inheritance means that it is unknown. 
Disorder Inheritance OMIM Gene/Locus Involved Ref 
Hypophosphatemic rickets/osteomalacia 
AD 193100 FGF23 
[195] 
AR 241520 DMP1 
AR 613312 ENPP1 
AR 241530 SLC34A3 
XLD 307800 PHEX 
XLR 300554 CLCN5 
Hypophosphatasia 
AR 241500 
ALPL [196] AR 241510 
AR, AD 146300 
Pseudohypoparathyroidism AD 103580 GNAS1 [197] 
Hypoparathyroidism 
AD 146200 GCM2 
[198-200] 
AD/AR 146200 PTH 
Alkaptonuria AR 203500 HGD [201] 
Acromegaly 
Somatic /AD 102200 AIP 
[202] 
 102200 GNAS1 
X linked 300943 GPR101 
AD 610755 CDKN1B 
AD 131100 MEN1 
Somatic 174800 GNAS 
AD 160980 PRKAR1A 
Familial Hypocalciuric Hypercalcemia 
AD 145980 CASR 
[203] AD 145981 GNA11 
AD 600740 AP2S1 
Abbreviations: AD - Autosomal Dominant, AR - Autosomal Recessive, XLD - X-linked Dominant and 
XLR X-linked Recessive, Ref: References, ALPL: Alkaline Phosphatase, Liver/Bone/Kidney, FGF23: 
Fibroblast growth factor 23, DMP1: Dentin matrix acidic phosphoprotein 1, ENPP1: ectonucleotide 
pyrophosphatase/phosphodiesterase 1, SLC34A3: Solute carrier family 34 member 3, PHEX: Phosphate 
regulating endopeptidase homolog, X-linked, CLCN5: Chloride voltage-gated channel 5, GNAS1: Guanine 
nucleotide binding protein, alpha stimulating, GCM2: Glial cells missing Homolog 2, PTH: Parathyroid 
hormone, HGD: Homogentisate 1,2-Dioxygenase, AIP: Aryl hydrocarbon receptor-interacting protein, 
GPR101: G protein-coupled receptor 101, CDKN1β: Cyclin-dependent kinase inhibitor 1β, MEN1: Menin 
1, PRKAR1A: Protein Kinase CAMP-Dependent Type I Regulatory Subunit Alpha, CASR: calcium-sensing 
receptor, GNA11: G Protein Subunit Alpha 11, AP2S1: Adaptor Related Protein Complex 2 Sigma 1 
Subunit. 
 
Alkaline phosphatase (ALPL) is present in matrix vesicles and has the ability to hydrolyze 
PPi, playing a role in bone mineralization. In hypophosphatasia the ALPL mutations 
leading to deficient activity of the tissue-non-specific alkaline phosphatase isozyme 
(TNAP), an enzyme which converts the inhibitor (PPi) into a promoter of mineralization 
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(Pi) [183]. Lastly, but not least is ENPP1 gene, which has been already mentioned 
previously. It is particularly interesting to see that the only report of an OPLL patient with 
hypophosphatemic rickets is caused by a novel homozygous mutation in the ENPP1 gene 
[195]. However, not all patient cases of Hypophosphatemic Rickets caused by mutations 
in ENPP1 present OPLL. 
Hypoparathyroidism cases associated with changes resembling DISH are reported in the 
literature [198-200]. The genes involved in Hypoparathyroidism GNAS, GCM2 and PTH 
are also involved in both calcium and phosphate metabolism. GNAS (GNAS Complex 
Locus) play a role in signaling pathways that regulate osteogenesis, normally preventing 
ectopic ossification in tissues where bone should not form [204]. GNAS mutations have 
been associated with several other disorders, including Progressive Osseous Heteroplasia 
(POH; MIM#166350). GCM2 (Glial Cells Missing Homolog 2) gene encodes a protein 
that possibly is involved in a backup endocrine mechanism for the regulation of calcium 
homeostasis in the absence of parathyroid glands [205]. The PTH gene encodes 
parathyroid hormone that is secreted when calcium levels drop and causes increased 
calcium absorption through the gut, and kidney and provokes an increase in bone 
resorption through direct and indirect processes. It is an essential hormone in bone 
homeostasis [206].  
Acromegaly is a rare condition characterized by excess growth hormone (GH) production 
by the pituitary gland and its principle mediator insulin-like growth factor 1 (IGF-1) 
[207]. Familial syndromes associated with GH hypersecretion can be seen in table 2-5. 
Excess GH and IGF-1 cause proliferation of articular chondrocytes and increased matrix 
production [208]. It is known that GH levels may act as a bone promoting factor in DISH 
[209].  
There is only one case report of a patient with Familial Hypocalciuric Hypercalcemia 
(FHH), a rare and benign cause of lifelong hypercalcemia, and DISH.  This particular 
case, a 45-year-old diabetic woman with hypercalcemia secondary to FHH, developed 
dysphagia because of external esophageal compression of DISH [210]. A causal 
association between FHH and DISH is not yet proven. 
2.5.2 Complex disorders 
Some authors suggest that DISH, instead of a disorder by itself is only a clinical 
expression of metabolic disorders being angiogenesis the link leading to new bone 
formation [211]. The aetiology of the following associated OSL disorders is complex and 
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determined by the interplay of genetic and environmental factors. Environmental factors 
such as age, smoking, alcohol, diet, and physical inactivity may directly influence Type 2 
Diabetes mellitus (T2D), metabolic syndrome and obesity. Nevertheless, although 
heterogeneous, there are some monogenic forms of these disorders; see table 2-6 for more 
details.   
Table 2-6. Complex disorders previously associated with OSL. Lack of inheritance means 
that it is not yet known. 
Disorder Type Inheritance OMIM Gene/Locus Involved Ref 
 
Non-insulin-dependent 
Type 2 Diabetes mellitus 
 
Monogenic 
- MODY 
 
AD 
 
606391 
Genetically Heterogeneous – 
associated with mutations in 13 
genes 
[212, 213] 
 
Polygenic 
? 
 
125853 
Many susceptibility locus 
identified, including in ENPP1 
Abdominal Obesity - 
Metabolic Syndrome 
Monogenic 
? 615812 DYRK1β 
[214] 
AR 200100 MTP 
 
Polygenic 
? 
 
605552 
AOMS1 locus 
AOMS2 locus 
 
 
Obesity 
 
 
Monogenic 
AR 614962 LEP 
[215] 
AR 614963 LEPR 
AR 600955 PCSK1 
AR 609734 POMC 
 
Polygenic 
? 601665 
Genetically heterogeneous but 
including ENPP1 as 
susceptibility gene 
Abbreviations: OMIM: Online Mendelian Inheritance in man, MODY: Maturity-Onset Diabetes of the 
Young, AD: Autosomal Dominant, AR: Autosomal Recessive, Ref: References, ENPP1: ectonucleotide 
pyrophosphatase/phosphodiesterase 1, DYRK1B: Dual specificity Tyrosine Phosphorylation regulated 
kinase 1β, MTP: Microsomal triglyceride transfer protein, AOMS1,2: Abdominal obesity-metabolic 
syndrome 1,2, LEP: Leptin, LEPR: Leptin receptor, PCSK1: Proprotein convertase subtilisin/kexin 1, 
POMC: Pro-opiomelanocortin. 
 
Diabetes mellitus is considered to be a heterogeneous group of disorders, which are 
characterized by persistent hyperglycemia. There are rare forms of diabetes that are 
monogenic, as is the case of maturity onset diabetes in the young (MODY; 606391), 
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however the two most common forms of diabetes are T1D, also known as insulin-
dependent diabetes and T2D, known as non-insulin-dependent diabetes. Both T1D and 
T2D are polygenic, caused by a combination of genetic and environmental risk factors. 
Individuals with T2D usually have a tendency for having obesity and manifestations of 
the metabolic syndrome, which is characterized by diabetes, insulin resistance, 
hypertension, and hypertriglyceridemia [216]. T2D can be associated with OSL by either 
hyperglycemia or by the high insulin rate [217]. Studies already performed are not 
conclusive. Although obesity is considered to be a complex and multifactorial disease, 
there are some monogenic cases described as rare and severe early-onset obesity 
associated with endocrine disorders. The phenotype, in monogenic cases, is due to 
mutations in genes of the leptin/melanocortin axis involved in food uptake regulation - 
genes of leptin ( LEP) and its receptor ( LEPR), Pro-opiomelanocortin ( POMC) and 
proprotein convertase subtilisin/kexin 1 ( PCSK1) [218]. Mutations in the LEPR gene, 
occurs in the ZFR rat model and can cause obesity, hyperinsulinemia, 
hypercholesterolemia and hyperlipidemia besides the ossification of spinal ligaments, 
resembling human OPLL [42]. It is also relevant to see ENPP1 as a susceptibility gene 
for both T2D [219] and obesity [220].   
2.5.3 Rheumatic disorders co-existing with OSL 
The co-existence of DISH with rheumatic disorders has been described since its first 
report by Forestier and Rotes Querol, in 1950 [221] and a high percentage of DISH cases 
are complicated by OPLL [6] suggesting that they share common aetiopathogenic factors. 
Simultaneous OPLL and OLF are also very common in the literature [222, 223]. 
Additionally, the co-existence of the three OSL disorders – DISH; OPLL and OLF has 
also been reported [32].  
The genetic basis of coexistent rheumatic conditions with OSL can be seen in table 2-7. 
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Table 2-7. Rheumatic disorders previously seen coexisting with OSL. Lack of inheritance 
means that it is not yet known. 
Disorder Inheritance OMIM Gene/Locus Involved Ref 
Ankylosing 
Spondylitis (AS) 
Multifactorial 106300 HLA-B  
AD 183840 SPDA2 locus  
 613238 SPDA3 locus  
Chondrocalcinosis 
AD 118600 ANKH 
[224, 225] 
AD 600668 CCAL1 locus 
Rheumatoid arthritis 
? 180300 6q23 (HLA) 
[22, 226-228] 
? 604302 IL6/MIF 
Gout 
AD;AR 612076 SLC2A9 
[22, 67, 229, 
230] 
AD 612671 SLC17A3 
AD? 138900 ABCG2 
Osteoarthritis 
Multifactorial 165720 FRZB 
[22] 
AD 140600 
MATN3 (with Heberden 
Nodes) 
AD 607850 ASPN 
? 612400 GDF5 
AD 604864 COL2A1 
? 610839 2q33.3 
? 612401 3p24.3 
Paget’s Disease 
AD 602080 TNFRSF11A 
[224, 225] 
AD 167250 SQSTM1 
AD 606263 PDB4 
AR 239000 TNFRSF11B 
AD 616833 ZNF687 
Abbreviations: AD: Autosomal Dominant, AR: Autosomal Recessive, Ref: References, ?: unknown, HLA-
B:  Human Leukocyte antigen B, SPDA2,3: Spondyloarthropathy, Susceptibility To, 2,3, ANKH:  
progressive ankyloses protein homolog, CCAL1: Chondrocalcinosis 1, IL-6- Interleukin-6, MIF: 
Macrophage inhibitory factor, SLC2A9- Solute carrier family 2 member 9, SLC17A3- Solute carrier family 
17 member 3, ABCG2: ATP Binding Cassette Subfamily G Member 2, FRZB- Frizzled-related protein 1, 
MATN3: Matrilin-3, ASPN- Asporin, GDF5- Growth/differentiation factor 5, COL2A1- Collagen Type II 
Alpha 1 Chain, TNFRSF11A, B: TNF Receptor Superfamily Member 11a,b, SQSTM1: Sequestosome-1, 
PDB4: Paget disease of bone 4, ZNF687- Zinc Finger Protein 687. 
 
The co-existence of DISH and AS is possible and has been thoroughly described in more 
recent years  due to the difficulty, sometimes, to distinguish them apart [7-21]. OPLL has 
also been reported in patients with AS but it was determined that OPLL in AS was 
associated with older age [231]. AS is a chronic, multisystem inflammatory disorder 
characterized by inflammation and ankylosis of the sacroiliac joints and the axial 
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skeleton. Structural damage in AS is dominated by new bone formation that can result in 
spinal fusion and marked functional limitation. In Online Mendelian Inheritance in Man 
database (OMIM), which collects known genetic lesions responsible for human inherited 
diseases, the following principal loci of AS susceptibility are mentioned: HLA-B locus 
(SPDA1; MIM106300), 9q31-q34 (SPDA2; MIM 183840) and 2q (SPDA3; MIM 
613238) (Table 2-7), however more than 100 genetic influences are reported in the 
literature [232] [233, 234], although many of them are pending confirmation. It is known 
that AS is a polygenic disorder and its heritability is estimated to be more than 90% and 
the MHC-1 region, particularly the HLA-B*27, is the main contributor for this proportion 
[235, 236], followed by a second gene definitively associated with AS, the ERAP1. Both 
contribute to MHC1 antigen processing pathway, and the role played by HLA-B27 in AS 
pathogenesis could be explained by the association between both, and actually this 
association is considered the two most powerful disease risk factors to AS. ERAP1 plays 
a role in trimming peptides within endoplasmic reticulum (ER) into the right length 
binding to MHC-I molecules, and so abnormal function of ERAP1 can lead to generation 
of abnormal peptides of incorrect length and sequence, which subsequent to HLA-B27 
binding can lead to peptide-HLA-B27 complex misfolding. These misfolded proteins 
could either accumulate within ER, thus contributing to the ER stress, or be transported to 
the cell surface as a free heavy chain. This mechanism seems to have a role in AS 
pathogenesis, but the degree of this contribution to the overall pathogenesis of AS 
remains hypothetical. The association of ERAP1 is restricted to HLA-B27 positive cases 
or HLA-B27 negative/HLA-B40 positive cases [232, 237, 238]. Several gain of function 
variants are reported as associated with AS and loss of function as protective to AS [239, 
240]. In SPDA3 locus the IL-1 gene seems to be associated with AS [241]. Another 
genetic contribution is the involvement of interleukin IL-23/IL-17 pathway, that has been 
shown to have significance in the pathogenesis of AS. The IL-23 drives the differentiation 
of CD4-positive Th17 cells, which produce IL-17. Il-17 in turn facilitate the production of 
IL-6, IL-8, TNF, chemokines, matrix metalloproteinases, and receptor activator of nuclear 
factor kβ ligant from a wide range of cell types [242]. Based on genome wide association 
and linkage studies several risk genes involved in ectopic calcification in AS were 
reported in the literature. The ANTXR2 (Anthrax toxin-receptor 2), was identified as one 
of the risk loci for AS [243]. This gene potentially affects new bone formation as it can 
interact with LRP6 protein, an important surface receptor in the Wnt/β-catenin pathway. 
In Han Chinese population the ANTXR2 gene is not associated with AS [244]. Other two 
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risks loci that seems to be relevant to bone formation in AS were also reported in the 
literature, the HAPLN1-EDIL3 at 5q14.3 and ANO6 at 12q12.1 [244]. HAPLN1 is 
involved in osteophyte formation and disc generation in Japanese women with spinal 
osteoarthritis [245], and EDIL3 has an inhibitory effect on WNT/β.catenin signaling 
[246]. The ANO6 gene controls bone mineralization by activating the calcium transporter 
NCX1. In mice, the lack of Ano6 is responsible to bone mineralization defects [247]. 
Another relevant gene in mineralization is ANKH (human homolog of progressive 
ankyloses), a gene that is also reported as associated with AS. Curiously this association 
is gender specific, in other words some SNPs of the ANKH gene are significantly 
associated with AS in men and other SNPs are present in females [248]. ANKH protein 
regulates PPi export from the cells. It is well known that abnormal PPi levels can be 
associated with aberrant bone formation and in the mutant mice (ank/ank), which have a 
premature stop codon in the 3' end of the ank gene, severe ankylosis occurs [106].  
The co-coexistence of some form of spinal ossification with chondrocalcinosis are 
reported in the literature [25, 26], suggesting that a genetic link exists between these 
diseases. The first evidence of a genetic link between OPLL and chondrocalcinosis was 
identified in the ttw mouse a model for OPLL which develops spinal ossification and 
hydroxyapatite arthropathy. Npps, also designated as PC-1, is the mutant gene that causes 
this mouse phenotype. In humans this gene, designated ENPP1, plays a role in regulating 
PPi levels thus regulating bone mineralization and soft tissue calcification [249]. Variants 
in ENPP1 are associated with GACI, diabetes (125853), obesity (601665) [250] and other 
diseases. The possible association of the ENPP1 gene with OPLL is not yet proven 
however several studies confirm a positive association (Table 2-3), the association with 
CC is considered a minor determinant for the disease [251, 252]. DISH and CC is very 
common in Terceira Island and this has led to the suggestion that both diseases share the 
same pathogenic mechanism [24]. The coexistence of CC and AS is also reported [253] 
and CC has also been associated with Gitelman syndrome (GS), a kidney disorder that 
causes an imbalance of potassium, magnesium and calcium ions, possibly due to their 
association with chronic hypomagnesaemia [254]. CC, also known as calcium 
pyrophosphate dehydrate (CPPD) disease, pseudogout or pyrophosphate arthropathy 
[255] is a disorder of ectopic calcification characterized by the deposition of calcium 
containing crystals in articular cartilage, synovial membranes and sometimes in 
periarticular soft tissues. The deposited salts are composed of CPPD although other 
calcium salts can also be found including hydroxyapatite [256]. In some cases, the 
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deposition of calcium crystals - hydroxyapatite or CPPD- can also occur in the spinal 
ligaments [257, 258], but it is usually difficult to distinguish from ossification [46]. The 
physicochemical mechanisms that cause this deposition are still unknown, but disordered 
PPi metabolism is suspected. The deposited crystal may be calcium hydroxyapatite (in 
which the local PPi concentration is presumed to be low) or CPPD (when PPi is high) 
[255]. In addition to the sporadic form, chondrocalcinosis a  hereditary form also occurs 
and it may also be associated with metabolic disorders - hyperparathyroidism [259], 
hemochromatosis [260], and hypomagnesemia [261]. In 1963, Zitnan and Sitaj [262], 
reported a hereditary form of “chondrocalcinosis articularis” in seven Czechoslovakian 
kindreds. Since then, familial aggregation has been reported in different ethnic groups 
most of them showing an autosomal dominant inheritance [25, 263-265]. Genetic linkage 
studies have mapped the familial forms of CC to two particular chromosome regions, 
CCAL1 (MIM 600668) on chromosome 8 [266] and CCAL2 (MIM 118600) on 
chromosome 5 [267]. The later contains the human homologue (ANKH) of the murine ank 
gene which is expressed in cartilage and other tissues and is associated with CC and 
spinal and peripheral joint ankylosis in the ank/ank mouse [106]. The ANKH gene maps 
to chromosome 5 (5p15.1) and encodes a transmembrane inorganic pyrophosphate 
transporter ANK that transports intracellular pyrophosphate into the extracellular matrix, 
where it acts as a potent inhibitor of mineralization [108]. Analysis of this gene has 
identified a variety of mutations that segregate with the CC phenotype  [110] [268] [29] 
[30] [31]. These mutations enhance ANK protein activity, thereby elevating extracellular 
pyrophosphate levels and promoting the formation of pyrophosphate crystals, which 
produce the manifestations of the disease [269]. For the moment, ANKH (CCAL2) is the 
only monogenic cause identified for CC. In humans, dysfunction of the ANKH gene also 
causes autosomal dominant craniometaphyseal dysplasia (OMIM #123000) [109]. The 
disease-causing gene in CCAL1 has never been identified but there is a strong possibility 
that this gene is primarily related to osteoarthritis (OA) and that the CPPD deposition is 
secondarily, enhanced by the degenerative changes in cartilage [266].  
The coexistence of Rheumatoid arthritis (RA) with DISH, OPLL and OLF is mentioned 
in the literature. RA is an inflammatory disease, primarily of the joints, with autoimmune 
features and a complex genetic component involving many different pathways within the 
innate and the adaptative immune system [270]. Among the genetic components, genes in 
the MHC region on chromosome 6 are widely acknowledged as major players in RA. 
MIF (Macrophage migration inhibitory factor) gene also seems to play a role in RA 
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pathogenesis, the gene encodes a lymphokine involved in cell-mediated immunity, 
immunoregulation, and inflammation. Other genes that are involved in the disease is 
Interleukin-6 (IL-6) which encodes a cytokine that functions in inflammation and the 
maturation of B cells. 
Gout is a form of arthritis caused by impaired urate metabolism, leading to high serum 
urate levels (hyperuricemia) and accumulation of sodium urate crystals in the joints. 
At least three genes are associated with gout - SLC17A3, SLC2A9 and ABCG2 - all of 
them correspond to urate transporters located in the epithelial cells of renal proximal 
tubules (Table 2-7). The genes most strongly linked to gout corresponds to the solute 
carrier 2A9 (SLC2A9), also known as glucose transporter 9 (GLUT9). This transporter 
was initially identified as a glucose/fructose transporter [271], however it is also a high-
affinity urate transporter and functions in renal urate reabsorption. The second locus 
linked to gout corresponds to the gene encoding the solute carrier 17A3 (SLC17A3), also 
known as the renal sodium phosphate transport protein 3 (NPT3), that excretes 
intracellular urate and organic anions. Mutations in the SLC17A3 gene caused reduced 
urate efflux compared to the wildtype when expressed in xenopus oocytes [273].The last 
gene linked to gout corresponds to ABCG2, a gene which encodes a multidrug resistance 
transporter belonging to the ATP-binding cassette (ABC) superfamily. It has recently 
been discovered that this transporter is also involved in renal urate elimination, and the 
presence of a specific polymorphism (Q141K) induces a decrease in urate efflux [274, 
275]. 
Osteoarthritis (OA) is a degenerative disease of the joints characterized by loss and/or 
remodeling of joint synovium, cartilage, and bone. The sites most frequently affected are 
knee, hip, feet and hands, although involvement of lumbar and cervical spine, elbows, 
wrists and other joints can also occur  [276, 277]. According to the OMIM database, 
osteoarthritis susceptibility (OS) has been associated with several regions/genes: FRZB 
(OS1; 165720), MATN3 (OS2; 140600), ASPN (OS3; 607850), region 2q33 (OS4; 
610839), GDF5 (OS5; 612400) and region 3p24 (OS6; 612401). Another susceptibility 
gene for osteoarthritis (with chondrodysplasia) (304864) is the COL2A1 gene (Table 2-7). 
Particularly, FRZB (Frizzled-Related protein 1) gene encodes a secreted protein 
antagonist of wingless (WNT) signaling involved in the regulation of bone development. 
It is known that functional polymorphisms within FRZB causes susceptibility for hip OA 
in females [278], implicating the WNT signaling pathway in the pathogenesis of this 
disease. The MATN3 (Matrilin 3) gene encodes a protein present in the cartilage 
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extracellular matrix and has a role in the development and homeostasis of cartilage and 
bone [279]. This gene has recently been shown to bind cartilage extracellular matrix 
proteins, including collagen types II and IX [280], and promotes chondrogenesis through 
an interleukin-1 receptor antagonist-dependent mechanism [280, 281]. Variants in this 
gene result in hand osteoarthritis [277, 282] and other skeletal diseases, including 
multiple epiphyseal dysplasia, which is characterized by abnormal ossification in the 
growth plate and early onset OA [283]. ASPN is another osteoarthritis susceptibility gene, 
which encodes asporin, a cartilage extracellular protein that regulates chondrogenesis by 
inhibiting transforming growth factor-beta 1-induced gene expression in cartilage. In 
addition, this protein also binds calcium and collagen and may induce collagen 
mineralization. Polymorphisms in this gene are associated with knee osteoarthritis 
susceptibility [284, 285]. Associations between this gene and lumbar disk degeneration 
[286] and AS are also reported [287]. The GDF5 (Growth Differentiation Factor 5) gene 
is a member of the TGF-β/BMP superfamily which is involved in bone and cartilage 
formation by inducing chondroblastic and osteoblastic differentiation and the formation 
of joints [288, 289]. Mutations in this gene seems to be involved in hip and knee OA 
progression [290] and other skeletal disorders, such as Acromesomelic dysplasia 
(AMDH; MIM #201250) [291], Chondrodysplasia (MIM; 200700) [292], among others. 
The other gene associated with OA is COL2A1 (Collagen Type II Alpha 1 Chain) which 
encodes Type II collagen, the major collagen synthesized by chondrocytes.  Besides the 
association of Osteoarthritis with mild chondrodysplasia (604864) [289, 293], this gene is 
also associated with achondrogenesis (MIM; 200610), Spondyloperipheral dysplasia 
(MIM; 271700), and other diseases. Lastly but not least, two candidate genes for 
osteoarthritis susceptibility were found in the region 2q33.3, the Parathyroid Hormone 2 
Receptor (PTHR2) and Frizzled Class Receptor 5 (FZD5), however only a missense 
variant in the  PTHR2 gene co-segregate with the disease [294]. For the region 3p24.3, 
several variants in collagen Type VI, alpha-4, pseudogene 1 (COL6A4P1 or DVWA) seem 
to contribute strongly to knee osteoarthritis susceptibility [295] and a functional role in 
cartilage has been suggested despite its pseudogene status [296]. 
Paget's disease (PD) is a metabolic bone disease characterized by an imbalance between 
osteoclast and osteoblast activity that typically begins with excessive bone resorption 
followed by an increase in bone formation [297]. It has a predilection for the axial 
skeleton but any bone may be affected [298]. Several susceptibility genes for PD have 
been identified (Table 2-7). The gene most frequent linked to PD is SQSTM1 which 
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encodes sequestosome 1 a multifunctional protein involved in the IL-1, TNF, and 
RANKL signaling pathways [297]. 
TNFRSF11A (TNF Receptor Superfamily Member 11a) and TNFRSF11B are genes 
which encodes the RANK protein and osteoprotegerin (OPG), respectively. Both RANK 
and OPG are involved in the RANKL/OPG/RANK signaling pathway, which is the 
principal regulator of osteoclastogenesis [299]. The TNFRSF11A gene is not only 
associated with PD, but also with familial expansile osteolysis (174810) and osteopetrosis 
(612301) and the TNFRSF11B gene could also be associated with bone mineral density 
and osteoporosis [300] and a gain of function mutation in this gene causes osteoarthritis 
with chondrocalcinosis [301]. The ZNF687 gene was recently found in a whole exome 
sequencing study as associated with PD [302]. There is not much information about this 
gene, however it is known that it encodes a C2H2 (Cys2His2-like) zinc finger protein 
involved in the transcriptional regulator complex Z3 [303]. It has been suggested that 
probably this zinc finger protein is involved in bone cell proliferation and differentiation 
since it is up-regulated during osteoblast and osteoclast differentiation and is highly 
expressed during the regeneration of caudal fins in zebrafish [302]. Lastly, a linkage to 
the 5q31 region, designated by PD bone 4 (PDB4), seems to be associated with PD, 
however no candidate gene has been found in this region yet. 
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3. MATERIAL AND METHODS 
3.1 Collections- patients/families and associated data 
The biobank Azores (AZORBIO) of the Specialized Service of Epidemiology and 
Molecular Biology (SEEBMO) has a collection of biological material (DNA; RNA; 
cartilage; plasma; serum; cell lines and urine) and associated data (clinical; 
epidemiological and genetic data) of Azorean patients with different pathologies. 
AZORBIO was founded in 1998 and has the facilities and equipment necessary for its 
operation.  All the samples and data are manipulated in the same way according to 
standard operating procedures and all the samples are tested by a quality control process. 
All the collections have the documentation required by Portuguese law (Lei nº 12/2005), 
such as informed consent of all individuals [304]. The main objective of this biobank is to 
store biological products and associated data for further confirmation of the disease and 
for research.  
3.1.1. Families DISH/CC  
Eleven probands from ten families (AZ1-10) (Figure 2-1) were identified through a 
record review conducted at the Rheumatic Diseases Clinic of the Hospital of Santo 
Espírito da Ilha Terceira (HSEIT). The 11 probands and 71 family members (Figure 3-1 
and table 3-1) were interviewed and examined for the presence of DISH and or CC by a 
rheumatologist (JBA). All participants gave informed consent, and standard X rays were 
taken from: knees, axial skeleton, wrists, hands, elbows, and pelvis. Pathological status 
was determined radiographically, with the diagnosis of DISH being made according to 
the Utsinger criteria [5], and the diagnosis of chondrocalcinosis on the classic radiological 
evidence of deposition of calcium in the fibrocartilage. All individuals were screened for 
secondary causes of chondrocalcinosis, using appropriate biochemical and genetic tests. 
The pedigrees and the associated data of the collaborating families were available in 
AZORBIO and were used in this work. 
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Figure 3-1. Azorean families included in the study. 
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Table 3-1. Azorean families included in the study and associated data (pedigree code; sex; 
age and other diseases). Probands are represented in bold. 
Code Sex Age DISH/CC 
Other 
diseases 
Code Sex Age DISH/CC 
Other  
diseases 
AZ1 AZ2 
II:1 M 94 A  II:1 M ? A  
II:2 F 90 UN  III:1 F 81 A Lithiasis; DM 
II:3 M 98 A  III:2 M 85 A 
Lithiasis; 
polyarthritis 
II:4 F 94 UN  III:3 M 94 A  
II:5 M 86 A AS; DM IV:2 F 58 A Obesity 
II:7 F 91 A AS IV:3 F 61 A  
II:9 M ? UN AS V:1 M 33 A  
III:1 M 56 A  AZ4 
III:2 M 61 A  II:3 M 93 A   
III:3 F 57 UN  III:1  F ? UN   
III:4 M 53 A Obesity; AS III:2 M 64 A Lithiasis 
III:5 M 56 UN  III:3 M 71 A  
III:6 F 71 A AS III:4 M 75 A  
III:7 F 76 A  III:5 F 70 A 
DM; obesity; 
lithiasis 
IV:1 M 31 ?  III:6 M 68 A Lithiasis 
IV:2 F 30 ?  III:7 M 81 A   
IV:3 F 34 ?  III:8 F 77 UN Kidney cramps 
IV:4 F 36 ?  III:9 M 90 A   
AZ3 III:11 M 87 A   
II:1 M 80 A Sjogren 
syndrome 
IV:1 M 53 UN  
II:4 F 89 A Obesity IV:2 F 48 A  
III:1 M 48 A AS ;LBP IV:3 M 43 A  
III:2 M 83 A  IV:4 F 58 A DR 
III:3 F 60 A Periodontitis AZ5 
AZ6 I:1 M 87 A  
I:2 F ? A  II:1 F 62 ?  
II:1 F 72 A  II:2 M 77 UN Coxarthrosis 
II:2 F 75 UN LBP II:3 M 58 A  
II:3 M 66 UN  II:4 M 55 A  
AZ7 II:5 M 52 UN Crohn disease 
I:1 M 93 A  AZ8 
II:1 M 61 A AS II:1 M 57 A Lung cancer 
II:2 M 67 ? LBP; AS II:2 M 65 A Parkinson 
II:3 M 66 UN  II:3 M 62 A AS 
AZ10 II:4 F 62 UN  
III:1 F 68 UN  AZ9 
III:2 M 71 A CC I:1 M 86 A 
Parkinson; 
Osteopoikilosis 
III:4 M 60 A  I:2 F 82 UN  
III:5 M 76 UN  II:1 F 61 UN  
III:6 F 70 A  II:3 F 54 A LBP 
III:7 M 68 A  II:4 F 54 A  
III:8 F 77 A  II:5 M 58 A  
IV:1 M 46 UN  III:1 M 31 UN  
IV:2 F 45 UN  III:2 M 32 UN  
IV:3 F 42 ?       
IV:4 F 35 ?       
Abbreviations: M: male, F: female, AS: Ankylosing spondylitis. A: Affected; UN: Unaffected, CC: 
Chondrocalcinosis, DM:  Diabetes mellitus, LBP: Low back pain, DR: Diabetic retinopathy, ?: Unknown. 
Chapter III 
46 
 
3.1.2 DISH/CC patients not related 
The 55 patients (36 males; 19 females) from this collection were identified through a 
record review conducted at the Rheumatic Diseases Clinic of HSEIT. Blood was obtained 
from all participants who gave informed consent. Standard X rays were taken from: 
knees, axial skeleton, wrists, hands, elbows and pelvis. All individuals were interviewed 
and examined for the presence of DISH and/or CC by a rheumatologist (JBA). Affected 
status was determined radiographically, with the diagnosis of DISH being made 
according to the Utsinger criteria [5], and the diagnosis of chondrocalcinosis on the 
classic radiological evidence of deposition of calcium in the fibrocartilage. The biological 
material and the associated data (Table 3-2) of these patients were available in 
AZORBIO.  
Table 3-2. Patients with DISH/CC and associated data. 
Abbreviations: M: male, F: female, DM:  Diabetes mellitus, DR: Diabetic retinopathy, BC: breast cancer. 
 
Code Sex Age Other diseases Code Sex Age Other diseases 
D1 M 72 Gastric cancer D29 F 77 Mieloproliferative disease 
D2 F 61  D30 M 60 Osteoid osteoma 
D3 F 65  D31 M 86  
D4 F 70  D32 M 73  
D5 M 64 
Parkinson disease; 
periodontitis 
D33 F 66  
D6 M 66 Colorectal cancer D34 F 74  
D7 M 54  D35 M 87  
D8 M 63  D36 F 70 Arterial disease 
D9 M 61  D37 F 62 Osteoarthritis; DR 
D10 M 59  D38 M 71  
D11 M 80 Sjogren syndrome D39 M 70 DM 
D12 M 88 DR D40 F 81  
D13 M 79  D41 F 68 BC 
D14 M 79  D42 F 56  
D15 M 65 Kidney cancer D43 F 73 DR 
D16 M 80 Prostate cancer D44 F 64 BC 
D17 M 62  D45 M 85  
D18 M 67 Lung cancer D46 F 68  
D19 M 60  D47 M 65 Arterial hypertension 
D20 M 67 Colorectal cancer D48 F 78  
D21 M 87 Colorectal cancer D49 F 72 BC 
D22 M 70  D50 M 65  
D23 M 94  D51 M 64  
D24 M 69  D52 M 78 Colorectal cancer 
D25 M 98  D53 F 91 Total hip replacement 
D26 M 55  D54 M 86 Parkinson disease; osteopoikilosis 
D27 M 66 Psoriatic arthritis D55 F 77 DM;DR 
D28 F 73   
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3.1.3 Gitelman syndrome family 
 
IV:23
III:26
II:1 II:2
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Figure 3-2.  Gitelman family. The proband with GS and chondrocalcinosis is indicated by 
an arrow.   
 
A proband with bilateral knee CC, hypomagnesemia and hypokalemia, was identified in 
the Rheumatic Diseases Clinic, HSEIT, Azores, Portugal. Blood was obtained from all 
family members who gave informed consent, and standard X rays were taken from: 
knees, axial skeleton, wrists, hands, elbows and pelvis. Proband and 13 family members 
(Figure 3-2) were interviewed and examined for the presence of CC by a rheumatologist 
(JBA). Pathological status was determined radiographically, with the diagnosis of CC on 
the classic radiological evidence of deposition of calcium in the fibrocartilage and 
Gitelman syndrome by the presence of a hypomagnesemia and hypokalemia. The 
biological material and the associated data (Table 3-3) of this family were available in 
AZORBIO. 
 
 
 
 
 
 
 
 
 
 
Chapter III 
48 
 
Table 3-3. Gitelman syndrome family and associated data (code, sex, age, biochemical 
analysis and diseases). Reference values: Magnesium (1.5-2.5 mg/Dl); Potassium (3.3-5.1 
mmol/L) and calcium (8.0-10.2 mg/dL). The proband are represented in bold. 
Individuals Biochemical analysis Diseases 
Code Sex Age Magnesium Potassium Calcium GS CC 
III.2 M 62 1,1 3,2 9,9 X X 
III.12 M 75 2,1 4,7 9,1   
III.13 F 67 2,2 4,1 9,5   
III.16 M 75 2 4,6 9,5  X 
III.19 F 79 1,9 4,7 9,7  X 
IV.1 M 35 2,3 3,7 ?   
IV.2 F 54 2,2 4,2 9,7   
IV.4 M 46 1,9 4 9,2   
IV.14 F 51 1,9 4 9   
IV.16 F 49 2,2 4,1 9,1   
IV.17 F 45 1,9 4,3 9   
IV.21 M 37 2,1 4,1 10   
IV.22 F 36 2 3,7 9,7   
V.1 F 25 2 4,7 9,5   
Abbreviations: M-Male, F- Female, GS- Gitelman Syndrome; CC-Chondrocalcinosis. 
 
3.1.4 Ankylosing Spondylitis (AS) patients 
The 25 ankylosing spondylitis patients in this collection were identified through a record 
review conducted at the Rheumatic Diseases Clinic of HSEIT. Blood was obtained from 
all participants who gave informed consent and axial skeletal radiographs and CT scans 
of the sacroiliac joints, as needed, were taken. The HLA–B27 typing was also performed 
in all patients. All individuals were interviewed and examined for the presence of AS by a 
rheumatologist (JBA). Affected status was determined radiographically, with the 
definitive diagnosis of AS being made in accordance with the modified New York criteria 
[305].  
The biological material and the associated data (Table 3-4) of these patients were 
available in AZORBIO: 
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Table 3-4. AS population and associated data (sex; age and other diseases). 
Code Sex Age Other diseases Code Sex Age Other diseases 
AS1 F 57 LBP AS14 M 51 DISH/CC; colorectal cancer 
AS2 M 58  AS15 M 58  
AS3 F 47 Polyarthritis; total hip replacement AS16 M 73 Dementia 
AS4 M 40  AS17 M 70 Psoriatic arthritis; uveitis 
AS5 M 46  AS18 M 91  
AS6 F 55 Uveitis AS19 F 74 Uveitis 
AS7 M 71  AS20 M 37  
AS8 M 63  AS21 M 47  
AS9 M 58  AS22 F 65 Uveitis; vasculitis 
AS10 F 81 DR AS23 F 37  
AS11 M 82 Psoriatic arthritis AS24 M 65  
AS12 M 57  AS25 M 90  
AS13 M 60 Psoriatic arthritis  
Abbreviations: M- male, F- female, LBP- Low back pain, DR- Diabetic retinopathy, CC- 
chondrocalcinosis, DISH- diffuse idiopathic skeletal hyperostosis. 
 
3.1.5 Control population without DISH/CC 
This population cohort consists of 36 individuals (16 Males and 20 Females), older than 
65 years of age, living in the Terceira Island, that were being followed by the Rheumatic 
Diseases Clinic and Oncology Service of HSEIT. Blood was obtained from all 
participants who gave informed consent, and radiographs of the axial spine, pelvis, knees, 
wrists, hands and elbows (assessed by a rheumatologist (JBA) to confirm the absence of 
calcifications and/or ossifications). The biological material and the associated data (Table 
3-5) of these patients were available in AZORBIO. 
 
Table 3-5. Population control without DISH and or CC and associated data (sex; age and 
other diseases). 
Code Sex Age Diseases Code Sex Age Diseases 
C1 M 64 RA; hypothyroidism C19 M 102  
C2 F 69 Chronic lymphoid leukemia C20 F 57  
C3 M 76 Colorectal and  lung cancer C21 F 74 BC 
C4 F 68 BC C22 F 72 
Myelofibrosis; 
myeloproleferative disease 
C5 F 77 Non hodgkin lymphoma C23 F 72  
C6 F 61  C24 F 63  
C7 M 67 Colorectal cancer C25 F 72 BC 
C8 F 75 BC C26 F 66 Colorectal cancer 
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Code Sex Age Diseases Code Sex Age Diseases 
C9 F 59 Colorectal cancer C27 M 69 Gastric cancer 
C10 M 73  C28 F 68 Lymphoma 
C11 M 74  C29 F 59 BC 
C12 M 63 Lung cancer C30 F 63 BC 
C13 M 62 Myelodysplastic syndrome C31 F 70 BC 
C14 M 80 Lung and colorectal cancer C32 F 68 BC 
C15 M 60 Lymphoma C33 F 67  
C16 M 63 Pancreas cancer C34 F 60 Colorectal cancer 
C17 M 82 Non hodgkin lymphoma C35 M 69 Non hodgkin lymphoma 
C18 M 63 BC C36 M 64 Lung cancer 
Abbreviations: M- male, F- female, RA- Rheumatoid arthristis, BC- breast cancer. 
 
3.1.6 Representative population of Terceira Island 
Presently, Terceira island is an autonomous Portuguese region with approximately 60,000 
inhabitants. The two collections used in this thesis consist of individuals living on 
Terceira Island.  
3.1.6.1 Randomized cohort 
This population cohort consists of 124 individuals (46 males; 78 females; mean current 
age 66; range, 35-100), older than 18 years of age, living in the Terceira Island. The 
randomization was performed by “Serviço Regional de Estatística dos Açores” using the 
census carried out in 1981. All participants were interviewed about: demographic 
information and personal and familial diseases. Blood was obtained from all participants 
who gave informed consent and individuals who reported back pain (11 males; 19 
females), radiographs of the axial spine was also performed. The biological material and 
the associated data (Table 3-6) of these patients were available in AZORBIO. 
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Table 3-6. Individuals from the randomized population and associated data (sex, age and 
diseases). 
Code Sex Age Diseases Code Sex Age Diseases 
R1 F 60 LBP; phlebitis R63 F 88 LBP 
R2 F 53 Hyperparathyroidism R64 F 74 DM 
R3 M 61  R65 F 76 RA; hypercholesterolaemia 
R4 M 46 Knee pain R66 F 88 DM 
R5 M 64  R67 F 54 LBP 
R6 M 85 Colorectal cancer R68 F 82 LBP 
R7 M 49  R69 F 96 Cardiac disease 
R8 M 63 Colorectal cancer R70 F 96 LBP 
R9 M 85 LBP R71 F 61 Epilepsy 
R10 M 53 Psoriasis; AS R72 F 61 LBP 
R11 F 100 LBP; poliomyelitis R73 F 57  
R12 F 90 Juvenil arthritis R74 F 70 Hand osteoarthritis 
R13 F 58  R75 F 94  
R14 F 46 LBP R76 F 77  
R15 F 60  R77 F 67  
R16 F 76  R78 F 78 LBP 
R17 M 61 LBP; kidney cramps; psoriasis R79 F 54  
R18 M 56  R80 F 90 LBP; colitis 
R19 F 70  R81 F 54 BC 
R20 M 76 LBP R82 F 63 Poliomyelitis 
R21 F 53  R83 F 68 
Left sacroiliitis; LBP; right 
sciatica 
R22 F 52  R84 F 73 
LBP; hypercholesterolaemia; 
DM; BC 
R23 F 89 DM; LBP R85 F 48 
Hypertension; transient schemic 
attack 
R24 F 56 Deformities in tibias R86 F 47  
R25 F 60 LBP; AS R87 F 35  
R26 M 78 DM R88 F 65 LBP 
R27 M 87  R89 F 64 Kidney cramps; BC 
R28 M 84  R90 F 71  
R29 M 55 LBP; leucopeny R91 F 53 AS 
R30 M 65  R92 F 61  
R31 F 53 LBP; multi brain strokes R93 F 86  
R32 F 56 Juvenil stroke R94 F 68 Anemia 
R33 M 89  R95 F 74  
R34 M 49 LBP R96 F 65  
R35 M 73 
Cardiac disease; DM; hand 
deformities; lung cancer 
R97 F 70 Enteritis; LBP 
R36 M 96 
Chronic obstructive pulmonary 
disease 
R98 F 61  
R37 M 71 LBP; CC R99 F 83 LBP; coxofemoral fracture 
R38 M 69 LBP R100 F 93  
R39 M 66  R101 F 81 AS 
R40 M 67  R102 F 79 DM; osteoarthritis; RA; LBP 
R41 F 93  R103 F 62  
R42 M 67 Kidney pain R104 F 76  
R43 F 80  R105 M 42  
R44 F 55 Colitis R106 F 46 AS 
R45 F 63  R107 F 81 BC 
R46 F 64  R108 F 45 Psoriasis 
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Code Sex Age Diseases Code Sex Age Diseases 
R47 F 55  R109 M 46  
R48 M 63 LBP R110 M 75  
R49 M 42  R111 M 51  
R50 M 81  R112 M 49  
R51 F 54  R113 M 42  
R52 F 71  R114 F 57  
R53 F 45 Scoliosis R115 F 50 Polyarthritis 
R54 M 78  R116 F 74  
R55 M 72 LBP; AS R117 F 41 Knee swelling; LBP 
R56 M 44 LBP R118 M 89  
R57 M 84 LBP; osteoporosis R119 M 55 Ischemic stroke 
R58 M 67  R120 F 79 Psychiatric disorder 
R59 M 77 Diabetes; two myocardial 
infarction 
R121 F 47  
R60 M 68  R122 M 42  
R61 M 92 Cardic disease; LBP R123 M 42  
R62 F 51  R124 F 77  
Abbreviations: M- male, F- female, AS- ankylosing spondylitis; CC- chondrocalcinosis; LBP- Low back 
pain; BC- breast cancer; RA- Rheumatoid arthritis, DM- Diabetes mellitus. 
 
3.1.6.2 Two regions – Angra do Heroísmo and Praia da Vitória  
This population cohort consists of 375 individuals (85 males; 290 females; mean current 
age 55; range, 25-91), older than 18 years of age, living in the Terceira Island, that were 
attended in clinical laboratories located in the two main municipalities of the Terceira 
island; Angra do Heroísmo and Praia da Vitória. All participants who gave informed 
consent were interviewed about breast cancer and other inherited diseases, socio and 
demographic information. Blood was obtained from all participants who gave informed 
consent. The biological material and the associated data (Table 3-7) of these patients were 
available in AZORBIO. 
 
Table 3-7. Representative population of two regions of Terceira Island and associated data 
(sex, age and diseases). 
Code Sex Age Diseases Code Sex Age Diseases Code Sex Age Diseases 
2R1 F 56  2R126 M 57  2R251 F 62  
2R2 F 41  2R127 M 37  2R252 F 75  
2R3 F 48  2R128 M 68  2R253 F 58  
2R4 F 47  2R129 M 84  2R254 F 56 
Bilateral 
uveitis 
2R5 F 47  2R130 M 56  2R255 F 74  
2R6 F 47  2R131 M 66  2R256 F 43  
2R7 M 56  2R132 M 46  2R257 M 34  
2R8 F 41  2R133 F 27  2R258 F 72  
2R9 F 35  2R134 M 45  2R259 F 72  
2R10 M 79  2R135 M 59  2R260 F 73  
2R11 F 84  2R136 M 59  2R261 F 59  
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Code Sex Age Diseases Code Sex Age Diseases Code Sex Age Diseases 
2R12 M 63  2R137 M 86  2R262 F 80  
2R13 M 65  2R138 M 64  2R263 F 70  
2R14 M 78  2R139 F 78 RA 2R264 F 46  
2R15 M 51  2R140 M 72 
Chronic 
lymphoid 
leukemia 
2R265 F 53  
2R16 F 75  2R141 M 59  2R266 F 51  
2R17 M 73  2R142 M 82  2R267 F 70  
2R18 F 52  2R143 M 36  2R268 F 71  
2R19 M 78  2R144 F 87  2R269 F 77  
2R20 F 56  2R145 M 73  2R270 F 49  
2R21 F 60  2R146 M 86 Dementia 2R271 F 65  
2R22 F 61  2R147 F 46  2R272 F 69  
2R23 F 43  2R148 F 62  2R273 F 56  
2R24 F 55  2R149 F 43  2R274 F 32  
2R25 F 65 Polyarthritis 2R150 F 45  2R275 F 86  
2R26 F 52  2R151 M 57  2R276 F 61 RA 
2R27 F 46  2R152 F 69  2R277 F 61 
Lacunar 
stroke 
2R28 F 60 DM 2R153 F 45  2R278 F 59  
2R29 F 59 AS; uveitis 2R154 M 68  2R279 F 70  
2R30 F 45  2R155 F 47  2R280 F 66  
2R31 F 66  2R156 F 56  2R281 F 49  
2R32 F 47 Dysuria 2R157 F 52  2R282 F 58  
2R33 F 74  2R158 F 58  2R283 M 40  
2R34 F 50  2R159 F 56  2R284 F 67  
2R35 F 52  2R160 F 63  2R285 F 55  
2R36 F 62  2R161 M 35  2R286 M 55  
2R37 F 46  2R162 F 50  2R287 M 47 
Psoriatic 
arthrtis; 
gonarthrosis 
2R38 F 45  2R163 F 53  2R288 F 69  
2R39 F 55  2R164 F 26  2R289 F 70  
2R40 F 59 AS 2R165 F 66  2R290 F 60  
2R41 F 37  2R166 F 53  2R291 M 64  
2R42 F 44  2R167 M 60  2R292 F 45  
2R43 F 36  2R168 F 55  2R293 F 65  
2R44 F 45  2R169 F 59  2R294 F 67  
2R45 F 41  2R170 F 62 AS; RA 2R295 F 34  
2R46 M 75  2R171 F 52  2R296 F 81  
2R47 F 32  2R172 F 47  2R297 F 79  
2R48 F 52  2R173 F 53  2R298 F 72  
2R49 F 39  2R174 F 56  2R299 F 65  
2R50 F 42  2R175 F 57  2R300 F 81  
2R51 M 56  2R176 F 72  2R301 F 57 BC 
2R52 F 34  2R177 M 37 Bilateral uveitis 2R302 F 51  
2R53 M 34  2R178 F 52  2R303 F 27  
2R54 F 76  2R179 F 44  2R304 M 38  
2R55 F 43  2R180 F 86  2R305 F 62  
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Code Sex Age Diseases Code Sex Age Diseases Code Sex Age Diseases 
2R56 F 41  2R181 F 57  2R306 F 39  
2R57 F 61  2R182 F 77  2R307 F 41  
2R58 F 38 
polyarthralgia; 
acrocyanosis; 
ischemic feet 
2R183 M 38  2R308 F 57  
2R59 F 56  2R184 F 76 Lacunar stroke 2R309 F 53  
2R60 F 38  2R185 F 58  2R310 F 34  
2R61 F 39  2R186 F 78  2R311 F 25  
2R62 M 55  2R187 F 87  2R312 M 50  
2R63 F 46  2R188 F 66  2R313 F 62  
2R64 M 35  2R189 F 76 
DISH/CC; 
colorectal 
cancer 
2R314 F 53  
2R65 F 39  2R190 F 57  2R315 M 69  
2R66 F 35  2R191 F 79  2R316 M 47  
2R67 M 56  2R192 F 44  2R317 M 45  
2R68 M 46  2R193 F 65  2R318 M 41  
2R69 F 43  2R194 F 48  2R319 F 25  
2R70 F 40  2R195 F 77  2R320 F 45  
2R71 M 32  2R196 F 70  2R321 F 48  
2R72 F 59  2R197 F 52 Oligoarthritis 2R322 F 44  
2R73 F 36  2R198 F 67  2R323 F 61  
2R74 M 75 
Ischaemic 
stroke 
2R199 M 76  2R324 F 39  
2R75 F 44  2R200 F 58  2R325 M 41  
2R76 F 58 Convulsion 2R201 F 48  2R326 M 57  
2R77 F 50  2R202 F 52  2R327 M 31  
2R78 M 42  2R203 F 62  2R328 M 40  
2R79 M 67  2R204 F 65  2R329 F 38  
2R80 F 45  2R205 F 76 DR 2R330 M 44  
2R81 F 39  2R206 F 54  2R331 M 42  
2R82 M 81  2R207 M 64  2R332 M 31  
2R83 F 55 AS 2R208 F 72  2R333 M 64  
2R84 F 54  2R209 F 69 
Peripheral 
arterial disease 
2R334 F 62  
2R85 F 54  2R210 F 91  2R335 F 31  
2R86 F 34  2R211 F 48  2R336 F 83  
2R87 F 26  2R212 F 39  2R337 F 54 Colorectal 
cancer 
2R88 M 84 AS 2R213 F 54  2R338 M 69 Neck pain 
2R89 F 47  2R214 F 29  2R339 F 55  
2R90 F 41  2R215 F 63 DISH/CC 2R340 F 36  
2R91 M 78  2R216 F 52  2R341 F 35  
2R92 M 65  2R217 F 68  2R342 F 62  
2R93 M 49  2R218 F 41  2R343 F 49 
Cerebral 
venous 
thrombosis 
2R94 F 55  2R219 F 29  2R344 M 43  
2R95 F 85  2R220 F 68  2R345 F 37  
2R96 M 73  2R221 F 71  2R346 F 32 Leukorrhoea 
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Code Sex Age Diseases Code Sex Age Diseases Code Sex Age Diseases 
2R97 F 59 Uveitis 2R222 F 54 
Cerebellar 
infarction left 
chemic 
2R347 F 55 RA 
2R98 F 52 BC 2R223 F 73  2R348 F 44  
2R99 F 53  2R224 F 55  2R349 F 38 DISH/CC 
2R100 F 54  2R225 F 81  2R350 F 37  
2R101 F 59  2R226 F 55  2R351 F 35  
2R102 M 38  2R227 F 61  2R352 F 40  
2R103 F 66  2R228 M 81  2R353 F 33  
2R104 F 63  2R229 F 64  2R354 F 25  
2R105 F 56 AS 2R230 F 70 
Betathalassemia 
syndrome 
2R355 F 32  
2R106 F 48  2R231 F 74  2R356 F 79  
2R107 F 51  2R232 F 53  2R357 F 42  
2R108 M 35  2R233 F 57  2R358 F 44  
2R109 M 53  2R234 F 59  2R359 F 25  
2R110 M 51  2R235 F 64  2R360 M 29  
2R111 F 49 
Multi brain 
strokes 
2R236 F 58  2R361 M 68  
2R112 F 55  2R237 F 55  2R362 F 88  
2R113 F 64  2R238 F 54  2R363 F 56  
2R114 F 72  2R239 F 53  2R364 F 35  
2R115 F 48  2R240 F 70  2R365 M 34  
2R116 F 59  2R241 F 90  2R366 M 75  
2R117 F 64  2R242 F 62  2R367 F 37 
Cerebral 
venous 
thrombosis 2R118 F 57  2R243 F 61 DISH/CC 2R368 F 27  
2R119 F 60  2R244 F 49  2R369 F 47  
2R120 F 27  2R245 F 61  2R370 F 41  
2R121 F 61  2R246 F 67 BC 2R371 F 63  
2R122 M 64  2R247 F 34  2R372 M 39  
2R123 M 49  2R248 F 91  2R373 F 45  
2R124 F 78  2R249 F 63 Spherocytosis 2R374 F 51  
2R125 M 66  2R250 F 83 RA 2R375 F 61  
Abbreviations: M- male, F- female, AS- Ankylosing spondylitis; RA- Rheumatoid arthritis; DR- Diabetic 
retinopathy; BC- Breast cancer, CC- chondrocalcinosis, DISH- diffuse idiopathic skeletal hyperostosis. 
 
3.1.7 Total hip replacement group 
This collection of 53 individuals (34 male, 17 female; mean current age, 71 years; range, 
47-93 years) (Table 3-8) was obtained from patients undergoing total hip replacement 
surgery. Informed consent was obtained from these patients for use of their rejected tissue 
in research. Sterile cartilage sections (of approximately 3 mm diameter) from the 
coxofemoral articular cartilage were prepared with a scalpel and a cutter and immediately 
stored at -80ºC in RNA later.  
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Table 3-8. Total hip replacement group. 
Code Sex Age Diseases Code Sex Age Diseases 
THR1 M 81 DR THR28 M 65   
THR2 F 79   THR29 M 47   
THR3 M 66   THR30 F 78   
THR4 F 67 DISH, BC THR31 M 53   
THR5 M 57   THR32 M 73   
THR6 M 74   THR33 F 82   
THR7 M 56   THR34 F 65   
THR8 M     THR35 M 82 CC (knees) 
THR9 M 72   THR36 F 64 CC (knees) 
THR10 F 91   THR37 F 72   
THR11 M 59   THR38 F 71   
THR12 F 84   THR39       
THR13 M 79 DISH THR40 F 68   
THR14 M 76   THR41 F 59   
THR15 M 79   THR42 F 89   
THR16 M 70   THR43 M 77 Osteoarthritis 
THR17 M 77   THR44 F 53   
THR18 M 72   THR45 F 59   
THR19 M 73   THR46 F 56   
THR20 M 77 Hypertension THR47 M 71 Lithiasis 
THR21 M 74   THR48   50   
THR22 M 87 Prostate cancer THR49 M 84   
THR23 M 81   THR50 M 72   
THR24 M 83   THR51 M 69 RA 
THR25 M 69   THR52 M 79   
THR26 M 62   THR53 F 93 DISH/CC; AS 
THR27 M 70       
Abbreviations: M-male, F- female, AS- Ankylosing spondylitis; R- Rheumatoid arthritis, D- Diabetic 
retinopathy; BC- Breast cancer, DISH- diffuse idiopathic skeletal hyperostosis. 
 
3.2 Methods 
3.2.1 Gene sequencing 
3.2.1.1 DNA extraction and quantification 
Genomic DNA was obtained from peripheral blood cells in EDTA (Ethylenediamine 
tetraacetic acid) anticoagulant, using a  standard Salting-Out extraction method [306], and 
an automatic procedure (EZ1;Qiagen) according to the manufacturer’s instructions. The 
DNA concentration and A260:A280 ratio was determined using the NanoVue 
spectrophotometer (GE Healthcare). 
3.2.1.2 Amplification of regions of interest  
PCR oligonucleotide primers were designed using the software Primer3 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) for intronic 
sequences with the objective of amplify/sequence fragments from the following genes: 
  Chapter III 
 
57 
 
SLC12A3, RSPO4, ENPP1, PPP2R2D, PLCG2, AMER3, FLNC, FGF2, COL11A2, VDR, 
BMP4 and BMP2. The primers used to amplify the LEMD3 gene (exon 13) were 
previously described by Hellemans and collaborators [307] and primers for ABCC6 gene 
fragments described by Miksch et al [308] and Cai et al [309]. PCR reactions were 
optimized for all primer sets (Table 3-9) in order to obtain the expected single reaction 
product.  
 
Table 3-9. Forward and reverse oligonucleotide primers (5’→3’) used in PCR reactions and 
sequencing of SLC12A3, RSPO4, LEMD3, ENPP1, PPP2R2D, PLCG2, AMER3, FLNC, 
FGF2, COL11A2, VDR, BMP4, BMP2 and ABCC6 genes. 
Gene Exon Forward Reverse 
SLC12A3 
1 CTCAGAAGAGCCACTCCAGG GAGGTCACACAGCAGGGAAG 
2 AGTGGGCTGGATGCAGAGA AGAGCTGAGCCTGGATGGA 
3 AGTGGGTGAAGAAGGGACC AGGATTCAGGCAAGCTGG 
4 AGATGAACGTAGGTCGCATGG CAGGATTAGGAGCCCACGAG 
5 CACGAGATGGCCTCAGCTATC TGGTTCCTGATGGGTGAAGTC 
6 ATCGTCCTAGCAGAGTGCACC CACGTGACCACCTCCATGTC 
7 GTGAATAATGGAGAAACGGGC TTCCTGGGTAGAGAGTCCCTG 
8 ACTGGGAGGATGGGATTACC CAGGATTCTGCTCATAGCCC 
9 GCCTAATGTCCTCCGTCCCT TGCTCTGATCATTGCCAAGATAC 
10 ATCATCTGCAGCACCTCGC CAGTGTCCACCCACAAGTCG 
11 CGCAGTAGGGAATGAAGTGC CCTATTGTGCCTCTAGCCCAG 
12 AAACAGACACCAGGACCCAG TGCCCACTAACTGTCAGGC 
13 CAGTCCTTGGCAGAGTTGC CTGACCTCAAGTGATCCGC 
14 CCTAGAAAGAGGCTCGACTGC GTTTCTTGCCACATTGGGAG 
15 AGAAGGCCGACATTACCTCTG GTCTAGGCTTGGAAACTCCCA 
16 CATGTAGGGTCATGCTGGTG GGCTGGTCTCAAACTCCTGA 
17 GTGAAGGCAGCTGGTGATGT CAAGCCGTAAGTCCTGTAGGG 
18 TTGAGAATCAGCACATCTGGAG CAATGGGCCCAAATTAACAG 
19 TGGTAGGAAGCAGAGCCAACT AACTTTCTGGGAGTGGGTGG 
20 CCTGTCAAGGAGGAACCCA AGTGCCCTGAGCTCTGAGTG 
21 TTCCTGTTCCACCTGCCA GGCGACTTCAGCTCTTCTCTC 
22 CACATAGTGCTCTGTCCTGAGTG TTTGGGACAATCTCAGTGCC 
23 GCAGAGGTTGCAGTGAATCG GTCTCCAGGCACACAGTTGG 
24 CCTCAACCCACTTTCTCGTC AGCTCAAGACATGCAGGACA 
25 AATGAGGCCATAGACGTGGT AGCTGAGACACCTGACTCTGG 
26 CTGAGGGACGGTAAACAGAC AGAGGCAATCAAGTTCCAAC 
RSPO4 
1 CAACGCCCTCACTAGACCTG AGCCTCAATCTCCCCATCTTA 
2 TGACCATCTCTCTCTCCCTTTC GAGCCCAGCACTAGCATAGAAC 
3 GGGGTGTCCCTGGCTCTA GCCCCTAACATCTCTCACCA 
4 TCTGTCTGTCTCTCCTTTCACC CAGCCTCGTGTGCCTGTC 
5 GCACCCTTGTCTTTCAGGACT AAGAGTAAGAGGAGAGGAGGAGAA 
LEMD3 13 CTTTTACCACAGTTAATTTTCTGC GAACCTTAAGACTTCTGGAACG 
ENPP1 4 CATGGTAGTGGCAGATTCTG TTCAGCTAATATAGTTGGCC 
PPP2R2D 7 GCCTGAAGATCCCAGCAGTA CCTATGAGCGTCCTCCTCTG 
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Gene Exon Forward Reverse 
PLCG2 
19 CCCACTGACAGCCTGGAG CTGAAGTTCCCCCTTGTCTCT 
21 TGAGGTTTCAACTCCTCTATCAAA AACAGAGTCAGGGTGGGAAT 
33 CCACTGCTGATGGTGAAATC TCTTACATTTCCAGCTCATCCTC 
AMER3 3 GAGGGCTACTATGATTCCTTCTCG AAGCTGCATATGGACAGTGG 
FLNC 26 TGTCATCGGCTTCTGGGAAC ATCCCCATTGTCCCGGATGT 
FGF2 3´UTR GCTTTAGGCGGCAGATGATA ACACAGCGGTTCGAGAAGTT 
COL11A2 6 ACCTTCCAATTACCCCATCC TGGGAGAAAGGGAAGAAATG 
VDR 5 CTGGCACTGACTCTGGCTCT TGCAGCCTTCACAGGTCATA 
BMP4 7 GGGACCAGTGAAAACTCTGC GGGGGCTTCATAACCTCATAA 
BMP2 3 TTCCGAGAACAGATGCAAGA TCAAAACTTTCCCACCTGCT 
ABCC6 
5’UTR-
LR 
TCCTGGAAATTGCTGGGTCCAAAGTGT 
TTAGGAAGTCT 
CAGCTCACCTGCCCAGGGGGCCAG 
GCAACT 
1 CCGAGCAGTCTGCCCAGAGACTT GGGGGTCTCTCCTCTCCCCAGTAT 
2 TGGCCCCCTGGGCAGGTGAG GTCCCCTGCCTCCCCCGAACA 
3-4-LR CCGGGGCTACCTCCGGATGTC 
GGCCTGTAAGACAGGAAATTGTGTTG 
ATAAGA 
3 CCGCCTACCAGTTTGCTGTGAC GGAGCCTCTTCTCTTCCCCTTGT 
4 CTGCTGCTTTGCCTGCCACAGT GTGCGGGAGTGGATTTTGTGTCTCT 
5 GTCCCCAGAGTGGGCACTGAC CTTTTGGTCACCTGGGGGAGAC 
6 TCCTGTCTTCCTACCCTTGCCACAT GGCCATGGCTGGGAATCAGAG 
7 GCCAGGATCCTGCAGGGGTGAA CGCACCCGGCCAATGATGAG 
8-9 LR AGGCTAGATCCACACCCACCCATCTCCACTGT CGTCCACGGACACCAGATTGACCACATCAC 
8 CCGCTGGCGGCTGAGAGTAT GGCCCTGGAAGGATGCCACTA 
9 TTGGGCAAAGGCAACACCCTTAG ACTGCTTTTCCTGGCTGGGAAGAC 
10-LR 
GAGCCCTGAGAGGTTGGCCTAAGAGA 
CTTTACTC 
TTCCCCCTAAAATGTTCTCCTCTTGTGTT 
TTGTG 
10 CCACCTGGGGCATCCCTCTG GGGGAAGGACGAGGGGGAGAA 
11 TGCTCTGGTTCACGTGCCTCTG TCAGCTCTCCCCTCCCCATCTC 
12 GGTGAGATGAATGGGATTTGCTGAAG GGGGGGCTCCACCTACCTCAC 
13 GCTTGCCCAGGCTGCCCTATC GGTAGGGAAGCTGGAGCCAGGTGTA 
14 GCCACACATCTTGAGACACCGACAC CCAGTACTGATGCTGGCTTGCCATTA 
15 ATGGTGCCTGGGGGCCTCTC GCAGGAGCCCCATGCATCTTCT 
16 TCAGCTCCGTCTGGGGCTCATC GTGGGAAGGCAGCGAGGAAGTG 
17 CAGCTCCCACTGCTCCTCAAAAC TCCATCATACTGCCCATGATGAGTC 
18 AGCCTGGGCACCCCAGTTTC AAACTTGGGTTAGGACTGGATGCTAAGT 
19 CCACATGCTTTGGCTTCCCAAAGTGT AGGGTGTGGCCAGAGCACTCCATTC 
20 AAGGCCACATAGTCAGTGGGTGTCA GCGGGTGGTCCCTTCAGCTACT 
21 TGGCTGTCAGTGGGCCTGAG GGTGAGTATCACTGCCAAGTGCTACA 
22 TCCCATCTGCCATGGGCATGTTTT TTTGCACACTGTTCCAGGGGGACAG 
23 CACCATGGGGTAGCGGGAGAGAC GGGAATTCTAGGAACAGCCCCTAGATGTC 
24 GGCTCTCTGTGCTTCTGGAAACTA GGATATGGATGAATTGCAAGGTCTT 
25 TCCTTGTGCCCAGAGAAGCATCTC CCACTAGCAGGGGTCCGACAGTC 
26 GGCTGTTGCAAGCCCTCAAGTG AAACTCCAAAGCCTGTAGCAGATGTCA 
27 GAAGCTGATAGAGGTGGGCCATCTTG GGTTTAGGGCCTTGTCCCTGGAGTC 
28 GAGGGATGGATAGACAGATCTCGGGTACA ATCCGCAGAGAGCCAGGGAACAG 
29 GGTGGAGGGGGTGGGCAAAGA GGCATGGCCATCCCCTCCTCTC 
30 CTGTTTCTGGGCACACCCACACATC CCAGGACTGCCTCCGCCTCCT 
31 CGCAGACACACTGGGCTCTCACA GATGACCACGGGTCACTTCCATCTC 
Abbreviations: LR- Long range. 
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PCR amplification for each gene fragment were performed using the PCR System 9700 
(Applied Biosystems) using the conditions described in table 3-10. Long range PCR 
reaction for E08-E09-LR in ABCC6 gene  were performed using Long and Accurate (LA-
Taq) polymerase (TAKARA) and a PCR cycle protocol according to the manufacturer’s 
instructions. PCR products were subjected to electrophoreses on a 1.7% agarose gel 
(Seakem), at 125V for 25 minutes and stained with GelRed (Olerup) to verify the 
presence of specific PCR products of the expected size (Table 3-10).  
 
Table 3-10. PCR conditions, annealing temperature and PCR product size for SLC12A3, 
RSPO4, LEMD3, ENPP1, PPP2R2D, PLCG2, AMER3, FLNC, FGF2, COL11A2, VDR, 
BMP4, BMP2 and ABCC6 genes. To amplify the exon 18 of SLC12A3 and exon 26 of 
ABCC6, 2 and 2.5 µl of DMSO were added. 
Gene Exon 
PCR conditions 
At 
(ºC) 
bp 
Buffer 
MgCl2 
(mM) 
dNTPs 
(mM) 
Primers 
(F+R) 
pmol 
BSA 
(mg/ml) 
GoTaq 
(U) 
DNA 
(ng) 
SLC12A3 
1 1X 2 0.15 0.2 0.3 0.04 50 65-55* 579 
2 1X 2 0.15 0.2 0.3 0.04 50 65-55* 292 
3 1X 2 0.15 0.2 0.3 0.04 50 65-55* 279 
4 1X 2 0.15 0.2 0.3 0.04 50 65-55* 240 
5 1X 2 0.15 0.16 0.3 0.02 50 55º 388 
6 1X 2 0.15 0.2 0.3 0.04 50 65-55* 263 
7 1X 1 0.15 0.2 0.3 0.04 50 50º 275 
8 1X 2 0.15 0.2 0.3 0.04 50 65-55* 309 
9 1X 1 0.2 0.8 - 0.01 30 56º 358 
10 1X 2 0.15 0.32 0.3 0.02 50 55º 429 
11 1X 2 0.15 0.32 0.3 0.02 50 55º 254 
12 1X 2 0.15 0.2 0.3 0.04 50 65-55* 378 
13 1X 0,8 0.16 0.64 - 0.01 50 58º 395 
14 1X 1 0.15 0.2 0.3 0.04 50 50º 370 
15 1X 2 0.15 0.2 0.3 0.04 50 65-55* 272 
16 1X 2 0.15 0.2 0.3 0.04 50 65-55* 476 
17 1X 2 0.15 0.2 0.3 0.04 50 65-55* 224 
18 1X 2 0.15 0.2 0.3 0.04 50 50º 266 
19 1X 2 0.15 0.2 0.3 0.04 50 65-55* 221 
20 1X 2 0.15 0.2 0.3 0.04 50 65-55* 181 
21 1X 2 0.15 0.16 0.3 0.02 50 55º 435 
22 1X 2 0.15 0.2 0.3 0.04 50 65-55* 297 
23 1X 0,8 0.16 0.64 - 0.01 50 58º 252 
24 1X 2 0.15 0.32 0.3 0.02 50 55º 549 
25 1.25X 2.5 0.19 0.25 0.4 0.05 50 65-55* 203 
26 1.25X 2.5 0.19 0.25 0.4 0.05 50 65-55* 315 
RSPO4 
1 1X 1 0.2 1 - 0.01 20 54º 407 
2 1X 1 0.2 0.5 - 0.01 50 50º 201 
3 1X 1 0.2 0.5 - 0.01 50 50º 243 
4 1X 1 0.2 0.5 - 0.01 50 50º 243 
5 1X 1 0.2 0.5 - 0.01 50 50º 282 
LEMD3 13 1X 3 0.15 0.4 0.3 0.05 25 65-55* 400 
ENPP1 4 1X 3 0.15 0.2 0.14 0.05 50 60º 396 
PPP2R2D 7 1X 1 0..2 0.5 - 0.01 50 60 363 
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Gene Exon 
PCR conditions 
At 
(ºC) 
bp 
Buffer 
MgCl2 
(mM) 
dNTPs 
(mM) 
Primers 
(F+R) 
pmol 
BSA 
(mg/ml) 
GoTaq 
(U) 
DNA 
(ng) 
PLCG2 
19 1X 1 0.16 1 - 0.01 30 55º 257 
21 1X 1 0.16 1 - 0.01 30 55º 584 
33 1X 1 0.16 1 - 0.01 30 55º 494 
AMER3 3 1X 1 0.2 1 0.4 0.01 30 65-55* 233 
FLNC 26 1X 1.25 0.2 1 - 0.03 25 65-55* 434 
FGF2 3´UTR 1X 1.5 0.2 0.5 - 0.01 50 52 135 
COL11A2 6 1X 1.25 0.2 0.5 - 0.01 50 60 170 
VDR 5 1X 1 0.2 0.5 - 0.01 50 60 133 
BMP4 7 1X 1 0.2 1 - 0.01 50 60 170 
BMP2 3 1X 1.5 0.2 0.5 - 0.01 50 52 167 
ABCC6 
5’UTR-LR 1X 1.5 0.2 0.5 - 0.03 50 68 1929 
2 1X 1.25 0.2 0.5 - 0.03 20 66 311 
3-4-LR 1X 1.25 0.2 0.5 - 0.03 20 68 2356 
5 1X 1.25 0.2 0.5 - 0.03 20 62 295 
6 1X 1.25 0.2 0.5 - 0.03 20 62 194 
7 1X 1.25 0.2 0.5 - 0.03 20 62 259 
ABCC6 
8-9-LR 1x 0.4 1 - 0.04* 40 68 5626 
10-LR 1X 1.25 0.2 0.5 - 0.03 20 64 1193 
11 1X 1.25 0.2 0.5 - 0.03 20 64 253 
12 1X 1.25 0.2 0.5 - 0.03 20 64 387 
13 1X 1.25 0.2 0.5 - 0.03 20 64 286 
14 1X 1.25 0.2 0.5 - 0.03 20 64 262 
15 1X 1.25 0.2 0.5 - 0.03 20 64 219 
16 1X 1.25 0.2 0.5 - 0.03 20 66 282 
17 1X 1.25 0.2 0.5 - 0.03 20 62 343 
18 1X 1.25 0.2 0.5 - 0.03 20 64 318 
19 1X 1.25 0.2 0.5 - 0.03 20 66 374 
20 1X 1.25 0.2 0.5 - 0.03 20 64 221 
21 1X 1.25 0.2 0.5 - 0.03 20 63 305 
22 1X 1.25 0.2 0.5 - 0.03 20 66 431 
23 1X 1.25 0.2 0.5 - 0.03 25 68 533 
24 1X 1.25 0.2 0.5 - 0.03 20 62 322 
25 1X 1.25 0.2 0.5 - 0.03 20 62 270 
26 1.25X 1.25 0.12 1 - 0.03 50 62 258 
27 1X 1.25 0.2 0.5 - 0.03 20 65 297 
28 1X 1.25 0.2 0.5 - 0.03 20 66 371 
29 1X 1.25 0.2 0.5 - 0.03 20 66 296 
30 1X 1.25 0.2 0.5 - 0.03 20 66 344 
31 1X 1.25 0.2 0.5 - 0.03 20 66 270 
Abbreviations: DMSO: Dimethyl sulfoxide, BSA: Bovine Serum Albumin, At: Annealing temperature, F: 
forward, R: reverse, bp: base-pair. * Long and accurate (LA) taq (TAKARA). 
  
 
3.2.1.3 Sequencing 
The PCR products with a positive band were then purified using ExoSAP-IT™ 
(Exonuclease I and Shrimp Alkaline Phosphatase) according to manufactures instructions.   
Sequencing reaction with BigDye Terminator v3.1 and v1.1 was performed in a 10 µl 
volume containing 2 µl template, 2 µl 5X Sequencing Buffer, 1 µl Sequencing Premix 
(Big Dye v3.1 or v1.1), 0.16 µl primer (10pmol) (Table 3-9) and ddH2O to achieve final 
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volume. Reaction conditions included an initial denaturation step at 96ºC for 1 minute 
followed by 25 cycles of: denaturing at 96◦C for 10 seconds, annealing at 50◦C for 5 
seconds, and elongation at 60◦C for 4 minutes. Purification of the products for sequencing 
was performed by precipitating with 0.5 M EDTA and 3 M sodium acetate, and a final 
precipitation with 70% and absolute EtOH. Templates were ressuspended in 15 µl highly 
deionized formamide (HiDi formamide) and sequenced using the ABI 3130xl (Applied 
Biosystems).  
3.2.1.4 Sequence analysis 
Genetic variants of exons and intron-exon boundaries of the genes were screened with 
Sequencing Analysis and SeqScape software (Applied Biosystems) using as reference 
the sequences present in NCBI (Table 3-11).  
 
Table 3-11. NCBI references for the genes studied. 
Gene NCBI reference 
SLC12A3 NG_009386.1 
RSPO4 NG_013043.1 
LEMD3 NG_016210.1 
ENPP1 NG_008206 
PPP2R2D NM_018461.4 
PLCG2 NG_032019.2 
AMER3 NM_152698.2 
FLNC NG_011807.1 
BMP4 NG_009215.1 
FGF2 NG_029067.1 
BMP2 NG_023233.1 
VDR NG_008731.1 
COL11A2 NG_011589.1 
ABCC6 NG_007558.2 
 
3.2.2 Tissue expression   
3.2.2.1 Cartilage homogenization 
Cartilage sections preserved in RNA later were reduced to a powder using a mortar and 
pestle and liquid nitrogen. The cartilage powder was placed in 1 ml TRIzol reagent and 
stored at -80ºC for 24 hours. 
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3.2.2.2 RNA isolation 
The RNA was obtained using a TRIzol RNA isolation protocol. Trizol reagent 
(Invitrogen) is a ready to use reagent for the isolation of total RNA from cells and tissues. 
The reagent, a mono-phasic solution of phenol and guanidine isothiocyanate is an 
improvement of the single-step RNA isolation method development by Chomezynski and 
Sacchi [310]. During sample homogenization or lysis, TRIzol reagent maintains the 
integrity of the RNA, while disrupting cells and dissolving cell components. Addition of 
chloroform followed by centrifugation was used to separate the aqueous phase containing 
RNA and the organic phase containing DNA and other material. 
 
• Separation phase 
- The samples were thawed by placing them at room temperature for 10 minutes; 
- Placed into the Thermo Mixer at 37◦C for 10 minutes and 1400 rotations per 
minute (r.p.m); 
- 0.2 ml of chloroform was added and the tubes vortexed for 15 minutes at the 
highest velocity; 
- Samples were then centrifuged for 10 minutes at 8◦C at 10600 r.p.m.. 
 
Note: Following centrifugation, the mixture separates into different phases: a lower red, 
phenol-chloroform phase, an interface, and a colourless aqueous phase. RNA remains 
exclusively in the aqueous phase.  
 
• RNA precipitation 
- The aqueous phase was transferred to a new RNase free tube (approximately 0.5 
ml); 
- The washing was repeated with chloroform, but it was vortex only 15 seconds, 
centrifuged for 10 minutes at 8◦C at 10600 r.p.m and the aqueous phase was 
transferred to a new RNase free tube; 
- The RNA was precipitated from the aqueous phase by mixing with 0.5 ml of cold 
(4◦C) 100% EtOH. The tube was inverted 5 times to mix; 
- The samples were incubated at -20ºC for 30 minutes and were centrifuged at 10 
minutes at 10600 r.p.m. 
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Note: The RNA precipitate forms a gel-like pellet on the side and bottom of the tube. 
 
• RNA wash 
- The supernatant was removed by inverting the tube and the RNA pellet washed 
with 1 ml of 75% EtOH; 
- The samples were mixed by inverting the tube. The samples were centrifuged at 
no more than 8400 r.p.m for 5 minutes at 8◦C; 
- The supernatant was taken off carefully with a 1000 µl pipet (always at the 
opposite side of the pellet).  
 
• Redissolving the RNA 
- The RNA pellet was dried in a Thermo Mixer at 37ºC for 2-5 minutes; it is 
important not to let the RNA pellet dry completely as this will significantly 
decrease its solubility; 
- The RNA was dissolved immediately in 24 µl RNase-free water. 
 
3.2.2.3 RNA purification 
 
3.2.2.3.1 RNA clean-up  
The clean-up of the RNA samples was performed using the RNeasy MinElute Cleanup kit 
(Qiagen) according to the manufacturer’s instructions. This clean-up protocol is important 
for RNA to be used for enzymatic reactions, for desalting, and for concentrating the 
RNA.  
3.2.2.3.2 DNase digestion 
All the samples were digested with DNase (Deoxyribonuclease I). We added to the RNA 
samples 10 µl of the DNA digestion buffer RDD (RNase-Free DNase Set) and 2,5 µl of 
DNase solution and the volume was completed with water up to 100 µl. The samples 
were placed into the Thermo Mixer at 23◦C for 10 minutes. Subsequently the samples 
were cleaned using RNeasy MinElute Cleanup kit (Qiagen) adding β-mercaptoethanol to 
RLT buffer (RNeasy Lysis Buffer) to obtain better results. 
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3.2.2.3.3 Ethanol precipitation of RNA 
For the samples with poor quality we used 3 EtOH wash. We added to the RNA sample 
1/10 volume of Sodium Acetate (3 M, pH 5.2) and 3 x volume of 100% EtOH. The 
samples were incubated on ice 15 minutes and centrifuged at 14,500xg for 30 minutes at 
room temperature. The supernatant was discarded and the pellet washed with 70% EtOH. 
The samples were centrifuged again for 15 minutes at the same speed. The supernatant 
was discarded and the pellet was dry at room temperature to evaporate all the EtOH. The 
pellet was dissolved in 14µl RNase free water. 
3.2.2.4. RNA quality assessment 
3.2.2.4.1 Concentration and integrity 
For detection of RNA quality, RNA yield, A260:A280 ratio (good ratios between 1.8 and 
2.0) and concentration were determined using a NanoVue spectrophotometer (GE 
Healthcare). RNA integrity was determined by measuring 28S/18S rRNA ratios and 
calculating the RNA integrity number (RIN) using an Agilent 2100 Bioanalyser and RNA 
6000 Nano LabChip (Agilent Technologies).  
3.2.2.4.2 Reverse transcription polymerase chain reaction (RT-PCR) and β-Actin test 
The RNA samples with RIN numbers above 4 were used for cDNA synthesis using 100 
ng of total RNA and a High Capacity cDNA Reverse Transcription kit and following the 
manufactures instructions. 
PCR amplification of a fragment of β-actin gene, the reference gene, was performed in a 
20 µl final reaction volume using the following conditions: 1X GoTaq Flexi Buffer; 0.125 
mM of each dNTP; 0.8 mM of MgCl; 5 pmol of each primer and 0.25 U of GoTaq 
(Promega). 100 ng of cDNA was used in each reaction and deionized water was used to 
attain the final volume. Primer sequences and optimal annealing temperatures applied are 
given in table 3-12. 
 
Table 3-12. Forward and reverse oligonucleotide primers (5’→3’) used in PCR reactions of 
β-Actin gene. 
Forward Reverse At (ºC) PCR band size (bp) 
TGGTGGGCATGGGTCAGA GTACATGGCTGGGGTGTTGA 54 249 
Abbreviations: At- Annealing temperature, bp- base-pair. 
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3.2.2.5 Gene Expression 
The Real-Time PCR reactions were performed with TaqMan chemistry using an Applied 
Biosystems 7500 Fast Real-Time PCR System. For each sample duplicate reactions were 
used and the TaqMan Gene Expression Assays: Hs00184566_m1 for the target gene 
(ABCC6 gene) and the Hs00237047_m1 for the endogenous control gene YWHAZ 
(Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta). 
The reactions were made using 200 ng of cDNA in the control assay plate and 400ng in 
the target gene plate. The PCR conditions were performed according to the 
manufacturer’s instructions. For each assay we used Standard run and the comparative Ct 
(cycle threshold) method. The data analysis was performed using the comparative ΔCt 
method (ΔCt). 
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4. CHONDROCALCINOSIS ASSOCIATED WITH 
GITELMAN SYNDROME 
4.1 Abstract 
 
Gitelman Syndrome (GS) is a rare autossomal recessive inherited tubulopathy caused by 
mutations in the SLC12A3 gene. The association of GS with chondrocalcinosis (CC) has 
been described in the literature as a typical example of hypomagnesemia-induced crystal 
deposition disease but its role in CC development is not fully understood.  We aimed to 
investigate the association between GS and CC, by analysing one Azorean kindred, with 
an index-case presenting CC, hypomagnesemia and hypokalemia.  
SLC12A3 gene was screened in the proband and the variant detected was procured in 
family members. The proband was homozygous for the S615L mutation and presented 
chondrocalcinosis. Seven of the tested individuals in the probands family were 
heterozygous for the mutation and one presented CC. The presence of CC in two other 
individuals of the family was most likely sporadic, and associated with their advanced 
age. 
The genetic cause for GS in a proband with secondary early onset CC was associated with 
S615L mutation of the SLC12A3 gene. 
 
Keywords: SLC12A3, Gitelman syndrome, Chondrocalcinosis, hypomagnesemia. 
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4.2 Introduction 
Gitelman Syndrome (GS, OMIM #263800) is a rare autossomal recessive tubulopathy 
with a prevalence of approximately 1:40.000 in the Caucasian population [311]. Onset 
usually occurs in adult life, but cases of childhood onset are also known [311]. The 
condition is characterized by hypomagnesemia, hypokalemia, metabolic alkalosis, 
hypocalciuria and hyperreninemic hyperaldosteronism [312]. The clinical spectrum is 
wide and includes: cramps, myalgies, muscle weakness, tetany, and paralysis [313]. GS is 
caused by inactivating mutations in member 3 of the solute carrier family 12 gene 
(SLC12A3), which consists of 26 exons and is located on the long arm of chromosome 16 
[311]. This gene encodes a thiazide-sensitive sodium-chloride cotransporter (NCCT) 
expressed in the distal convoluted tubule of the kidney. NCCT is a polypeptide which 
consists of 1021 amino acids. Its 2-D structure is predicted to contain 12 transmembrane 
domains and intracellular amino- and carboxyterminal regions [313, 314]. To date, 
according to the Human Gene Mutation Database (http://www.hgmd.cf.ac.uk/), more than 
300 different mutations have been identified in patients with GS. Detected mutations 
include missense, non-sense, frame-shift, and splice-site mutations and are scattered 
throughout the transporter protein with a possible clustering of mutations in the carboxy-
terminal tail [315, 316]. Genetic heterogeneity exist, and a minority of patients with GS 
phenotype, who do not have mutations in the SLC12A3 gene, has been shown to have 
mutations in the CLCNKB gene [317, 318]. This gene encodes the renal chloride channel 
ClC-Kb, located in the basolateral membrane of cells of the thick ascending limb of 
Henle’s loop and the distal tubules. Mutations in CLCNKB gene have also been 
associated with classic Bartter syndrome, the most important genetic disorder to consider 
in the differential diagnosis of GS. Both loss-of-function mutations in NCCT and in CLC-
Kb lead to disruption of NaCl reabsorption in the distal convoluted tubule. Therefore, it is 
important to screen the CLCNKB gene in patients with GS who do not have mutations in 
the SLC12A3 gene [319].  
The association of GS with CC has been described in the literature as a typical example of 
hypomagnesemia-induced crystal deposition disease [312]. CC is characterized by 
deposition of crystals of calcium pyrophosphate dihydrate (CPPD) in articular hyaline 
and fibro-cartilage [312]. Several cases of GS associated with CC have been published in 
the literature [261, 312, 320-331]. The role of hypomagnesaemia in the development of 
CC, however, is not fully understood. A cross-sectional study demonstrated that CC was 
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significantly higher in patients with lower serum magnesium levels (OR 13.5, 95% CI 
2.76-127.3, P<0.0001) [332]. Magnesium is an important cofactor for alkaline 
pyrophosphatase, an enzyme that plays a key role by converting inorganic pyrophosphate 
(PPi) to orthophosphate (Pi). A reduction in the activity of this enzyme due to 
hypomagnesaemia could induce CPPD by raising extracellular levels of PPi that with 
calcium is a crucial precursor for CCPD crystal nucleation  [333]. CPPD may be found in 
other conditions associated with hypomagnesaemia, such as short bowel syndrome or 
tacrolimus therapy in liver transplantation patients [333].  
The aim of this study was to investigate the association between GS and CC, by analysing 
one Azorean kindred, with an index-case presenting CC, hypomagnesemia and 
hypokalemia. The SLC12A3 gene was screened in the proband and the variant detected 
was procured in family members and they were also clinically evaluated to determine if 
they presented CC.  
4.3 Material and methods 
The proband, a 60 years-old Caucasian male, was first observed in the Rheumatic 
Diseases Clinic, Hospital de Santo Espírito da Ilha Terceira (HSEIT), Azores, Portugal 
when he was 48 years old. The proband and his parents were born in Terceira island. 
Symptoms started when the proband was 33 years old, mainly affecting knees, ankles, 
wrists, elbows and achilles tendons.  In the proband, pyrophosphate crystals were 
identified in the synovial fluid aspirated from a right knee effusion. From that time he was 
treated with colchicine, NSAIDS (Nonsteroidal anti-inflammatory drugs), and oral 
potassium and magnesium. Laboratory tests revealed normal leukocyte, erythrocyte and 
platelet count. Blood urea was 33 mg/dl, creatinine 0.9 mg/dl and glucose 177 mg/dl. 
Serum electrolyte concentrations were as follows: sodium 139 mEq/L, potassium 3.2 
mEq/L, calcium 9.8 mg/dl, and magnesium 1.1 mg/dl. In spite of the treatment with 
colchicine, patient remained hypokalemic and hypomagnesemic, however he showed 
some improvements. Using the diagnostic criteria of Bettinelli et al [334] a clinical 
diagnosis of GS was suspected, and a diagnosis of knee CC was made after the 
identification of bilateral knee cartilage calcification (Figure 4-1). The family members of 
the proband were investigated and a blood sample and x-rays were taken from all of them. 
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Figure 4-1. X-rays of proband showing classical CC in knees (image A) and his son without 
CC (image B). The presence of CC is indicated by arrows. 
 
Genomic DNA was extracted from peripheral blood cells using the salting out procedure 
and used as the template for PCR amplification of individual exons of the SLC12A3 gene. 
Twenty-six pairs of oligonucleotide primers were generated to amplify all 26 exons 
(primer sequences and PCR conditions available in chapter 2 of this thesis).  
PCR products were purified using ExoSAP-IT™ and following the manufactures 
instruction and then sequenced using BigDye Terminator v3.1. In brief, PCR amplicons 
were ressuspended in 15 µl formamide and directly sequenced using the ABI 3130xl 
sequencer (Applied Biosystems). Genetic variants of all the 26 exons and intron-exon 
boundaries of the SLC12A3 gene were screened with SeqScape (Applied Biosystems) 
using as reference the NCBI sequence NG_009386.1. SLC12A3 gene was screened in the 
proband and the variant detected was then screened in family members. This study was 
approved by the HSEIT Ethics Committee and all participants provided informed consent. 
4.4 Results 
Through SLC12A3 direct sequence analysis in the proband a silent variant, A to G 
transition at position c.366 (rs2304479) in exon 2 and a missense substitution in exon 15 
(rs779160677) previously described as associated to GS were detected [335]. This 
mutation (rs779160677), a C to T transition at position c.1869, changed the small size and 
polar amino acid serine to a medium size and hydrophobic leucine at position 615 
(S615L), and had a SIFT score of 0 and a PolyPhen value of 0.996, both values 
suggestive of a deleterious variation.  
The presence of the mutation in thirteen family members was investigated (5 men, 8 
women; 25-79 years; mean age 51 years) and blood tests and x-rays were obtained from 
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each family member (data not shown). The pedigree with investigated individuals is 
shown in figure 4-2.  
 
Figure 4-2. Heredogram with investigated individuals; Proband with GS and CC is 
indicated by the arrow.  
 
 
Biochemical data in these patients revealed they had normal levels of serum magnesium 
ranging from 1.9 to 2.3 mg/dL and normal levels of potassium ranging from 3.7 to 4.7 
mmol/L. Taking in consideration the ratio K/Mg, we found that all the individuals with 
CC ( III.2, III.16 and III.19) had a racio >2.3. The only individual with a K/Mg ratio > 2.3 
that did not present any signs of CC, is a Human leukocyte antigen (HLA) B27+ young 
female of only 25 years of age (Table 4-1).  
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Table 4-1. Characteristics and SLC12A3 gene variants and blood chemistry levels in the 
proband and the thirteen selected individuals from their family pedigree. The proband is 
indicated by bold. a Normal serum magnesium  1.5 - 2.5 mg/Dl : b Normal serum potassium 
3.3 - 5.1 mmol/L. 
Individuals Sex Age Mg a 
mg/dL 
 
K b 
mmol/L 
Racio 
(K/Mg) 
CC 
SLC12A3 variants 
A122A S615L 
III.2 M 62 1.1 3.2 2.9 + A122A/A122A S615L/S615L 
III.12 M 75 2.1 4.7 2.23 - A122A/WT S615L/WT 
III.13 F 67 2.2 4.1 1.86 - WT/WT WT/WT 
III.16 M 75 2.0 4.6 2.3 + WT/WT WT/WT 
III.19 F 79 1.9 4.7 2.47 + A122A/WT S615L/WT 
IV.1 M 35 2.3 3.7 1.6 - A122A/WT S615L/WT 
IV.2 F 54 2.2 4.2 1.9 - A122A/WT S615L/WT 
IV.4 M 46 1.9 4.0 2.1 - A122A/WT S615L/WT 
IV.14 F 51 1.9 4.0 2.1 - WT/WT WT/WT 
IV.16 F 49 2.2 4.1 1.86 - WT/WT WT/WT 
IV.17 F 45 1.9 4.3 2.26 - WT/WT WT/WT 
IV.21 M 37 2.1 4.1 1.95 - A122A/WT S615L/WT 
IV.22 F 36 2.0 3.7 1.85 - A122A/WT S615L/WT 
V.1 F 25 2.0 4.7 2.35 - WT/WT WT/WT 
Abbreviations: M- male, F- female, CC- Chondrocalcinosis, WT- wild type, Mg- Magnesium, K- 
potassium. 
 
Seven of the 13 family members analysed were found to be heterozygous for the S615L 
mutation, but only one, a female of 79 years of age, presented CC. Furthermore, six 
individuals of the 13 were wild-type homozygous at position 615 in the gene, 
nonetheless, one of them, a male of 75 years of age (III.16) presented CC (Figure 4-2 and 
table 4-1). 
4.5 Discussion 
The GS patient described in this study has the S615L variation in homozygosity, while all 
of the other cases of GS with this variation were reported in compound heterozygote’s (2, 
10). In our study, seven individuals heterozygous for the S615L mutation did not have 
either hypokalemia or hypomagnesemia, indicating that they were asymptomatic carriers 
of this mutation. Hypomagnesemia and hypocalciuria are found in most cases of GS, 
however, some cases with mutations in the NCCT do not show these conditions [336]. It 
is believed that hypomagnesaemia causes CC by increasing the formation and at the same 
time reducing the solubility of CCP crystals [333]. It is known that an excess of PPi is the 
main precursor for CPP crystal nucleation. Because magnesium is a necessary cofactor 
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for numerous enzymes, such as pyrophosphatases, and considering the fact that it 
increases the solubility of CPP crystals, it has been proposed that low levels of 
magnesium could induce CPP deposition disease by raising PPi and/or reducing the 
saturation product of CPP crystals [329].As far as we know the ratio Mg/K was never 
considered in CC development. In this study, this ratio seems relevant since all the 
patients with CC show a ratio >2.3. Individual V.1, presenting a K/Mg ratio of 2.35 does 
not show any signs of CC yet, however she is HLA-B27+ (B*2705;49). HLA-B*27 
belongs to the MHC complex on chromosome 6 that is strongly associated with 
ankylosing spondylitis, a disease characterized by the presence of calcifications on the 
axial skeleton [131, 132].  
The prevalence of CC increases with age (10-15% for people between 65 and 75 years) 
and is hence called sporadic in patients older than 60 years, whereas in younger 
individuals there are several putative underlying disorders causing CPPD deposition 
disease, such as hemochromatosis, hyperparathyroidism, hypomagnesemia or 
hypophosphatemia [337]. The assumption that GS is caused by a defect in the NCCT 
cotransporter in the renal distal tubule has been demonstrated  by the association of a 
number of different mutations in the SLC12A3 gene in patients with GS [311, 315, 336, 
338]. In spite of the growing number of causative mutations identified in GS patients, 
more than 40% of patients carry only a single mutation in SLC12A3, instead of being 
compound heterozygous or homozygous, suggesting mutations may predispose to the 
disease and in the presence of other factors, yet to be identified, the disease develops or 
not [3]. 
In the present study, the specific involvement of this cotransporter in the aetiology of this 
disorder is further substantiated by the finding that the proband is homozygous for the 
S615L variation. The S615L identified in this study has previously been described by 
Cruz and co-workers [335] in a study involved 36 kindreds from the United States, 
Canada and England and later reported in a study by Syrén et al [339] in which 21 
patients from 19 unrelated families were investigated and fifteen new mutations were 
identified. Although the SLC12A3 variations reported in previous studies are distributed 
throughout the whole protein [315, 340], the study of Lemmink et al [315] indicates that 
the carboxy-terminal end represents a hot spot for variations. S615L is located at the 
intracellular C-terminal end of the NCCT protein. It is conceivable that structural 
alterations due to SLC12A3 variations in the C-terminal domain interfere with 
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phosphorylation of the NCCT protein and as such with its regulation and that this creates 
physiological conditions that favour CCP crystal formation [315].  Evidence for an 
association between CC and GS mainly comes from uncontrolled case reports, case series 
and only one cross-sectional study. As a result, its epidemiology remains unknown [333]. 
There have been few cases described with a definite diagnosis of CC due to GS. In some 
patients with CPPD deposition disease secondary to hypomagnesemia, the stabilization of 
magnesium and potassium levels can reduce the deposition of CPP crystals in the 
synovium and synovial fluid, reducing the frequency of attacks of articular pain [329]. 
We are facing a case of a pedigree where the genetic cause for GS has been identified. 
The presence of CC in two individuals of this family is probably sporadic since they are 
both older than 65 years old. In this study, the number of patients included was small (one 
family); however our results suggest that our proband had an early onset of CC because it 
was secondary to GS. Further studies are needed in order to gain insight into the 
pathophysiology and prevalence of CC in patients with GS. 
4.6 Conclusion 
GS is a hereditary disease characterized by defective tubular reabsorption of magnesium 
and potassium, mostly caused by mutations in the SLC12A3 gene. Sometimes GS 
patients, as in our study, might come with a CC diagnosis. We identified the genetic cause 
for GS in a proband with secondary early onset CC. Further studies are needed in order to 
shed light on the pathophysiology and prevalence of CC in patients with GS. 
4.7 Future work  
1) Typing the HLA-B-allele of all family members to verify from where derives 
the B27+ 
2) Verify the relevance of Mg/K ratio in one cohort of CC patients comparing 
with a control group. 
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5. INVESTIGATING THE ROLE OF THE RSPO4 AND 
LEMD3 GENES WITH DISH/CC PHENOTYPE 
5.1 Abstract 
 
DISH/CC is a poorly understood phenotype characterised by peripheral and axial 
enthesopathic calcifications, frequently fulfilling the radiological criteria for DISH, and in 
some cases associated with CPPD Chondrocalcinosis (CC). The concurrence of DISH and 
CC suggests a shared pathogenic mechanism. To date, the ANKH gene is the only 
monogenic cause identified for CC and COL6A1 and FGF2 are two susceptibility genes 
with a weak genetic link to DISH. Two genes; RSPO4 and LEMD3 were identified in a 
previous analysis of shared chromosomal segments across 4 DISH/CC families from 
Terceira Island. The current study aims to investigate the possible link between RSPO4 
and LEMD3 genetic variants in the aetiology of DISH/CC. 
DNA from 55 patients with DISH/CC and 36 controls without DISH/CC were obtained 
for a case control association study. To verify the segregation within families, 74 family 
members from 9 families harbouring one or more genetic variant in RSPO4 or LEMD3 
genes were investigated. The entire DNA coding region of the candidate gene RSPO4 and 
exon 13 of the LEMD3 gene were amplified by PCR and Sanger sequencing and 
statistical analysis was performed using Plink V1.9. 
Nine genetic variants were identified in the RSPO4 gene; 3 regulatory region variants 
(rs146447064, rs149154047 and rs6056520), 1 splice site variant (rs775644973), 2 
synonymous (rs150446609 and rs41275604) and 3 missense mutation variants 
(rs6140807, rs201485021 and rs61740632). No statistically significant difference in the 
occurrence of these genetic variants was observed in DISH/CC phenotype relative to the 
control. However, two regulatory variants (rs146447064 and rs14915407) are 
significantly more frequent in controls than in DISH/CC patients. The 10 genetic variants 
in RSPO4 and in LEMD3, did not segregate within the families studied. 
The results of the present study revealed that the RSPO4 gene regulatory variants: 
rs146447064 rs149154047, may protect against the DISH/CC phenotype in Terceira 
Island, possibly by altering gene expression of the RSPO4 gene. Variant rs201930700 in 
LEMD3 is extremely rare thus, its effect is difficult to ascertain at this point. 
Keywords: RSPO4, LEMD3, Chondrocalcinosis, DISH, sequencing, variants. 
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5.2 Introduction 
Diffuse Idiopathic Skeletal Hyperostosis (DISH, MIM 106400) and Chondrocalcinosis 
(CC; MIM #118600) are diseases characterized by ectopic calcifications. DISH is 
characterized by the ossification of enthesis in the axial and peripheral skeleton, affecting 
the anterior longitudinal ligament, in particular the right side of the spine, with 
preservation of the intervertebral disc space [1]. CC is characterized by the deposition of 
calcium containing crystals in articular cartilage, synovial membranes and, less often, in 
periarticular soft tissues [341, 342]. ANKH mutations are the only known cause for a very 
small number of cases of monogenic CC (CC; MIM #118600) [110, 343-345] as well as 
craniometaphyseal dysplasia (CMDD; MIM #123000) [346-348]. The ANKH gene maps 
on chromosome 5 (5p15.1) and encodes a multipass transmembrane protein ANK that 
transports intracellular PPi to the extracellular milieu [106], where it acts as a potent 
inhibitor of mineralization [108].  The aetiology of DISH is still unknown, but several 
lines of evidence suggest that genetic factors might be involved in its aetiology [64, 77, 
78]. Very few genetic studies on DISH have been published and up until now only two 
genes - COL6A1 [33, 146] and FGF2 [147] - have been shown to have a positive 
association with DISH susceptibility.  Nonetheless, variants that showed significant 
association, in both genes, are located in non-coding regions and are very common 
variants within the general population, which suggests that these variants have only a 
minor effect on DISH susceptibility. DISH is very similar to, and can coexist with 
Ossification of the Posterior Longitudinal Ligament (OPLL; MIM 602475), a disease in 
which the genetic background is considered relevant in its aetiology. Unlike DISH, OPLL 
has been extensively investigated and despite some conflicting studies, a great number of 
susceptibility genes have been reported along the years. These included genes for 
Collagen 6A1 and 11A2 (COL6A1 and COL11A2) [33, 177], Bone morphogenetic protein 
2 and 4 (BMP2 and BMP4) [158, 161], Ectonucleotide 
Pyrophosphatase/Phosphodiesterase 1 (ENPP1) [166], Transforming growth factor 1 and 
3 receptor (TGFβ1 and TGFβ3) [154, 170], Estrogen receptor 1 (ESR1) [154], R-Spondin 
2 (RSPO2) [172, 349] among others. However, as in DISH, genetic variants with a 
positive association with OPLL seem to have a minor effect on susceptibility to the 
disease. 
The coexistence of DISH with CC is very common on Terceira Island-Azores leading our 
group to hypothesise that both diseases, hereafter designated  as DISH/CC phenotype,  
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share the same pathogenic mechanism [23]. A similar phenotype has been reported in 
several studies in the past [25, 26]. In a previous study, our group, try to determine the 
genetic cause for this phenotype using a whole genome linkage analysis followed by an 
“Identity-by-state/descent” mapping in 10 affected individuals from 4 different families. 
Identity by descent (IBD) mapping is a statistical method for detection of genetic loci that 
share an ancestral segment among “unrelated” affected pairs of individuals. IBD mapping 
is more robust to allelic heterogeneity and can be used as a complementary method to 
genome-wide linkage studies, to identify rare inherited variants when combined with 
sequence data. The chromosome zones considered of interest were selected taking into 
consideration the maximum pairs sharing. Two zones, in chromosome 12 (65667554 – 
68670915) and 20 (821749-1266214 and 5157217-6074302) had the maximum number 
of pairs and thus the genes within this region were investigated. Two candidate genes 
were further investigated: RSPO4 in chromosome 20 (Chr 20:958452 – 1002284) and 
LEMD3 located very near the chromosome 12 (65169571-652483279). RSPO4 encodes a 
member of the R-spondin family, a group of four proteins which positively regulate 
canonical Wnt signaling by reducing Wnt receptor turnover and thereby increasing beta-
catenin stabilization. R-spondins may contribute to the maintenance of adult bone mass 
by regulating osteoblastogenesis and bone formation [350]. Loss of function mutations in 
the RSPO4 gene cause congenital anonychia (NDNC4; MIM #206800) or the absence of 
nails [351]. LEMD3 (LEM Domain Containing 3) encodes the Inner nuclear membrane 
protein Man1, which helps to control two important signaling pathways namely the 
Transforming Growth Factor-βeta (TGF-β) and the Bone Morphogenetic Protein (BMP) 
signaling. Man1 can interact directly with the TGF-β superfamily ligands, including bone 
morphogenic proteins (BMPs) and activin, or via its C-terminal domain, directly with 
Smad, which bind to specific areas of DNA to activate specific genes [352]. Genetic 
variants of LEMD3 have been associated with Osteopoikilosis and Buschke-Ollendorff 
Syndrome (BOS; MIM #166700) [353]. The present study targets genetic variants of the 
RSPO4 and LEMD3 genes located in chromosomal segments identified in a previous 
study as being associated with DISH/CC.  
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5.3 Material & methods 
5.3.1 Subjects 
This study involved nine DISH/CC families and studied 74 members (44 males; 30 
females). Blood was obtained from all members who gave informed consent. Genomic 
DNA was extracted from peripheral blood cells using a standard Salting-out procedure. 
Standard X- rays were taken from: knees, axial skeleton, wrists, hands, elbows and pelvis. 
Amongst the 74 members, 46 were affected with DISH/CC, 20 had no signs of the 
disease and 8 were too young (< 25 years old) to establish likely disease status. A group 
of 55 unrelated Azorean patients with a diagnosis of DISH/CC (36 male, 19 female; age 
of onset around 40 years) and 36 unrelated controls (with no signs of DISH/CC) with a 
similar ethnic background (16 male, 20 female; mean current age, 68 years; range, 57-
102) were also included.  
The LEMD3 rs201930700 frequency was evaluated on a randomized population of 124 
individuals from Terceira Island (45 males, 79 females; mean age, 66 years; range, 35-
100). This study was conducted with the approval of the HSEIT Ethics Committee.  
5.3.2 RSPO4 & LEMD3 sequencing  
RSPO4 gene primer pairs were designed using the software Primer3 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) to amplify/sequence 
regulatory, coding regions and intron exon boundaries, from 55 patients with DISH/CC 
disease and from 36 unaffected controls subjects. The LEMD3 variant (rs201930700) was 
typed using primers previously described by Hellemans and collaborators [307].  
All primers, amplification conditions and codes for reference sequences are available in 
the materials and methods section of this thesis. PCR fragments were purified with 
ExoSAP-IT™ and sequenced using ABI Big Dye chemistry (unidirectional, or when 
necessary, bidirectional) followed by purification with EDTA/Sodium Acetate and 
ethanol precipitation. Sequencing products were run on an automated DNA sequencer 
ABI 3130XL (Applied Biosystems®) and genetic variants were screened by sequence 
analysis and SeqScape (Applied Biosystems). Base calling for heterozygous positions 
was made if the lower peak of the two co-incident peaks was higher than 25% of the 
highest peak. 
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The genetic variants found in the RSPO4 gene were screened within the families, where 
they occurred, whenever possible. The LEMD3 rs201930700 variant was typed in a 
representative randomized group of 124 individuals from Terceira Island. 
5.3.3 Statistical analysis 
All SNPs were checked for Hardy-Weinberg equilibrium (HWE). For all DISH/CC 
families, a transmission disequilibrium test (TDT) was used to assess the difference of the 
allele frequencies between the affected patients with DISH/CC and unaffected 
individuals. The TDT test was calculated for CHISQ, odds ratios (OR) (95% confidence 
interval) and corresponding p-values. To assess the difference in allele frequencies 
between the 55 patients with DISH/CC and the 36 control individuals and between males 
and females a Fisher exact test was used. The Fisher exact test was calculated for odds 
ratios (OR) (95% confidence interval) and corresponding p-values.  
To perform an association between the DISH/CC disease and an allele variant other tests 
were employed: Cohran-Armitage trend, dominant and recessive gene action tests with 1 
degree of freedom and genotypic test with 2 degree of freedom. For all statistical tests 
used a p-value of ≤0.05 was considered statistically significant.  All statistical analysis 
were performed using PLINK software [354]. 
5.4 Results 
5.4.1 RSPO4 sequencing 
Nine genetic variants were identified in the RSPO4 gene; 3 missense variants (rs6140807 
and rs61740632), 1 splice site variant (rs775644973), 2 synonymous (rs150446609 and 
rs41275604) and 3 regulatory region variants (rs146447064, rs149154047 and rs6056520) 
(Table 5-1). All of them were in HWE. Two of the variants located on the regulatory 
region of the RSPO4 gene (rs146447064 and rs149154047) were located in a fully 
conserved region and were rare, with a MAF value of 0.01 (Table 5-1). The same was 
observed for the synonymous variant rs150446609 which was very rare (<0.01) and was 
located in a fully conserved region. The missense variant rs201485021 was located in 
exon 3 and the SIFT score of 0 and PolyPhen value of 1 indicates that this variant has a 
deleterious and a damaging effect on the protein, respectively. In addition, this variant 
was located in a fully conserved region and was extremely rare (MAF <0.01); in the 
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“1000 genomes” (genomes from 26 different populations) the variant was identified in 
only 2 males from an Iberian population in Spain. 
Table 5-1. Genetic variants identified in the RSPO4 gene and functional significance 
information. Nucleotide conservation was obtained using an alignment of: Human, 
Chimpanzee, Mouse lemur, Pig, Hedgehog and Elephant available in the Ensembl database 
database (http://www.ensembl.org/index.html) (Accessed on January 2017). 
Exon/ 
Intron 
Variant SNP 
Type of 
variant 
MAF SIFT PolyPhen 
Nucleotide 
Conservation 
Upstream 
gene 
c.-131C>T rs146447064 
Regulatory 
region 
0.01 NA NA Fully conserved 
Upstream 
gene 
c. -115G>A rs149154047 
Regulatory 
region 
0.01 NA NA Fully conserved 
5’prime c. -85 G>A rs6056520 
Regulatory 
region 
0.35 NA NA 
1 species non conserved 
(Mouse lemur) 
Exon 1 c. 12 A>C rs150446609 
Synonymous 
p.Pro4= 
<0.01 NA NA Fully conserved 
Intron 1 c.79+1G>A rs775644973 
Splice donor 
(HGMD 
mutation) 
<0.01 NA NA Fully conserved 
Exon 3 
c.317G>A rs6140807 
Missense 
p.Arg106Gln 
0.03 0.21 0.072 
2 species non conserved 
(Pig and Hedgehog) 
c.367 C>G rs201485021 
Missense 
p.Pro123Ala 
<0.01 0 1 Fully conserved 
Exon 4 c.471C>T rs41275604 
Synonymous 
p.Cys157= 
0.01 NA NA 
1 species non conserved 
(Hedgehog) 
Exon 4 c.524A>T rs61740632 
Missense 
p.His175Pro 
0.01 0.3 0 
4 species non conserved 
(Mouse lemur, Pig, 
Hedgehog and Elephant) 
Abbreviations: SNP- Single nucleotide polymorphism, MAF- Minor allele frequency, SIFT- Sorting 
Intolerant From Tolerant, PolyPhen- Polymorphism Phenotyping, HGMD- Human gene mutation database, 
Pro- Proline, Arg- Arginine, Gln- glutamine, Ala- alanine, Cys- Cysteine, His- histidine, NA- not 
applicable. 
 
In our study, this variant was found in only one female in our control group (n=36).The 
other two missense variants (rs6140807 and rs61740632), despite presenting SIFT and 
PolyPhen values indicatives of a minor effect on the protein (tolerated and benign, 
respectively), were both relatively rare. We found an extremely rare HGMD mutation 
(rs775644973 or CS065613), that has been associated with congenital anonychia [355]. 
The variant was found in only one female in our group of 55 DISH/CC patients, which is 
unaffected by congenital anonychia. 
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In order to perform a segregation analysis we tracked back the variants within 7 DISH/CC 
families, available in the AZORBIO biobank, where the variants were found. We 
investigated 7 variants: rs146447064 in AZ2, rs149154047 in AZ4, rs6056520 in AZ1, 
AZ2, AZ4 and AZ9, rs150446609 in AZ5, rs6140807 in AZ7 and AZ8, rs41275604 in 
AZ1 and AZ5 and rs61740632 in AZ1 and AZ7 families (Figure 5-1). 
 
 
Figure 5-1. Typing results for RSPO4 gene in DISH/CC families. 
 
In AZ2 family we studied three individuals and we found the regulatory region variant 
rs146447064 in heterozygosity in two of them (III:1 and IV:2) (Figure 5-1). In this 
family, all the individuals studied were affected and so the results from this family were 
not used for statistical tests. 
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The other regulatory region variant - rs149154047 - was found in heterozygosity in 9 
individuals; 7 DISH/CC affected and in 2 unaffected. According to the statistical analysis 
shown in table 5-2, the variant rs149154047 was not associated with DISH/CC phenotype 
in AZ4 family. However, an important consideration in relation to this family was that of 
the 15 individuals studied, 12 of them are affected and only 3 were unaffected (individual 
III-1; III-8 and IV-1, with unknown age, 77 and 53 years, respectively). 
 
Table 5-2. Family based association test (TDT test) results for variants of RSPO4 gene. 
SNP Family 
Alleles 
M/m 
TDT 
TR:UT OR CHISQ P 
rs146447064 AZ2 C/T 1:0 NA 1 0.317 
rs149154047 AZ4 G/A 1:1 1 0 1 
rs6056520 
AZ1 T/C 0:2 0 2 0.157 
AZ2 C/T 0:1 0 1 0.317 
AZ4 C/T 1:1 1 0 1 
AZ9 C/T 2:1 2 0.333 0.564 
rs61740632 AZ1 A/C 0:1 0 1 0.317 
Abbreviations: SNP- Single nucleotide polymorphism, M/m – major allele/minor allele, TDT- 
Transmission disequilibrium test, TR:NT-Transmitted/Untransmitted minor allele account, OR- odds ratio, 
P- pvalue, p value, NA- not applicable. 
 
The variant rs6056520 was heterozygous in several families in a great number of 
individuals. However it was homozygous only in DISH/CC affected males of the families 
AZ1 and AZ4 (Figure 5-1).  
The synonymous variant rs150446609 in the AZ5 family was present in all DISH/CC 
affected individuals, however the variant was also found in one unaffected individual 
(II:5 individual) (Figure 5-1). In the AZ5 family few individuals were studied (6 
individuals; 3 affected, 2 unaffected and 1 unknown), so it is not possible to draw great 
conclusions.  
The missense variant rs6140807 was present in all the individuals studied in AZ7 and 
AZ8 families, except the affected individual (proband) in AZ8 family (individual II:1) 
which was the wild type for this variant (Figure 5-1).  
The synonymous variant rs41275604 was found in AZ1 and AZ5 families. In the AZ5 
family the 3 DISH/CC affected individuals were carriers of the rs41275604 variant, 
which contrasts with the AZ1 family in which none of the 9 DISH/CC affected 
individuals presented the variant. In this family the rs41275604 variant was only found in 
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one unaffected female (III:3). No relationship was found between this variant and the 
DISH / CC phenotype. 
The variant rs61740632 in the AZ1 family was only found in one unaffected woman (II: 
4), however segregation with the DISH/CC phenotype seemed to occur in the AZ4 
family; the variant was present in all DISH/CC affected individuals and absent in the 
unaffected individuals. No association was verified maybe because the number of 
individuals studied was too small to reach statistical significance.  
The RSPO4 gene was further sequenced in 36 unrelated control individuals without 
DISH/CC in order to perform a case/control association study. The results are shown in 
table 5-3.  
 
Table 5-3. Association study results of genetic variants found in RSPO4 gene in Azorean 
patients with DISH/CC and controls without DISH/CC disease. The minor allele is 
represented in bold. 
SNP 
A
ll
el
es
 
MAF Fisher exact test 
DISH/CC Controls DISH/CC vs Controls 
All         
N=55 
F 
N=19 
M      
N=36 
All          
N=36 
F  
N=22 
M      
N=14 
All F M 
OR P OR P OR P 
rs146447064 
C
/T
 
0.05 0.03 0.06 0.14 0.18 0.07 0.30 0.03 0.12 0.03 0.76 0.67 
rs149154047 
G
/A
 
0.05 0.07 0.03 0.10 0.07 0.14 0.44 0.22 1.17 1 0.17 0.05 
rs6056520 C
/T
 
0.28 0.18 0.33 0.19 0.18 0.21 1.63 0.22 1.02 1 1.83 0.33 
rs150446609 
A
/C
 
0.05 0.05 0.04 0.01 0.02 0 3.38 0.41 2.39 0.59 NA 0.56 
rs775644973 
G
/A
 
0.01 0.03 0 0 0 0 NA 1 NA 0.46 NA 1 
rs6140807 
G
/A
 
0.18 0 0.03 0 0 0 NA 0.52 NA 1 NA 1 
rs201485021 
C
/G
 
0 0 0 0.01 0.02 0 0 0.40 0 1 NA 1 
rs41275604 C
/T
 
0.04 0.05 0.03 0.03 0.05 0 1.32 1 1.17 1 NA 1 
rs61740632 
A
/C
 
0.04 0 0.06 0.01 0.02 0 2.68 0.65 0 1 NA 0.57 
Abbreviations: SNP- Single nucleotide polymorphism, MAF- Minor allele frequency, OR- odds ratio, P- 
pvalue, N- number of individuals, NA- not applicable, F- Female, M-Male. 
 
The regulatory region variant rs146447064 in heterozygosity was found in 9% of the 
DISH/CC patients and in 11% of the controls (Supplementary table 5-1). In 
homozygosity the variant was only found in the controls, particularly in 3 females 
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(Supplementary table 5-1). There was a significant statistical difference in frequencies 
between DISH/CC patients and controls (p=0.03) and when adjusted for gender it was 
statistically different in females (p=0.03), but not in males (Table 5-3). Similar results for 
significance were obtained using the Cochran-Armitage trend and allelic tests (Table 5-4). 
 
Table 5-4. Statistical results using the Cochran-Armitage trend and allelic tests of genetic 
variants found in RSPO4 gene in Azorean patients with DISH/CC and controls without 
DISH/CC disease. 
SNP 
 (A1/A2) 
DISH/CC (A1/A2) Controls (A1/A2) 
T
es
t 
DISH/CC vs Controls 
A
ll
 
N
=
1
1
0
 
M
 
N
=
7
2
 
F
 
N
=
3
8
 
A
ll
 
N
=
7
2
 
M
 
N
=
2
8
 
F
 
N
=
4
4
 
All M F 
C
H
IS
Q
 
P
 
C
H
IS
Q
 
P
 
C
H
IS
Q
 
P
 
rs146447064 
(T/C) 
5/105 4/68 1/37 10/62 2/26 8/36 
T 3.73 0.05 0.10 0.76 3.10 0.08 
A 5.02 0.03 0.09 0.76 5.05 0.02 
rs149154047 
 (A/G) 
5/105 2/70 3/35 7/65 4/24 3/41 
T 2.04 0.15 5.06 0.02 0.04 0.85 
A 1.89 0.17 4.73 0.03 0.03 0.85 
rs6056520  
(T/C) 
31/79 24/48 7/31 14/58 6/22 8/36 
T 1.41 0.23 0.95 0.33 0 0.89 
T 1.79 0.18 1.36 0.24 0 0.98 
rs150446609 
 (C/A) 
5/105 3/69 2/36 1/71 0/28 1/43 
A 0.82 0.36 0.73 0.39 0.31 0.58 
T 1.36 0.24 1.20 0.27 0.52 0.47 
rs775644973 
 (A/G) 
1/109 0/72 1/37 0/72 0/28 0/44 
A 0.66 0.42 NA NA 1.19 0.28 
T 0.66 0.42 NA NA 1.17 0.28 
rs6140807 
 (A/G) 
2/108 2/70 0/38 0/72 0/28 0/44 
T 1.34 0.25 0.81 0.37 NA NA 
A 1.32 0.25 0.79 0.37 NA NA 
rs201485021  
(T/C) 
0/110 0/72 0/38 1/71 0/28 1/43 
T 1.55 0.21 NA NA 0.89 0.35 
A 1.54 0.22 NA NA 0.87 0.35 
rs41275604  
(G/C) 
4/106 2/70 2/36 2/70 0/28 2/42 
T 0.08 0.78 0.81 0.37 0.02 0.90 
T 0.10 0.75 0.79 0.37 0.02 0.88 
rs61740632  
(C/A) 
4/106 4/68 0/38 1/71 0/28 1/43 
T 0.85 0.36 1.69 0.16 0.89 0.35 
A 0.82 0.36 1.62 0.20 0.87 0.35 
Abbreviations: SNP- Single nucleotide polymorphism, M-Males, F-females, T-trend, A- allelic, OR- odds 
ratio, P- p-value, N- number of individuals, A1- allele 1, A2- allele 2, M- males, F- females, NA- Not 
applicable. 
 
The other regulatory region variant rs149154047 in heterozygosity was found in 9% of 
DISH/CC patients and in 19% of the controls (Supplementary Table 5-1). There was a 
significant statistical difference in frequencies between DISH/CC male and control males; 
the frequency of the “G/A” genotype in male DISH/CC was significantly lower than in 
males of the control group (p=0.05) (Table 5-3). But, significant statistical differences 
were not found in female DISH/CC patients relative to control females (Table 5-3). 
Similar results, but with a more significant p-value were obtain using the Cochran-
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Armitage trend test (p=0.02, CHISQ=5.06, Df=1) and allelic test (p=0.03, CHISQ=4.73, 
Df=1) (Table 5-4). 
5.4.2 LEMD3 sequencing 
All the coding region of LEMD3 gene had previously been sequenced in probands from 
the 4 IBD/IBS families. Three intronic (rs11175678, rs11610822 and rs10534559) and 1 
missense mutation (rs201930700) were found (Table 5-5). In this study only the missense 
variant rs201930700 was investigated. 
Table 5-5. Genetic variants identified in LEMD3 gene in the four probands, previously 
investigated, and functional significance information. 
Abbreviations: SNP- Single nucleotide polymorphism, MAF- Minor allele frequency, SIFT- Sorting 
Intolerant From Tolerant, PolyPhen- Polymorphism Phenotyping, Ht- heterozygous, Hm- homozygous, 
NA- not applicable.  
 
Variant rs201930700 was located in exon 13 of the LEMD3 gene and the SIFT score of 0 
and PolyPhen value of 0.995 indicates that this variant has a deleterious and a damaging 
effect on the protein, respectively. The variant was extremely rare, the MAF was 
unknown due to insufficient data to establish population frequency, it was identified in 
only 5 of 121412 alleles (ExAc_Aggregated_Populations), indicating that it was 
unquestionably very rare (MAF 0.00004). A cohort of 124 individuals, all from Terceira 
Island, was typed for this mutation and one other individual carrying the variant was 
identified. This individual and his family were examined (interviewed for clinical 
purposes, x-rayed and typed). The two families that presented the rs201930700 variant 
were further investigated (Figure 5-2). 
Exon/Intron Variant SNP 
Type of 
variant 
MAF SIFT PolyPhen Family/Proband 
Intron 1 C.1523 -12 C>T rs11175678 Intronic 0.04 NA NA AZ1/ II:1 (Ht) 
Intron 5 c. 1695 +100 G>A rs11610822 Intronic 0.25 NA NA 
AZ1/ II:1 (Ht) 
AZ4/ III:5 (Ht) 
Intron 7 
c.2024 -34_2024 -
31 del GATT 
rs10534559 
 
Intronic 
(deletion) 
? NA NA 
AZ1/ II:1 (Ht) 
AZ3/II:1 (Hm) 
AZ4/ III:5 (Ht) 
Exon 13 c.2701 C>T rs201930700 Missense ? 0 0.995 AZ3/II:1 (ht) 
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Figure 5-2. Typing results for LEMD3 gene in DISH/CC families. 
 
The rs201930700 variant was in HWE. Of the 5 individuals studied in the AZ3 family, 4 
individuals (2 males and 2 females) were DISH/CC affected and carriers of the 
rs201930700 variant and 1 individual (male) was DISH/CC affected however, he was a 
non-carrier of the variant (Figure 5-2). In the AZ3 family it was impossible to verify 
segregation since all the individuals studied were DISH/CC affected, so the association 
test was not performed in this family. 
Interestingly, the male individual from the AZ10 family found in the randomized 
population of 124 individuals that were tested for the rs201930700 variant, had DISH/CC 
disease, as did some of their relatives. Of the 11 individuals studied in the AZ10 family, 5 
individuals (3 males and 2 females) were DISH/CC affected, in which one individual was 
a carrier of the rs201930700 variant and the other 4 were wild type. The variant was also 
found in 1 male of the 4 unaffected individuals (2 males and 2 females) and in 2 younger 
females (Figure 5-2). As can be seen in figure 5-2, the majority of individuals in the 
AZ10 family were DISH/CC affected and apparently no segregation occurs in this family 
. 
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5.5 Discussion 
DISH/CC is a poorly understood phenotype characterised by peripheral and axial 
enthesopathic calcifications, fulfilling the radiological criteria for DISH, and in some 
cases associated with CC [26, 356, 357]. The concurrence of DISH and CC suggest a 
shared pathogenic mechanism [24]. The aetiology of DISH/CC is unknown, however, 
since it is a bone forming disease it is expected that genes related to the calcification and 
ossification process are implicated in its aetiology. The two genes investigated in the 
present study, RSPO4 and LEMD3, fulfil the expectations of good candidate genes. In the 
present study we have found two interesting variants in RSPO4 gene (rs146447064 and 
rs14915407) which are significantly more frequent in controls than in DISH/CC patients 
indicating a possible protective role for these variants in the DISH/CC phenotype. 
According to what we know the variants rs146447064 and rs14915407 were not 
associated with Nail disorder or Anonychia (MIM #206800), an autosomal recessive 
disorder caused by a homozygous or compound heterozygous mutation in the RSPO4 
gene [355]. The rs146447064 variant is a regulatory region variant located in the 
promoter region, which indicates that this variant could affect the expression of RSPO4. It 
is an extremely rare variant with a MAF value of 0.01 in all populations and 2% in 
European populations. Interestingly this variant, that in our study gave a protective effect 
against the disease, does not exist in Asian populations, where the prevalence of OPLL is 
higher, a disorder very similar to DISH. In addition, the variant is significantly more 
frequent in control females (p=0.02) than in control males, which could be explained by 
the fact that 3 control females were homozygous for this rare variant. The variant was 
also found in heterozygosity in four controls (2 females and 2 males) and in 5 DISH/CC 
patients (1 female and 4 males).  
The rs149154047 variant is also a regulatory region variant located in the promoter region 
(20: 1002275-1002283). It is also an extremely rare variant with a MAF value of 0.01 in 
all populations and 3% in European populations. The variant rs149154047 was not 
associated with the occurrence of the DISH/CC phenotype, however when adjusted for 
gender, the analysis revealed a significant association between the A allele of the 
rs149154047 variant and the occurrence of the DISH/CC phenotype in control males 
(p=0.02) but not in control females. The variant was also found in heterozygosity in 7 
controls (3 females and 4 males) and in 5 DISH/CC patients (3 female and 2 males). As 
far as we known no phenotype was associated with this variant.  
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The R-spondin proteins activate Wnt/beta-catenin signaling pathways [358] through 
LRP6 (low density lipoprotein receptor related protein 6) by antagonizing Dickkopf 
(DKK1) function, which is an inhibitor of osteoblastogenesis and its lower levels are 
linked to new bone formation [359]. A recent study show, that DISH patients have the 
levels of total serum DKK1 significantly lower than in healthy controls [360]. It is known 
that the induction of the Wnt signaling pathway by R-spondin proteins may be a direct 
consequence of DKK1 inhibition [359, 361]. Based on this knowledge we hypothesise 
that rs146447064 and rs14915407 are variants associated with the reduction in RSPO4 
gene expression, thus reducing Wnt activation and consequently enhanced the DKK1 
which protects against bone formation. However, further studies are needed to ascertain 
this theory.  
In the LEMD3 gene the missense variant, c.2701 C>T (rs201930700) was found in two 
families. This variant has been identified very few times previously and both families in 
which it was typed present the phenotype DISH/CC. This variant causes the substitution 
of amino acid 901 from a large and basic arginine to a large and aromatic tryptophan. 
According to the Ensembl database the modified nucleotide is highly conserved in all 
vertebrates and is located in the carboxyl-terminal nucleoplasmic region of the Man1 
protein. This region (amino acids 782-911) is predicted to be an RNA recognition motif-
like (RRM-like) protein interaction domain named the U2AF homology motif [362, 363]. 
This conserved region that contains the UHM domain (U2AF homology motif kinase 1) 
is exclusive to Man1 proteins and is essential for smad2 and smad3 binding [364]. It is 
known that interaction between Man1 and Smad1 or Smad2 and Smad3 inhibits bone 
morphogenic protein (BMP) and TGF-β signaling, respectively [352, 365]. It is reported 
that heterozygous loss-of-function mutations in LEMD3 enhance TGF-β signaling leading 
to sclerosing bone dysplasia osteopoikilosis, and Buschke-Ollendorff syndrome [307]. As 
this variant (rs201930700) is not a loss-of-function mutation, the carriers of this variant 
do not present any signs of Osteopoikilosis or Buschke-Ollendorff Syndrome. The effect 
that the rs201930700 variant produces in the investigated phenotype is difficult to 
ascertain at this point. We postulate that the rs201930700 variant may lead to enhanced 
TGF-β signaling, leading to increased bone formation.  Our hypothesis was not confirmed 
by the segregation analysis which might be explained by the characteristics of the sample, 
in which almost all individuals were DISH/CC affected, making it very difficult to verify 
segregation. Other studies are necessary to verify the importance of this rare variant on 
the phenotype under study in order to establish a possible association.  
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In conclusion, our results suggest a protective role for two RSPO4 gene regulatory 
variants, probably by altering gene expression of the RSPO4 gene. The relevance of the 
extremely rare variant of LEMD3 (rs201930700) in the phenotype DISH/CC is difficult to 
ascertain at this point. To our knowledge, this study is the first to investigate the 
relationship between RSPO4 and LEMD3 genes and DISH and or CC diseases. 
5.6. Supplementary material 
 
Supplementary table 5-1. Results of genetic variants found in the RSPO4 gene in Azorean 
patients with DISH/CC compared to the controls. 
 
SNP 
Genotype 
DISH/CC CONTROLS 
All: n=55 All: n=36 
Female: n=19 Female: n=22 
Male: n=36 Male: n=14 
All 
n(%) 
Female 
n (%) 
Male 
n (%) 
All       
n(%) 
Female      
n (%) 
Male          
n (%) 
rs146447064 
C/C 50 (91) 18 (95) 32 (89) 29 (81) 17 (77) 12 (86) 
C/T 5 (9) 1 (5) 4 (11) 4 (11) 2 (9) 2 (14) 
T/T 0 (0) 0 (0) 0 (0) 3 (8) 3 (14) 0 (0) 
rs149154047 
G/G 50 (91) 16 (84) 34 (94) 29 (81) 19 (86) 10 (71) 
G/A 5 (9) 3 (15) 2 (6) 7 (19) 3 (14) 4 (29) 
A/A 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs6056520 
C/C 31 (56) 12 (63) 2 (6) 25 (69) 15 (68) 10 (71) 
C/T 17 (31) 7 (37) 10 (28) 8 (22) 6 (27) 2 (14) 
T/T 7 (13) 0 (0) 7 (19) 3 (8) 1 (5) 2 (14) 
rs150446609 
A/A 52 (95) 18 (95) 34 (94) 35 (97) 21 (95) 14 (100) 
A/C 1 (2) 0 (0) 1 (3) 1 (3) 1 (4) 0 (0) 
C/C 2 (4) 1 (5) 1 (3) 0 (0) 0 (0) 0 (0) 
rs775644973 
G/G 54 (98) 18 (95) 0 (0) 36 (100) 22 (100) 14 (100) 
G/A 1 (2) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 
A/A 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs6140807 
G/G 53 (96) 19 (100) 34 (94) 36 (100) 22 (100) 14 (100) 
G/A 2 (4) 0 (0) 2 (6) 0 (0) 0 (0) 0 (0) 
A/A 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs201485021 
C/C 55 (100) 19 (100) 36 (100) 35 (97) 21 (95) 14 (100) 
C/G 0 (0) 0 (0) 0 (0) 1 (3) 1 (5) 0 (0) 
G/G 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs41275604 
C/C 53 (96) 18 (95) 34 (94) 34 (94) 20 (91) 14 (100) 
C/T 2 (4) 0 (0) 2 (6) 2 (6) 2 (9) 0 (0) 
T/T 1 (2) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 
rs61740632 
A/A 51 (93) 19 (100) 32 (89) 35 (97) 21 (95) 14 (100) 
A/C 4 (7) 0 (0) 4 (11) 1 (3) 1 (5) 0 (0) 
C/C 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Abbreviations: SNP- Single nucleotide polymorphism, n- number of invividuals, %- percentage, MAF- 
Minor allele frequency, SIFT- Sorting Intolerant From Tolerant, PolyPhen- Polymorphism Phenotyping, 
Ht- heterozygous, Hm- homozygous, NA- not applicable.  
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6. WHOLE EXOME SEQUENCING OF PATIENTS 
SHOWING EXUBERANT ECTOPIC CALCIFICATIONS IN 
THE AXIAL AND APPENDICULAR SKELETON 
6.1. Abstract 
Diffuse idiopathic skeletal hyperostosis (DISH) is a common skeletal disorder 
characterized by the presence of new bone formation in ligaments and entheses. To date, 
only two susceptibility genes (COL6A1 and FGF2) have a weak genetic link to DISH. In 
order to identify genetic variants associated with DISH we performed whole exome 
sequencing in four patients with ectopic calcifications that displayed the rare coexistence 
of two different rheumatic entities: Diffuse Idiopathic Skeletal Hyperostosis (DISH, MIM 
106400) and chondrocalcinosis (CC).  
DNA was extracted by a standard salting out procedure. Four DISH/CC patients from 
different affected families were selected (two females and two males). Sequencing of all 
coding regions and intron-exon boundaries was performed using an ABI-SOLiD 
platform. Exome data were filtered in order to find a variant or a group of variants that 
could be associated with the DISH/CC phenotype. The variants of interest were 
subsequently confirmed by Sanger sequencing. Selected variants were screened in 
different pedigrees and in a cohort of DISH/CC patient’s vs controls. The statistical 
analysis was performed using PLINK V1.9. 
We successfully identified 21 relevant genetic variants in 17 genes that were directly or 
indirectly related to mineralization. The commonly used algorithms; SIFT and PolyPhen 
revealed that several of the gene variants were predicted to be deleterious and damaging 
to the coded proteins. We identified a significant association between DISH/CC disease 
and a genetic variant in BMP4 (rs17563), a gene involved in endochondral bone 
formation (p=0,009; OR=2.331). 
The results of the present study revealed that the variant rs17563 in BMP4 gene was 
significantly associated with DISH/CC phenotype. Further studies with an enlarged 
number of samples will be needed to clarify this association with the phenotype under 
study. 
Keywords: WES, BMP4, ABCC6, DISH, CC, variants. 
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6.2 Introduction 
Whole exome sequencing is a technique that makes use of the massive parallel 
sequencing capabilities of next-generation platforms to rapidly identify rare variants in 
the ∼1% of the genome that codes for proteins. The power of exome sequencing comes 
from the fact that the majority of monogenic diseases arise from mutations within this 
protein-coding portion of the genome. Furthermore, whole-exome sequencing is now a 
realistic strategy for detecting pathogenic variants in families in which linkage analysis 
was not conclusive. Most exome sequencing studies are based on a small number of 
samples for identification of the causal variants for disease and PCR and Sanger 
sequencing is then used to extend and reinforce the identified causal variants in a greater 
number of individuals [366, 367].  
Previous studies, undertaken by our group, led to the identification and characterization of 
twelve families multiply affected with DISH and/or Chondrocalcinosis (CC). A common 
pathogenic mechanism, was suggested to be shared by the two conditions [24]. Diffuse 
idiopathic skeletal hyperostosis (DISH, MIM 106400) is a common skeletal disorder 
characterized by progressive calcification and ossification of ligaments and entheses [1, 
2]. The exact prevalence and incidence of DISH is unknown, however it is well known 
that DISH is more frequent in males and its prevalence rapidly increases with age, 
affecting mainly subjects over the age of 40 [5]. Weinfeld and colleagues found the 
prevalence of DISH in patients over 50 years of age to be 25% in males and 15% in 
females [368], and this disease is becoming a serious problem in aging societies. DISH 
can co-exist with a great number of other similar rheumatic diseases, and examples of 
these are the ossification of the posterior lateral ligament (OPLL, MIM 602475) [6], 
Ossification of the ligamentum flavum [32], Ankylosing spondylitis (MIM 106300) [7-
21] and CC [22, 23]. CC is characterized by the deposition of crystals of calcium 
pyrophosphate (CPP) in articular hyaline and fibro-cartilage [312]. For the moment 
ANKH (CCAL2; #118600) is the only monogenic cause identified for chondrocalcinosis 
[269], and one study shows that the gene TNFRSF11B, encoding osteoprotegerin, is 
involved in the development of osteoarthritis with chondrocalcinosis [301]. Several lines 
of evidence suggest that genetic factors may play a part in the aetiology of DISH, such as 
the existence of familial cases with early onset (in the third decade of life) [64] and the 
higher frequency of DISH in a specific dog breed, the boxer [77, 78]. So far, however, no 
single gene has been conclusively associated with the disease. Molecular genetic studies, 
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therefore, are important to the understanding of the genetic aetiology of DISH. Several 
linkage and association studies have identified candidate genes/loci that could be linked 
to DISH susceptibility, including Human Leukocyte Antigens (HLA), Collagen 6A1 gene 
(COL6A1) [34], Fibroblast Growth factor 2 (FGF2), [147], Vitamin D (1,25- 
Dihydroxyvitamin D3) Receptor (VDR) and Collagen Type Iα1 (COL1A1) [145]. 
However, none of the preceding genes have been demonstrated to be pathogenetically 
relevant for DISH patients.  
DISH is considered a bone forming disease and so genes related to the calcification and 
ossification process are considered good candidate genes for this disease. In the present 
study, we performed targeted exome sequencing on four DISH/CC patients, with an 
apparently autosomal dominant DISH/CC phenotype. The aim was to capture rare and 
pathogenic variants that are expected to have potentially damaging effects on protein 
function that leads to modified calcification and/or ossification. To our knowledge this 
study represents the first report of exome sequencing analysis in DISH disease. 
6.3 Material & methods 
6.3.1. Subjects 
This study involved four patients from four distinct DISH/CC families (AZ1-AZ4) which 
were selected for whole exome sequencing (2 males and 2 females; age of onset around 
40 years). The four families (AZ1-4) contain 35 members (20 males and 15 females; 
mean age of onset, 36 years; range, 20-50) in which 33 were affected with DISH/CC and 
8 had no signs of the disease (see material and methods of this thesis). Standard X rays 
were taken from: knees, axial skeleton, wrists, hands, elbows, and pelvis. The 4 patients 
were radiologically characterized (Table 6-1). A group of 55 unrelated Azorean patients 
with a diagnosis of DISH/CC (36 male, 19 female; age of onset around 40 years) and 36 
unrelated healthy controls with a similar ethnic background (16 males and 20 females; 
mean current age, 68 years; range, 57-102) were also included. This study was approved 
by the HSEIT Ethics Committee and all participants provided informed consent. 
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Table 6-1. Radiology results from four selected patients for WES. 
P
a
ti
en
t 
S
ex
 Radiology Age 
at 
onset 
Other 
diseases 
C-Spine T-Spine L-Spine Knees Elbow 
AZ1 M Normal Normal 
Sindesmophytosis 
Inc DISH 
? 
Enthesopathy 
; calcifications 
<40 Obesity 
AZ2 F 
DISH 
inc C5-
C6 
DISH DISH 
Arthrosis, 
enthesopathy 
Enthesopathy, 
osteophytosis, 
calcifications 
30 
Lithiasis, 
Diabetes 
mellitus 
AZ3 F N/A DISH inc DISH inc 
Enthesopathy, 
osteophytosis, 
arthrosis 
Calcifications, 
enthesopathy 
? Obesity 
AZ4 M Normal Sindesmophytosis 
Syndesmophytosis, 
anterior 
osteophytosis 
Osteophytosis
, calcifications 
in capsule, 
arthrosis 
Calcifications, 
enthesopathy 
osteophytosis 
<40 
Lithiasis, 
cardiac 
arrythmia 
Definition of Radiological terminology 1) DISH: continuous ossification along the anterolateral aspect of 
four contiguous vertebral bodies. DISH/CC inc: Continuous ossification along the anterolateral aspect of 
two or three contiguous vertebral bodies. 2) Sindesmophytosis: Vertical and symmetrical calcification of 
the lateral margins of the intervertebral disc space. 3) Osteophytosis: presence of spurs, which are 
outgrowths of bone tissue. 4) Enthesopathy: calcification/ossification process at the site of the insertion of 
ligaments, tendons, fascia or articular capsule into bone. 5) Arthrosis: presence of joint space narrowing, 
sclerosis and osteophytosis. 
Abbreviations: M- male, F- female, DISH- diffuse idiopathic skeletal hyperostosis, C-Spine- Cervical 
spine, T- Spine- Thoracic spine, L-Spine- Lumbar spine, ?- unknown, N/A- not available. 
 
6.3.2. Exome capture  
The selection of patients was made after ruling out mutations in ANKH, the only 
monogenic disease causing gene yet known for CC. All secondary causes for CC were 
also ruled out by appropriate biochemical testing. DNA was extracted using a standard 
salting out procedure. Samples were resequenced, using an Applied Byosystems - 
Sequencing by Oligonucleotide Ligation and Detection platform (ABI-SOLiD) and 
Agilent’s SureSelect Target Enrichment System for 38 Mb, by “Sistemas Genómicos, 
S.L.” in Valencia, Spain. The quality and quantity of extracted DNA was evaluated by 
agarose gel electrophoresis, measurement of absorbance at 260 nm was established using 
a NanoDrop 1000 and Qubit fluorescence quantification. SOLiD Fragment libraries were 
prepared and enriched with SureSelect All Human Enrichment Target Exon. The quality 
and quantity of the libraries were assessed by analysis with Agilent 2100 Bioanalyzer and 
Qubit. Each library went through a process of emulsion PCR for clonal amplification of 
the fragments, followed by an enrichment process and chemical modification to allow 
loading in the reaction chamber. The quality and quantity of the beads obtained for each 
library were estimated taking into account the parameters given by Work Flow Analysis. 
Then, ligation sequencing was done to obtain sequences of 50 nucleotides +35nucleotides 
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(Paired-end) in SOLiD4. The data quality was estimated using the parameters provided 
by the software SETS (SOLiD Experimental Tracking System). Single Nucleotide 
Variants (SNVs) were classified using Ensembl’s nomenclature and grouped using the 
following the scheme: Known and Novel (Coding, Splicing, Others). The coding variants 
were divided into Non-synonymous and Synonymous. The `Others´ included intronic, 
untranslated (UTR), regulatory region, intergenic, downstream and upstream variants.  
6.3.3. WES filtering  
Three filtering strategies were applied in order to find a variant or a group of variants that 
could be associated with the DISH/CC disease. 
6.3.3.1. Filtering candidate genes provided by WES results 
Two different models (dominant and recessive) were used to identify candidate genes. 
The most probable model for inheritance of the disorder under study is an autosomal 
dominant model. Taking into consideration that the majority of the families used for the 
study come from a restricted area of the Terceira Island, a genetic founder effect was 
expected. A recessive model cannot be ruled out, due to the high consanguinity present on 
the island, but it is less likely due to the distribution pattern of the disease in pedigrees. 
 A list of 815, 917, 872 and 593 genes, was generated to include the candidate genes 
under a dominant model (Table 6-2).  These genes were then filtered based on sharing 
between the four investigated DISH/CC patients. A group of 52 genes were common to 
the four patients (Table 6-3), and from this group the candidate genes for testing were 
selected taking into consideration their function. For this reason priority was given to 
candidate genes involved in the calcification and/or ossification process or related 
conditions that could be associated with DISH/CC disease.  
Table 6-2. Number of candidate genes per sample. 
Samples 
Number of candidate genes 
Dominant model Recessive Model 
AZ1 815 48 
AZ2 917 58 
AZ3 872 47 
AZ4 593 25 
 
There was only one gene that came out as a good candidate gene for a recessive model: 
HLA-DQA2 (Table 6-3), which was also present in the list of candidate genes when using 
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a dominant model of inheritance. There is not much information available about the HLA-
DQA2 gene and the IPD-IMGT/HLA Database does not have typing results for this gene. 
The study of this gene was not therefore carried out in the present study, due to time 
constraints.  
Table 6-3. Number of candidate genes shared by the investigated DISH/CC patients. 
Patients 
Number of candidate genes shared: 
Dominant model Recessive Model 
AZ1+AZ2+AZ3+AZ4 52 1 
AZ1+AZ2+AZ3 118 2 
AZ1+AZ2+AZ4 65 1 
AZ2+AZ3+AZ4 78 2 
AZ1+AZ3+AZ4 77 1 
AZ1+AZ2 220 6 
AZ1+AZ3 212 4 
AZ1+AZ4 139 4 
AZ2+AZ3 249 6 
AZ2+AZ4 149 4 
AZ3+AZ4 162 3 
 
We then procured all the variants in the shared genes and focused on nonsynonymous, 
splice sites, stop loss/gain and frameshift variants, anticipating that synonymous and 
intronic variants would be far less likely than functional variants to be relevant in the 
pathogenicity.  
6.3.3.2. Filtering within candidate genes 
A group of 20 candidate genes was selected through a literature search, and included 
genes that are possibly involved in bone metabolism and/or related conditions. These 
genes are Alkaline Phosphatase (ALPL/TNAP), the Calcium Sensing Receptor (CASR), 
Bone morphogenetic protein receptor type 1B (BMPR1B), Osteopontin (OPN/SPP1), 
Integrin binding sialoprotein (IBSP), Fibroblast Growth factor 2 (FGF2), Inorganic 
Pyrophosphate Transport Regulator (ANKH), Collagen type XI, alpha 2 (COL11A2), 
Nucleotide pyrophosphatase 1 (ENPP1), Runt-related transcription factor (RUNX2), 
Dickkopf WNT signaling pathway (DKK-1), Insulin like growth factor 1 (IGF1), Matrix 
Gla protein (MGP); Vitamin D (VDR), Bone morphogenetic protein 4 (BMP4), Collagen 
type 1 alpha 1 (COL1A1), Transforming growth factor beta 1 (TGFβ1), Solute carrier 
family 29 member 1 (SLC29A1), Bone morphogenetic protein 2 (BMP2) and Collagen 
type VI, alpha 1 (COL6A1). The genes selected were screened against the WES results 
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and the variants were annotated in an excel file. Subsequently we focused only on 
nonsynonymous, splice sites, loss or gain of a stop and frameshift variants.  
6.3.3.3. Filtering pathogenic variants  
In this filtering strategy we used two levels; variant and knowledge level (Figure 6-1). In 
the variant level we first filtered according to variant type and focused on variants with 
functional significance (splice sites, frameshift coding, nonsynonymous coding, lost or 
gained stop variants. Only the SIFT prediction with Damaging and Unknown and GERP 
values equal or higher than 3 were included. We excluded variants with MAF values 
higher than 0.05 by filtering the SNP_IDs (rs number or by chromosome position) against 
a public Ensembl tool, Variant Effect Predictor 
(http://www.ensembl.org/info/docs/tools/vep/index.html). Then at the “knowledge level” 
we focused only on genes associated with calcification and/or ossification processes or 
related conditions. Lastly we evaluated the functional significance and pathogenic 
potential of each variant found in the selected genes. 
 
Figure 6-1. The two-level filtration approach used to analyze the WES results from 4 
patients with DISH/CC disease. WES: Whole exome sequencing, SIFT: Sorting Intolerant 
From Tolerant, GERP: Genomic Evolutionary Rate Profiling score and MAF: Minor Allele 
Frequency. 
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6.3.4. Validation and Evaluation of Genes/Variants  
PCR primers were designed using the software Primer3 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) to amplify and 
validate variants detected by Exome Sequencing (primers sequences and PCR conditions 
are indicated in the materials and methods of this thesis). PCR products were purified 
using ExoSAP-IT™ following the manufacturer’s instructions. After purification with 
ExoSAP-IT, sequencing reactions with BigDye Terminator were performed 
unidirectionally, or when necessary, bidirectionally. Sequencing reactions were purified 
with acetic acid and EDTA followed by ethanol precipitation. The templates were 
ressuspended in Hi-Di formamide and analysed using an automated DNA sequencer ABI 
3130xl (Applied Biosystems). Genetic variants were screened using Sequencing analysis 
and SeqScape software’s (Applied Biosystems) and using as a reference NCBI 
sequences (see the material and methods section of this thesis for more detail). 
The information about each gene was obtained from several databases, including Ensembl 
(http://www.ensembl.org/index), National Center for Biotechnology Information (NCBI) 
(http://www.ncbi.nih.gov) and Pubmed (https://www.ncbi.nlm.nih.gov/pubmedwe), 
GeneCards (http://www.genecards.org/), Online Mendelian Inheritance in Man (OMIM) 
(http://www.omim.org/) and MalaCards (http://www.malacards.org/). 
The functional significance and the potential deleterious effect of each variant was 
explored in the following databases: Ensembl (http://www.ensembl.org/index), Human 
Gene Mutation Database (HGMD) (http://www.hgmd.cf.ac.uk/ac/index.php) and dbSNP 
(https://www.ncbi.nlm.nih.gov/projects/SNP/), making use of algorithms, such as 
PolyPhen-2 (Polymorphism Phenotyping v2) (http://genetics.bwh.harvard.edu/pph2/) that 
defines severity as, benign, [0-0.2], possibly damaging (0.2-0.85), and probably damaging 
[0.85-1]) and for SIFT, damaging if less than 0.05 and for GERP, this ranges from -12.3 
to 6.17, with 6.17 being the most conserved [369]). The MAF values of each variant were 
also analyzed. Protein conservation analysis was performed using ClustalW 
(http://www.genome.jp/tools/clustalw/) to compare homologous amino acid sequences 
among multiple vertebrates at the sites where the variations occur. The accession numbers 
of the transcript are available in supplementary table 6-1. 
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6.3.5. Association studies 
In order to verify a possible association with DISH/CC phenotype selected variants were 
screened in family members (affected with DISH/CC and unaffected), and the more 
conserved variants, those that were present in three or four WES patients, were selected 
for screening in a group of DISH/CC patients and controls. 
6.3.6. Statistical analysis 
All SNPs were checked to assess their compliance with the Hardy-Weinberg equilibrium 
(HWE). For all DISH/CC families, a basic family based association test (transmission 
disequilibrium test -TDT) was used to assess the allele transmission. The TDT test was 
calculated for CHISQ, odds ratios (OR) (95% confidence interval) and corresponding p-
values. To assess the difference in allele frequencies between the 55 patients with 
DISH/CC and the 36 control individuals a Fisher exact test was used. The Fisher exact 
test was calculated for odds ratios (OR) (95% confidence interval) and corresponding p-
values. For all statistical tests used a p-value of ≤0.01 was considered statistically 
significant. All statistical analysis were performed using PLINK software [354]. 
6.4 Results 
6.4.1. Exome capture - variants detected 
An average of approximately 3.8 billion bases of sequence per patient were generated and 
the capture specificity and sensibility in all samples was about 55% and 94%, 
respectively. The average sensibility for all four samples was over 94%. Table 6-4 
summarizes the results after the SNV calling and indel identification steps for each 
sample. 
Table 6-4. Known, novel and total number of SNVs and Indels for the four samples analysed 
(AZ1-4). 
Sample 
SNVs Indels 
Total TOTAL/sample 
Known Novel Total Known Novel Complex 
AZ1 17281 1619 18900 457 405 51 913 19813 
AZ2 18086 1759 19845 440 496 66 1002 20847 
AZ3 18327 1650 19977 524 505 73 1102 21079 
AZ4 17575 1223 18798 475 424 72 971 19769 
Abbreviations: SNVs: Single nucleotide variants 
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6.4.2. Filtering Results 
From the three filtering strategies deployed we obtained 21 missense, deletion and splice 
site variants in 17 genes: PLCG2, obtained in the first filtering strategy that was based on 
candidate genes in a dominant model; ALPL, CASR, FGF2, COL11A2, ENPP1, MGP, 
VDR, BMP4, COL1A1, TGFβ1, BMP2 and COL6A1, were obtained from the second 
filtering based on candidate genes and FLNC, AMER3, PPP2R2D and ABCC6, were 
obtained from the third filter based on predicted pathogenic variants (Table 6-5).  
After analysis of the functional significance of the variants we found several with a 
possible effect on protein function and/or low MAF values, which are indicative of a 
deleterious variant. The variants c.2054+7G>A and c.3786G>C (K1262N) in PLCG2 
gene are both extremely rare. The c.2054+7G>A is a splice site variation located seven 
bases after exon 19 and the c.3786G>C (K1262N) is a missense variant which causes 
substitution of lysine with asparagine at amino acid 1262. The amino acid lysine is basic 
and polar and asparagine is neutral and polar. The logarithm SIFT (0) in c.3786G>C 
(K1262N) suggests the variation has a deleterious effect on the PLCG2 protein. The 
splice site variant c.2054+7G>A was present in patients AZ3 and AZ4 and the missense 
variant c.3786G>C (N1260K) was present in AZ2 and all were heterozygous (Table 6-5).  
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Table 6-5. List of variants found by WES and confirmed by Sanger Sequencing. 
 
Abbreviations: Chr- chromosome, SNP-Single nucleotide polymorphism, AA- Amino acid, MAF- Minor allele frequency, SIFT- Sorting Intolerant From Tolerant, PolyPhen- Polymorphism Phenotyping v2, ht-heterozygous, hm-homozygous, NA- Not 
Applicable, PLCG2- Phospholipase C Gamma 2, ALPL- Alkaline Phosphatase, Liver/Bone/Kidney, CASR- calcium-sensing receptor, FGF2- Fibroblast growth factor 2, COL11A2- Collagen Type XI Alpha 2 Chain, ENPP1– ectonucleotide 
pyrophosphatase/phosphodiesterase 1, MGP- Matrix Gla Protein, VDR- Vitamin D Receptor, BMP4- Bone morphogenetic protein 4, COL1A1- Collagen Type I Alpha 1 Chain, TGFβ1- Transforming Growth factor Beta 1, BMP2- Bone morphogenetic 
protein 2, COL6A1- Collagen Type VI Alpha 1 Chain, FLNC- Filamin C, AMER3- APC Membrane Recruitment Protein 3, PPP2R2D- Protein Phosphatase 2 Regulatory Subunit B delta, ABCC6 – ATP-binding cassete subfamily C, member 6. 
 
Gene Gene function Chr SNP Variant AA MAF SIFT PolyPhen 
Patient 
AZ1 AZ2 AZ3 AZ4 
PLCG2 
A calcium dependent phosphatidylinositol-specific phospholipase C, which is crucial in transmembrane signalling. Involved in the Wnt receptor signaling pathway. 
This gene regulates osteoclastogenesis, and in a mice model, a deletion of this gene leads to an osteopetrotic phenotype [370]. 
16 
rs138158454 c.2054+7G>A NA 0,01 NA NA   ht ht 
rs374430619 c.3786G>C K1262N ? 0 0,008  ht   
ALPL Play a role in bone mineralization. Hypophosphatasia in adult (#146300), Infantil (#241500) and Childhood (#241510) are caused by mutations in this gene. 1 
rs149344982 c.455G>A R152H 0,01 0,56 0,077 
 
ht 
  
rs3200254 c.787T>C Y263H 0,27 1 0 ht  ht  
CASR 
Plays a pivotal role in systemic calcium metabolism. Loss of function mutations cause hyperparathyroidism neonatal (#239200) [371], whereas gain of function result 
in hypocalcemia with Bartter syndrome (#601198) [371]. 
3 
rs1801725 c.2956G>T A986S 0,09 0,22 0,01  ht  ht 
rs1801726 c.3031G>C E1021Q 0,08 1 0  hm hm hm 
FGF2 
Osteoblast gene expression and differentiation [148]. Diseases associated with FGF2 include Corneal Neovascularization and Crouzon Syndrome. One study associated 
this gene with DISH susceptibility [147]. 
4 rs1048201 c.*757C>T NA ? NA NA ht ht  ht 
COL11A2 
Involvement in the ossification process. Mutations in this gene cause Otospondylomegaepiphyseal dysplasia (#215150), Weissenbacher-Zweymuller syndrome 
(#277610), Fibrochondrogenesis 2 (#614524), Stickler syndrome, type III (#184840) and Deafness (#601868 and #609706). Mutations in this gene may also be 
associated with OPLL disease (%602475). 
6 
rs9277934 c.826G>A E276K 0,32 0.45 0.557 hm ht hm ht 
rs2229792 c.5165C>T P1722L 0,01 0.01 0.088 
   
ht 
ENPP1 
Regulates soft-tissue calcification and bone mineralization by producing PPi [89]. Mutations in this gene are associated with Cole disease (#615522), 
Hypophosphatemic Rickets (#613312) and Arterial calcification generalized of infancy 1(#208000). Mutations in this gene have been also associated with OPLL [165]. 
6 rs1044498 c.517A>C K173Q 0,34 0,19 0,014 ht ht ht  
MGP Physiological inhibitor of ectopic calcification. Diseases associated with this gene include Keutel Syndrome (#245150) and Vitamin K deficiency Hemorrhagic Disease. 12 rs4236 c.304A>G T102A 0,39 1 0 ht  ht ht 
VDR 
Involved in mineral metabolism; control the absorption of calcium and phosphate. Diseases associated with this gene include Rickets, vitamin D-resistant (#277440) 
and osteoporosis (#166710). 
12 rs2228570 c.2T>C M1T 0.35 0 0.995 hm hm ht ht 
BMP4 Involved in endochondral bone formation. Diseases associated with BMP4 include Microphthalmia Syndromic 6 (#607932) and Orafacial Cleft 11 (#600625). 14 rs17563 c.455T>C V152A 0,37 0,57 0,005 hm  hm ht 
COL1A1 
Involved in bone maturation, development and mineralization [372]. Mutations in this gene cause Caffey Disease (#114000) and Osteogenesis Imperfecta Type I-IV 
(#166200, #166210, #259420 and #166220, respectively). 
17 rs372029024 c.3247G>T A1083T ? 0.08 0 hm    
TGFβ1 
Bone remodeling; potent stimulator of osteoblastic bone formation. Diseases associated with this gene include Camurati-Engelmann Disease (#131300) and Cystic 
Fibrosis (#219700). 
19 rs55659002 c.713-8delC NA ? NA NA   ht  
BMP2 Induce bone and cartilage formation. Diseases associated are Brachydactyly, Type A2 (#112600) and Hemochromatosis (#235200). 20 rs235768 c.570A>T R190S 0,24 0 0,977 ht  ht ht 
COL6A1 Play a role in maintaining the integrity of various tissues. Mutations in this gene could cause ectopic bone formation in OPLL and DISH [34, 146]. 21 rs1053312 c.2549G>A R850H 0.27 0,11 0,018  hm   
FLNC 
Involved in reshaping of the cytoskeleton. Mutations in this gene cause Myofibrillar myopathy-5 (MFM5 #601419) [373] and distal myopathy-4 (MPD4; MIM 
614065), which shows a different pattern of muscle involvement [374]. 
7 rs2291569 c.4700G>A R1567Q 0.06 0,01 0.999  ht   
AMER3 Is a positive regulator of Wnt-β-catenin signaling pathway. 2 rs72854996 c.1300C>G L434V 0.05 1 0 ht    
PPP2R2D 
Catalyze the removal of phosphate groups from serine and/or threonine residues by the hydrolysis of phosphoric acid monoesters. The protein belongs to the TGF-β 
pathway. 
10 rs34473884 c.1072G>A G358S 0,18 0.03 0.173 hm ht ht ht 
ABCC6 
Unknown function however during the last few years has been extensively related to ectopic calcification. Cause Pseudoxanthoma elasticum (PXE; MIM#264800), a 
disorder with calcification of the elastic fibres and in some cases can cause arterial calcification generalized of infancy type 2 (GACI2; MIM#614473). 
 
16 rs41278174 c.3190C>T R1064W 0.01 0 0.932   ht  
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COL11A2 gene variants c.826G>A (E276K) and c.5165C>T (P1722L) are both missense; the 
c.826G>A (E276K) causes a glutamate substitution for a lysine at amino acid position 276. 
The amino acid glutamate is acidic and lysine is basic. The c.5165C>T (P1722L) variant is 
extremely rare (MAF of 0.01) and causes a proline substitution for a leucine in 1722 protein 
position. Both amino acids are non-polar. The logarithm PolyPhen (0.557; possibly 
damaging) in c.826G>A (E276K) and the SIFT (0.01; deleterious) in c.5165C>T (P1722L) 
suggests a damaging and deleterious effect, respectively on the COL11A2 protein. The 
c.826G>A (E276K) was identified in homozygosity in AZ1 and AZ3; and in heterozygosity 
in AZ2 and AZ4. The c.5165C>T (P1722L) was identified in heterozygosity in AZ4 patient 
(Table 6-5). 
The variant c.2T>C (M1T) in the VDR gene is a missense mutation which causes a 
methionine substitution for a threonine in amino acid 1 of the protein. The amino acid change 
is from non-polar (methionine) to polar (threonine). According to the conservation analysis 
this amino acid position is totally conserved between all mammals analyzed (Supplementary 
figure 6-1), and the logarithms SIFT (0; deleterious) and PolyPhen (0.995; probably 
damaging) suggest a strong effect on the VDR protein. The variant was homozygous in AZ1 
and AZ2; and heterozygous in AZ3 and AZ4 (Table 6-5). 
The variant c.570A>T (R190S) in the BMP2 gene is a missense which causes an arginine 
substitution for a serine in amino acid 190 of the protein. The amino acid change is from basic 
(arginine) to polar (serine). The amino acid position is totally conserved between all the 
vertebrates studied so far (Supplementary figure 6-1). In addition, the logarithms SIFT (0; 
deleterious) and PolyPhen (0.977; probably damaging) suggest a strong effect on the BMP2 
protein. The variant was found in AZ1, AZ3 and AZ4 in heterozygosity (Table 6-5). 
In the FLNC gene we found the missense variant c.4700G>A (R1567Q) which causes an 
arginine substitution for a glutamine at amino acid 1567 of the protein. The amino acid 
change is from a large, basic amino acid (arginine) to a medium and polar amino acid 
(glutamine). According to the conservation analysis this amino acid position is highly 
conserved in vertebrates (Supplementary figure 6-1), furthermore the logarithms SIFT score 
(0.01; deleterious) and PolyPhen (0.999; probably damaging) indicates that this variant has a 
damaging effect on the protein. The frequency of this variant is relatively low in Europe with 
a MAF of 0.06. The variant was heterozygous in AZ2 (Table 6-5). 
The variant c.1072G>A (G327S) found in PPP2R2D gene is a missense variant which causes 
substitution of glycine for serine at amino acid 327 in the protein. These two amino acids are 
hydrophilic but glycine is non-polar and serine is polar. The amino acid position is totally 
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conserved in all vertebrates studied (Supplementary figure 6-1), and the variant has a low, 
deleterious, SIFT score (0.03) but the Polyphen score (0,173) does not corroborate its harmful 
effect. The frequency of this variant is high in Europe with a MAF of 0.18 and this variant 
was identified in all four DISH/CC patients used for WES; AZ1 was homozygous and AZ2, 3 
and 4 were heterozygous (Table 6-5). The variant c.3190C>T (R1064W) in the ABCC6 gene 
is a conserved missense variant that seems to be of fundamental importance since the 
algorithms SIFT score (0; deleterious) and PolyPhen (0.932; probably damaging) indicates 
that this mutation has a deleterious effect on the protein and is a rare variant (MAF of 0.01). 
The variant was heterozygous in AZ3 (Table 6-5). We found eight genetic variants, in 
heterozygous and/or homozygous states, in conserved positions in proteins associated with 
mineralization; four variants were in regions that are normally highly conserved across the 
vertebrates (CASR ((rs1801725), BMP2 (rs235768), FLNC (rs2291569) and PPP2R2D 
(rs34473884)), and four other variants were in positions normally conserved in mammals 
(VDR (rs2228570), BMP4 (rs17563), COL1A1 (rs372029024) and ABCC6 (rs41278174)) 
(Table 6-6). 
Table 6-6. Conservation analysis of the variants identified in this study. In bold are represented 
the conserved variants found in at least 3 patients. 
Patient 
(sex) 
Mutational spectrum 
Highly conserved 
Conserved between 
mammals 
Relaxed regions 
AZ1 
(M) 
BMP2 (rs235768/ht) 
PPP2R2D 
(rs34473884/hm) 
VDR (rs2228570/hm) 
BMP4 (rs17563/hm) 
COL1A1 (rs372029024/hm) 
ALPL (rs3200254), ENPP1 (rs1044498), 
MGP (rs4236), AMER3 (rs72854996), 
COL11A2 (rs9277934). 
AZ2 
(F) 
CASR (rs1801725/ht) 
FLNC  (rs2291569/ht) 
PPP2R2D 
(rs34473884/ht) 
VDR (rs2228570/hm) 
CASR (rs1801726), COL6A1 (rs1053312), 
PLCG2 (rs374430619), ALPL 
(rs149344982), COL11A2 (rs9277934), 
ENPP1 (rs1044498). 
AZ3 
(F) 
BMP2 (rs235768/ht), 
PPP2R2D 
(rs34473884/ht) 
BMP4 (rs17563/hm) 
ABCC6 (rs41278174/ht) 
PLCG2 (rs138158454), ALPL (rs3200254), 
ENPP1 (rs1044498), MGP (rs4236), VDR 
(rs2228570), TGFB (rs55659002), CASR 
(rs1801726), COL11A2 (rs9277934). 
AZ4 
(M) 
CASR (rs1801725/ht) 
BMP2 (rs235768/ht), 
PPP2R2D 
(rs34473884/ht) 
VDR (rs2228570/ht) 
BMP4 (rs17563/ht) 
PLCG2 (rs138158454), COL11A2 
(rs2229792), MGP (rs4236), CASR 
(rs1801726). 
Abbreviations: M- male, F-female, ht-heterozygous, hm-homozygous, PLCG2- Phospholipase C Gamma 2, 
ALPL- Alkaline Phosphatase, Liver/Bone/Kidney, CASR- calcium-sensing receptor, COL11A2- Collagen Type 
XI Alpha 2 Chain, ENPP1– ectonucleotide pyrophosphatase/phosphodiesterase 1, MGP- Matrix Gla Protein, 
VDR- Vitamin D Receptor, BMP4- Bone morphogenetic protein 4, COL1A1- Collagen Type I Alpha 1 Chain, 
BMP2- Bone morphogenetic protein 2, COL6A1- Collagen Type VI Alpha 1 Chain, FLNC- Filamin C, AMER3- 
APC Membrane Recruitment Protein 3, PPP2R2D- Protein Phosphatase 2 Regulatory Subunit B delta, ABCC6 – 
ATP-binding cassete subfamily C, member 6. 
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As can be seen in table 6-6, all patients have at least 2 highly conserved genetic variants in 
combination with other variants that are normally conserved in mammals.   
6.4.3. Association between variants and DISH/CC phenotype  
6.4.3.1. Segregation of variants 
We selected 6 variants in genes PLCG2 (c.2054+7G>A and c.3786G>C (K1260N)), FLNC 
(c.4700G>A (R1567Q)), AMER3 (c.1300C>G (L434V)), PPP2R2D (c.1072G>A (G327S)) 
and ABCC6 (c.3190C>T/R1064W) to verify the segregation within families of the 
investigated patients (Figure 6-2). 
 
Figure 6-2. Segregation results with DISH/CC phenotype in families AZ1-4. WES sequencing 
patients: III:4 (AZ1), III-2 (AZ2), II:4 (AZ3) and III:6 (AZ4). 
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Most of the individuals were affected by DISH/CC disease and this made it difficult to verify 
segregation in these families. The selected variants, individually studied, did not segregate 
within families mainly because these families were uninformative and lacked unaffected 
individuals, and therefore the segregation analysis was not performed for all the candidate 
genes presented in table 6-5. Although not statistically significant, it was possible to evaluate 
the variants in AMER3 and FLNC genes (Table 6-7). 
Table 6-7. Family based association test (TDT test) results for variants of AMER3 gene in AZ1 
family and FLNC gene in AZ2 family. 
Gene SNP 
Alleles 
M/m 
TDT 
TR:UT OR CHISQ P 
AMER3 rs72854996 C/G 1:2 0.5 0.3333 0.5637 
FLNC rs2291569 G/A 2:0 NA 2 0.1573 
Abbreviations: SNP- Single nucleotide polymorphism, M/m – major allele/minor allele, TDT- Transmission 
disequilibrium test, TR:NT-Transmitted/Untransmitted minor allele account, OR- odds ratio, P- pvalue,  NA- not 
applicable. 
 
6.4.3.2. Case/control studies  
The variants rs34473884, rs9277934 and rs2228570 in PPP2R2D, COL11A2 and VDR genes, 
respectively, were present in all 4 WES patients. The variants rs1048201, rs235768, 
rs1044498 and rs17563 in FGF2, BMP2, ENPP1 and BMP4 genes, respectively were present 
in three of the four WES patients. All these variants had a high degree of conservation. The 
variants rs4236 in MGP gene and rs1801726 in CASR gene were present in three of the four 
WES patients however they were not conserved and therefore the case/control study of these 
genes was not performed. Seven variants were screened in a group of 55 DISH/CC patients 
and 36 controls and the results are indicated in table 6-8. The variant rs17563 in BMP4 gene 
was found to be more frequent in DISH/CC group than in controls (p=0.009; OR=2.331) 
(Table 6.8). 
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Table 6-8. Association study between seven variants from seven genes and DISH/CC phenotype. 
The risk allele are in bold. 
Chr Gene SNP 
Allele 
M/m 
MAF 
OR p-value 
DISH/CC (N=55) Controls (N=36) 
4 FGF2 rs1048201 C/T 0,155 0,139 1,133 0,771 
6 COL11A2 rs9277934 G/A 0,373 0,389 0,934 0,826 
6 ENPP1 rs1044498 A/C 0,191 0,208 0,897 0,773 
10 PPP2R2D rs34473884 G/A 0,255 0,181 1,550 0,243 
12 VDR rs2228570 T/C 0,382 0,389 0,971 0,924 
14 BMP4 rs17563 T/C 0,473 0,278 2,331 0,009 
20 BMP2 rs235768 A/T 0,264 0,250 1,074 0,837 
Abbreviations: SNP- Single nucleotide polymorphism, M/m – major allele/minor allele, MAF- Minor allele 
frequency, OR- odds ratio, Chr- chromosome.  
6.5. Discussion 
Many human diseases appear to have a strong hereditary component. A large number of 
studies, using the WES technique, have reported variants and genes responsible for several 
monogenic diseases of unknown causes [163, 366, 375]. In this study, we used WES as a 
method to identify candidate genes for DISH/CC aetiology, and association studies to 
investigate specific variants. As expected, thousands of protein coding variants per patient 
were identified across each exome, which meant a huge number of variants had to be filtered 
and identification of the causative variant is like “finding a needle in a haystack”. 
Consequently, different filtering strategies were used to find potential high risk variants in 
genes that could be associated with the DISH/CC phenotype. It is not easy to draw 
conclusions from segregation study since most of the individuals studied were DISH/CC 
affected making these families uninformative, however the association study performed in 
this study indicated that the SNP rs17563 in BMP4 gene was significantly associated with the 
DISH/CC phenotype. Bone morphogenetic proteins (BMPs) are multi-functional growth 
factors that belong to the transforming growth factor beta (TGFβ) superfamily. BMP4 has the 
same origin as BMP2 and they are similar in structure and function. BMP2 and BMP4 are 
genes mapping to chromosomes 20 and 14, respectively that encode important regulators of 
bone formation [376]. In one study, Ono et al [377] found that BMP2 and TGF-β played an 
important role in ossification in the conditions OPLL, a disorder that is very similar to, and 
can coexist with DISH [6], and ligamentum flavum, by acting on the progenitor cells in the 
ligament, causing them to proliferate, form cartilage and then ossify. BMP4 also seems to 
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play a crucial role in the pathogenesis of OPLL, as demonstrated in a large scale study by 
Furushima and collaborators that found evidence of linkage with this gene [159]. Despite the 
association of BMP2 and BMP4 with ectopic bone formation, their association with OPLL is 
controversial, and there is both evidence in favor [160, 161] and against this idea [72]. 
Interestingly, Kan et al [378] produced a mice overexpressing BMP4 and observed the 
development of progressive postnatal heterotopic endochondral ossification, a phenotype 
similar to human Fibrodysplasia ossificans progressive (FOP). In rabbits, recombinant human 
BMP4 enhances posterior spinal fusion [379]. In the present study we identified two variants 
in BMP genes. The variant (R190S) in the BMP2 gene had a low SIFT score and a higher, 
PolyPhen, which predicted a deleterious and a damaging effect on the protein and this variant 
has previously been associated with the occurrence of OPLL [158] and with Immunoglobulin 
A nephropathy [380]. The missense variant c.455T>C (V152A) in the BMP4 gene, which in 
this study was significantly more frequent in the DISH/CC group relative to the control group, 
was located in the translated region of BMP4 exon 5 and caused the substitution of a valine by 
an alanine at amino acid position 152, a position conserved between species (Supplementary 
figure 6-1). The structure and function of the protein was apparently not significantly affected 
by the substitution due to physicochemical similarities of the involved amino acids. 
Furthermore, the algorithms SIFT (0.57; tolerated) and PolyPhen (0.005; benign) did not 
suggest a strong effect on the protein. However, according to Capasso et al [381] the variant 
rs17563 affected BMP4 gene expression; this variant promotes a change in the structure of the 
mRNA, and the levels of BMP4 mRNA were significantly higher in carriers of this variant 
relative to non-carriers. Tanno et al [382] found that the mRNA and expression of BMP4 
protein were significantly increased in OPLL cells derived from ossified spinal ligament when 
compared to non OPLL cells. This variant was associated with the occurrence and severity of 
OPLL in Chinese males [160] and has been reported to affect hip bone density in 
postmenopausal women [383].  
Polymorphisms in other genes such as COL6A1 [33, 146] and FGF2 [147] have been r 
associated with DISH susceptibility, however these associations do not fully explain the 
disease. The COL6A1 gene encodes an extracellular matrix protein that might serve as a 
scaffold for osteoblast or pre-osteoblast cells or chondrocytes that subsequently proceed to 
membranous or endochondral ossification [34]. According to several authors, this gene is 
strongly associated with OPLL and certain polymorphisms are considered helpful markers of 
OPLL [33, 146]. One of these polymorphisms, intron 32 (-29), associated with OPLL was 
also significantly associated with DISH Japanese patients but not with  DISH Czech 
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patients[34]. In our study, we identified the variant rs1053312 in COL6A1 and it was 
homozygous in one WES patient, however no differences were found between DISH/CC 
patients and controls groups. This variant was already studied in OPLL disease but, as in our 
study, no association was found [146]. The other gene with a positive association with DISH 
is FGF2 which encodes a member of the fibroblast growth factor family and is involved in 
FGF signalling, which controls bone formation by regulating the expression of various genes 
involved in osteoblast differentiation and apoptosis [148], and thus abnormalities in this gene 
are closely related to ectopic ossification diseases. Disruption of the FGF2 gene results in 
decreased bone mass and bone formation [384]. Jun and colleagues [147] found association 
between 2 polymorphisms in FGF2 (rs1476217 and rs3747676) and DISH, however no other 
studies have confirmed this association. In our study we identified the 3’UTR variant 
rs1048201, which was heterozygous in three patients, however no differences were found 
between DISH/CC patients and controls. This variant (rs1048201) seems to contribute to 
osteoporosis susceptibility, most likely through their effects on altered binding affinity for 
specific miRNAs [385]. The 3’UTR region often contains regulatory elements that influence 
post transcriptional gene expression by MicroRNAs (miRNAs) [385, 386]. According to the 
miRNA related SNP database (miRNASNP v2.0, 
http://www.bioguo.org/miRNASNP2/online.php), this variant causes the loss of a binding site 
for hsa-miR-196a-3p miRNA. Probably in absence of the rs1048201 variant the has-miR-
196a-3bp would bind optimally to FGF2 mRNA transcripts and negatively regulate protein 
expression by repressing mRNA translation and/or promoting mRNA degradation. On the 
other hand, the presence of rs1048201 variant may contribute to reduce binding efficacy 
between has-miR-196a-3bp and FGF2 and therefore would allow higher levels of FGF2 
expression, which would be expected to stimulate osteoblastogenesis through osteoblasts 
formation and therefore bone formation. A recent study showed that the variant rs1048201 
has also been reported to be associated with the risk of cleft palate [387], a disease which the 
etiopathogenesis is mostly unknown.  
Normally, variants in the human genome with a deleterious effect on proteins are the basis for 
the development of diseases. However, all the COL6A1 and FGF2 variants reported in the 
literature with a significant association with DISH have a non-functional effect on protein and 
are common variants within the general population, which suggests that the gene variants 
found so far have a minor effect on the development of the disease. The findings of our study 
lead us to suggest, as described in OPLL [181], that DISH can also be influenced by the 
interaction of multiple gene variants in which BMP4 gene could be one of them. 
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6.6. Conclusion 
The variant rs17563 in BMP4 gene was significantly associated with DISH/CC phenotype and 
may contribute to the development of DISH/CC phenotype. Further studies with a larger 
number of samples will be needed to clarify this association with the phenotype under study.  
6.7. Future work  
1) Explore how rs17563 in BMP4 gene affects BMP4 signaling in appropriate model 
systems. 
2) Perform case/control studies in all the conserved genetic variants; 
3)  Investigate the role of HLA-DQA2 in this disorder by sequencing (typing) this 
gene in families and cohorts of patients/controls if necessary; 
4)  Design a customized panel (NGS) and by means of NGS sequence a cluster of 
genes involved in mineralization (including the genes identified in this study) in a 
cohort of patients and controls. 
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6.8. Supplementary material  
 
Supplementary table 6-1. List of genes and their accession transcript numbers, used for 
conservation analysis. Data was retrieved from the Ensembl genome database; accessed on 
November 2016). 
Genes 
Specie 
Human Chimp Dog 
PLCG2 ENST00000564138.5 ENSPTRT00000015479.3 ENSCAFT00000031815.3 
ALPL ENST00000374840.7 ENSPTRT00000000592.2 ENSCAFT00000023578.3 
CASR ENST00000498619.3 ENSPTRT00000043996.4 ENSCAFT00000018760.3 
COL11A2 ENST00000341947.6 ENSPTRT00000048564.4 ENSCAFT00000001409.4 
ENPP1 ENST00000360971.6 ENSPTRT00000034356.3 ENSCAFT00000000001.3 
MGP ENST00000539261.5 ENSPTRT00000008732.4 ENSFCAT00000031714.1 
(Cat) 
VDR ENST00000229022.7 Ni ENSCAFT00000043473.2 
BMP4 ENST00000245451.8 ENSPTRT00000011643.4 ENSCAFT00000023624.3 
COL1A1 ENST00000225964.9 ENSPTRT00000017231.4 ENSCAFT00000026953.3 
BMP2 ENST00000378827.4 ENSPTRT00000024606.3 ENSCAFT00000049690.1 
COL6A1 ENST00000361866.7 ENSPTRT00000026156.3 ENSCAFT00000018918.3 
FLNC ENST00000325888.12 ENSPTRT00000036444.5 ENSCAFT00000002504.3 
AMER3 ENST00000423981.1 ENSPTRT00000023124.3 ENSCAFT00000006747.2 
PPP2R2D ENST00000455566.5 ENSPTRT00000005829.4 ENSCAFT00000044416.1 
ABCC6 ENST00000205557.11 ENSPTRT00000014398.4 ENSCAFT00000028908.3 
Genes 
Specie 
Mouse Chicken Zebrafish 
PLCG2 ENSMUST00000081232.8 ENSGALT00000050238.1 ENSDART00000021399.7 
ALPL ENSMUST00000030551.10 ENSGALT00000068960.1 ENSDART00000131101.2 
CASR ENSMUST00000063597.13 XM_416491.5.1 ENSDART00000010934.8 
COL11A2 ENSMUST00000087497.10 Ni ENSDART00000105754.4 
ENPP1 ENSMUST00000105520.7 ENSGALT00000066498.1 ENSDART00000127350.3 
MGP ENSMUST00000032342.2 ENSGALT00000019173.4 ENSDART00000149622.2 
VDR ENSMUST00000023119.14 ENSGALT00000071682.1 ENSDART00000161892.1 
BMP4 ENSMUST00000074077.11 ENSGALT00000020316.5 ENSDART00000075150.4 
COL1A1 ENSMUST00000001547.7 XM_015273228.1.1 ENSDART00000009393.7 
BMP2 ENSMUST00000028836.6 ENSGALT00000065435.1 ENSDART00000166657.1 
COL6A1 ENSMUST00000001147.4 ENSGALT00000039669.3 ENSDART00000110608.3 
FLNC ENSMUST00000065090.7 NM_204573.1.1 Ni 
AMER3 ENSMUST00000052670.10 ENSGALT00000055960.1 ENSDART00000149992.2 
PPP2R2D ENSMUST00000041097.12 ENSGALT00000081063.1 ENSDART00000172175.1 
ABCC6 ENSMUST00000002850.7 ENSGALT00000048627.1 ENSDART00000172943.1 
Abbreviations: Ni: note identified, PLCG2- Phospholipase C Gamma 2, ALPL- Alkaline Phosphatase, 
Liver/Bone/Kidney, CASR- calcium-sensing receptor, COL11A2- Collagen Type XI Alpha 2 Chain, ENPP1– 
ectonucleotide pyrophosphatase/phosphodiesterase 1, MGP- Matrix Gla Protein, VDR- Vitamin D Receptor, 
BMP4- Bone morphogenetic protein 4, COL1A1- Collagen Type I Alpha 1 Chain, BMP2- Bone morphogenetic 
protein 2, COL6A1- Collagen Type VI Alpha 1 Chain, FLNC- Filamin C, AMER3- APC Membrane Recruitment 
Protein 3, PPP2R2D- Protein Phosphatase 2 Regulatory Subunit B delta, ABCC6 – ATP-binding cassete 
subfamily C, member 6. 
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Supplementary figure 6-1. Analysis of sequence conservation among six vertebrates (some genes 
are not available in all species) of variants identified in candidate genes possibly associated with 
DISH/CC phenotype. The variant for FGF2 gene is not presented since it is a 3’prime region 
variant. 
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7. INVESTIGATING THE ROLE OF ABCC6 GENE IN 
ECTOPIC CALCIFICATION 
7.1 Abstract 
Ectopic calcification is a pathological process caused by deposition of calcium salts or 
inappropriate biomineralization in soft tissues such as the eyes, skin, arteries, entheses, and 
cartilage. Both DISH/CC and Ankylosing Spondylitis (AS) are bone forming conditions that 
share many common features and often coexist, and therefore it has been proposed that their 
susceptibility genes may overlap. The ABCC6 gene has been extensively related to dermal 
ectopic calcification and has recently become a new member of the calcification regulators in 
mammals. ABCC6 deficiency causes an imbalance in the homeostasis of multiple organs 
leading to BMP activation and consequently bone formation in these sites. The present study 
investigates the role of the ABCC6 gene in the aetiology of the following axial and peripheral 
ectopic calcification disorders: DISH, CC and AS. We test the hypothesis that if ABCC6 is 
involved in DISH, CC and AS it’s mutated in affected individuals. A preliminary expression 
study of the ABCC6 gene was performed to verify gene expression and abundance in cartilage 
tissues. 
DNA from 55 patients with DISH/CC, 25 with AS and 36 controls without DISH/CC and or 
AS were obtained for a case control association study. All 31 ABCC6 exons and the proximal 
ABCC6 gene promoter were amplified by PCR and Sanger sequencing of the products and 
statistical analysis was performed using Plink V1.9. ABCC6 gene expression was performed 
using a quantitative RT-PCR (qPCR) in 13 cartilage samples obtained from the femoral head 
during hip replacements. The data analysis was performed using the comparative Ct method 
(ΔCt). 
We identified 31 sequence variants of the ABCC6 gene that were classified according to 
character into: regulatory (n = 3), missense (n = 6), splice site (n = 3), synonymous (n = 5), 
intronic (n = 13) and 1 variant located in the 3’UTR region. Using Cochran-Armitage trend 
adjusted for gender, the variant rs12931472 located in exon 14 of ABCC6 gene was 
statistically more frequent in AS than in controls, but only in females. Furthermore, a gender-
specific protective association of the rare variant rs41278174 located on exon 23 of the 
ABCC6 gene was detected in both DISH/CC and AS males. When comparing DISH/CC with 
AS we observed that the regulatory variant rs778876717 was statistically more frequent in AS 
than in DISH/CC. The expression studies by qPCR showed that ABCC6 transcripts was very 
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low abundance in in cartilage tissues, and in the patients with DISH and CC the gene was up-
regulated in relation to a control patient. 
Our findings support the hypothesis that the ABCC6 gene plays a role in the axial ectopic 
calcification process and possibly reveals a gender specific interaction, however the statistical 
significance of our results is limited due to the relatively small cohort size, and larger cohort 
studies are required to further test this association. The gene expression studies on cartilage, 
although preliminary and not yielding statistically significant support reveals that differential 
expression could play a role in the disease process. To our knowledge, this is the first study to 
investigate the relationship between the ABCC6 gene and diseases characterized by 
ossification of the axial skeleton, such as DISH and AS.  
Keywords: ABCC6, DISH, CC, sequencing, qPCR. 
 
7.2. Introduction 
Ectopic calcification is caused by the inappropriate mineralization of soft tissues and is 
responsible for a significant number of disorders characterized by extraskeletal deposition of 
calcium and phosphate crystals [388]. Diffuse Idiopathic Skeletal Hyperostosis (DISH, MIM 
106400), Chondrocalcinosis (CC, MIM 118600) and Ankylosing Spondylitis (AS, MIM 
106300) are common rheumatic disorders characterized by ectopic calcification. DISH is 
characterized by the ossification of enthesis in the axial and peripheral skeleton, affecting the 
anterior longitudinal ligament [1] and CC by the deposition of calcium containing crystals in 
articular cartilage, synovial membranes and, less often, in periarticular soft tissues [341, 342]. 
AS is a chronic, multisystem inflammatory disorder characterized by inflammation and 
ankylosis of the sacroiliac joints and the axial skeleton. It is known that AS is strongly 
associated with HLA-B27 [235, 236], but other genes, including ERAP1 and IL23R, have also 
been associated with the disease [243]. Studies of HLA association with DISH were 
performed due to the similarity of the radiographic images with AS. The association between 
DISH and the HLA locus is unclear and some studies have refuted the results [136-141], 
while others have demonstrated association [142, 143]. The discrepancy between the results 
obtained by different studies may be explained by the coincidence of DISH and AS, or by 
difficulties in differentiating between these two disorders. The association of HLA antigens 
with DISH has never been proven and this association has now been shelved. The aetiology of 
DISH is still unknown, but several lines of evidence suggest that genetic factors might be 
involved in its aetiology [64, 77, 78]. A small number of cases of monogenic CC (CC MIM 
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118600) are caused by mutations in the ANKH gene [110, 343-345], which encodes a 
multipass transmembrane protein ANK that transports intracellular inorganic pyrophosphate 
(PPi) to the extracellular milieu [106]. The coexistence of DISH with CC is very common on 
Terceira Island, Azores and it was hypothesized that both diseases share common pathogenic 
mechanisms [23].  
Little is known about the reasons why calcification or ossification occurs outside the skeleton 
and considerable efforts have been made to understand why such events occur. Three proteins 
have been identified as central regulators of extracellular PPi and Pi levels, tissue-nonspecific 
alkaline phosphatase (TNAP) which converts the inhibitor (PPi) into a promoter of 
mineralization (Pi) [183], ectonucleotide pyrophosphatase 1 protein (ENPP1), which 
generates PPi from nucleoside triphosphates (ATP) [93] and the Inorganic Pyrophosphate 
Transport Regulator (ANK) which mediates intracellular to extracellular channelling of PPi 
[106]. Several other genes have been associated with the regulation of the biomineralization 
process, such as the ABCC6 gene (ATP Binding Cassete Subfamily C Member 6), which 
maps to chromosome region 16p13.11 and encodes the transmembrane transporter MRP6 
(Multidrug Resistance Protein 6) [389]. Inactivating mutations in this gene are the cause of 
most cases of Pseudoxanthoma elasticum (PXE; MIM#264800) and some cases of arterial 
calcification generalized of infancy type 2 (GACI2; MIM#614473)[390]. GACI is 
characterized by the calcification of the internal elastic lamina of muscular arteries and 
stenosis due to myointimal proliferation. Mutations in the ENPP1 gene are the main cause for 
the GACI cases [96], and can also cause PXE [390]. In GACI the ectopic tissue 
mineralization occurs as a result of reduced ENPP1 activity and consequently an increase in 
the Pi to PPi ratio. PPi is hydrolyzed by TNAP to generate Pi, which is a component of 
hydroxyapatite crystal deposition and plays a role in the regulation of osteoblast 
differentiation [391]. PXE, in turn is characterized by aberrant mineralization of soft 
connective tissue with degeneration of the elastic fibers, involving primarily the eyes, the 
cardiovascular system, and the skin [392]. There have also been some studies associating 
polymorphisms in the ENPP1 gene to a higher risk of developing ossification of the posterior 
longitudinal ligament (OPLL) [180]. 
There is a consensus that the ABCC6 gene is mainly expressed in the liver and kidneys [393, 
394], although two studies have reported its ubiquitous tissue expression [124, 395]. The 
majority of PXE causing mutations in ABCC6 gene normally lead to an altered folding and/or 
protein stability leading to intracellular retention and reduced trafficking [112]. However, 
PXE is not caused by a lack of the functional MRP6 protein in the affected tissues but rather 
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by the absence of an unknown factor provided to the central circulation by an MRP6 
dependent mechanism [396]. It is known that PPi is the central regulatory metabolite 
preventing matrix calcification in PXE, however the underlying molecular mechanism leading 
to reduction of PPi in PXE is unknown since the substrate(s) of this transporter remains to be 
elucidated. One theory suggested [129, 397] that MRP6 mediates the release of ATP directly 
from the liver into the circulation; ATP is converted into AMP and PPi and represents the 
main source of the mineralization inhibitor PPi in plasma. This explain why patients with 
PXE [397] and Abcc6-/- mice [129] have reduced PPi plasma levels compared to healthy 
individuals and wild type control mice, respectively. In the Enpp1-/- mouse model for GACI 
ectopic calcification also depends on plasma PPi levels and not on local PPi production [398]. 
The zebrafish mutant, gräte (grt; abcc6ahu4958) that carries a abcc6a mutated gene, shows 
signs of excessive hypermineralisation in the craniofacial and axial skeleton. In the zebrafish 
model the abcc6a gene is strongly expressed at the site of mineralisation and secretes ATP 
from cells increasing PPi locally, and this is unlike the mammalian model in which PPi is 
hepatically derived [113].  
Although the PXE and GACI are considered two distinct diseases linked to ABCC6 and 
ENPP1 genes, respectively, the overlap of genotype and phenotype of both diseases suggests 
that the pathophysiology of both may derive from the same physiological mechanism or 
pathway [97, 390], probably involving reduced PPi [399]. Under physiological conditions PPi 
serves as a powerful anti-mineralization factor, preventing ectopic mineralization and 
dysregulated cellular production, degradation, and transport [400]. For instance, mutations in 
genes encoding known PPi-regulating enzymes like ENPP1, progressive ankylosis protein 
homolog (ANKH) and tissue-nonspecific alkaline phosphatase (TNAP) causes OPLL [195], 
CC [110] and Hypophosphatasia [401] , respectively. Furthermore, a recent study showed that 
polymorphisms in ENPP1, TNAP and ANKH are important genetic risk factors contributing to 
PXE [130]. 
The ABCC6 gene has recently joined the list of calcification regulators as a new member 
playing a role in pyrophosphate metabolism. The present investigation is a follow-up study of 
the chapter 6 of this thesis, which includes the genetic analysis of all ABCC6 gene (exons, the 
adjacent introns and the proximal promoter region). We test the hypothesis that if ABCC6 is 
involved in DISH, CC and AS its expression will be modified in affected individuals. A 
preliminary expression study of the ABCC6 gene was performed to verify gene expression 
and abundance in cartilage.  
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7.3. Material & methods 
7.3.1. Subjects 
This study involved a group of 12 probands (patients who are the initial members of a family 
to come under study) with a diagnosis of DISH/CC (8 male, 4 female; age of onset around 40 
years), a cohort of 55 unrelated Azorean patients with a diagnosis of DISH/CC (36 male, 19 
female; age of onset around 40 years), a cohort of 25 unrelated Azorean patients with a 
diagnosis of Ankylosing Spondylitis (18 male, 7 female; mean current age, 61 years; range, 
37-91) and 36 unrelated healthy controls with a similar ethnic background (16 male, 20 
female; mean current age, 68 years; range, 57-102). Standard X rays, to evaluate the severity 
status of the disease, were taken from: knees, axial skeleton, wrists, hands, elbows, and pelvis 
from selected DISH/CC patients.  
In order to evaluate variant frequency two representative populations of Terceira Island, one 
with 124 individuals (45 male, 79 female; mean age, 66 years; range, 35-100) (population 1) 
and the other with 375 individuals (85 male, 29 female; mean age, 55 years; range, 25-90) 
(population 2) were used. This study was approved by the HSEIT Ethics Committee and all 
participants provided informed consent. 
From 2008 to 2013 a collection of samples from the coxofemoral articular cartilage was 
obtained from 53 patients undergoing total hip replacement surgery (34 male, 17 female; 
mean current age, 71 years; range, 47-93 years). Sterile cartilage sections (of approximately 3 
mm diameter) were prepared with a scalpel and a cutter and flash-frozen in RNA later at -
80°C. Informed consent was obtained from these patients for use of their rejected tissue in 
research.  
7.3.2. Gene sequencing  
7.3.2.1. Mutation screening 
Mutation screening was performed by Sanger sequencing of the 31 exons of ABCC6, 
including the exon–intron boundaries after polymerase chain reaction (PCR) amplification 
using previously described primers [308, 309], excluding the amplification of the two 
ABCC6-pseudogenes ABCC6P1 and ABCC6P2, previously described [402] (primers 
sequences and PCR conditions available in the material and methods of this thesis). DNA 
from 12 DISH/CC probands was first sequenced followed by a group of 55 DISH/CC 
patients, 25 AS patients and 36 controls without DISH/CC disease. 
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Sequencing was carried out using ABI Big Dye chemistry on an ABI 3130xl automated 
sequencer (Applied Biosystems) and genetic variants  were screened with sequencing 
analysis and SeqScape (Applied Biosystems) using as reference the NC_000016.10 
sequence (see the material and methods section of this thesis for more detail). 
The functional significance and the potential effect of each variant on the protein was 
subsequently explored in the following databases: dbSNP 
(https://www.ncbi.nlm.nih.gov/projects/SNP/,  Human Gene Mutation Database (HGMD) 
(http://www.hgmd.cf.ac.uk/ac/index.php), Human Splicing Finder 
(http://www.umd.be/HSF3/HSF.html), Ensembl (http://www.ensembl.org/index), making use 
of various algorithms, such as PolyPhen-2 (Polymorphism Phenotyping v2) 
(http://genetics.bwh.harvard.edu/pph2/) (benign, [0-0.2], possibly damaging (0.2-0.85), and 
probably damaging [0.85-1]) and SIFT (Sorting Intolerant From Tolerant) (damaging if less 
than 0.05). The Minor Allele Frequencies (MAF) of each variant were also analyzed.  
Protein conservation analysis was performed using ClustalW 
(http://www.genome.jp/tools/clustalw/) to compare homologous amino acid sequences among 
multiple vertebrates at the sites where the variations occur. The accession numbers of each 
transcript are available in table 7-1. 
 
Table 7-1. List accession transcript numbers for ABCC6 gene, used for conservation analysis. 
Data was retrieved from the Ensembl genome database; accessed on Jully 2015. 
Species Accession numbers 
Human ENST00000205557.11 
Chimpanzee ENSPTRT00000014398.4 
Mouse ENSMUST00000002850.7 
Cow ENSBTAT00000050284.3 
Dog ENSCAFT00000028908.3 
Chicken ENSGALT00000048627.1 
Xenopus ENSXETT00000042610.2 
Spotted gar ENSLOCT00000008702.1 
7.3.2.2. Statistical analysis 
To assess the difference in allele frequencies between the 55 patients with DISH/CC and the 
36 control individuals and between males and females a Fisher exact test was used. The same 
test was also used to assess the difference in the AS patients and controls. The Fisher exact 
test was calculated for odds ratios (OR) (95% confidence interval) and corresponding p-
values.  
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To determine the association between the DISH/CC disease and allele variants other tests 
were employed: Cochran-Armitage trend, dominant and recessive gene action tests with 1 
degree of freedom and genotypic test with 2 degrees of freedom. For all the statistical tests 
used a p-value of ≤0.05 was considered statistically significant.  All statistical analysis were 
performed using PLINK software [354]. 
To compare the two groups of patients (DISH/CC and AS) a contingency table analysis for 
calculation of Fisher’s exact probability test was performed using the VassarStats: Website 
for Statistical Computation (http://vassarstats.net/tab2x2.html). 
7.3.3. Gene expression 
7.3.3.1.RNA isolation and quality control 
Cartilage samples were prepared using a combination of physical, chemical and enzymatic 
treatments. In brief, coxofemoral articular cartilage sections were minced, frozen, and 
pulverized in liquid nitrogen with a mortar and pestle. The tissue powder was placed in Trizol 
and total RNA was isolated using the Trizol RNA isolation protocol, developed by 
Chomezynski and Sacchi [310].  
Purification of RNA samples was performed an RNeasy MinElute Cleanup kit (Qiagen) 
according to the manufacturer’s instructions, a DNase (Deoxyribonuclease I) digestion and 
ethanol wash were subsequently performed. RNA integrity was assessed using a NanoVue 
spectrophotometer (GE Healthcare) and an Agilent 2100 Bioanalyser and RNA 6000 Nano 
LabChip (Agilent Technologies). 
7.3.3.2 Reverse transcription- RT-PCR 
RNA (100 ng) samples with RNA Integrity Number (RIN) above 4 were reverse-transcribed 
using High Capacity cDNA Reverse Transcription kit (Thermofisher) following the 
manufacturer’s instructions. To verify the efficiency of RT-PCR the cDNA from human 
cartilage was used as a template for PCR amplification of the β-actin gene using a PCR 
System 9700 (Applied Biosystems). The β-actin amplicon of 249 bp was visualized on 1.7% 
agarose gel (sequence primers and PCR conditions available in material and methods of this 
thesis). 
7.3.3.3.Quantitative RT-PCR (qRT-PCR) 
Gene expression evaluation was performed using quantitative RT-PCR (qRT-PCR) with 
TaqMan chemistry. FAM-labeled TaqMan Gene Expression Assays (Applied Biosystems) 
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were used for the target gene ABCC6 (ABCC6, Hs00184566_m1) and the primers include the 
17-18 exon junction of this gene. The housekeeping gene YWHAZ (Tyrosine 3-
Monnoxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta) is one of the most 
stable genes in cartilage tissues and is considered the best normalizer [403, 404] for use in this 
type of tissues. FAM-labeled TaqMan Gene Expression Assays (Applied Biosystems) were 
used for the internal control (YWHAZ, Hs00237047_m1), and the primers include the 1-2 
exon junction of this gene. 
The qPCR was performed for 20 μl final reactions using 20X TaqMan Gene Expression 
Master mix and 20X TaqMan Gene Expression assay for ABCC6 and YWHAZ genes. 
Reactions were performed using the Applied Biosystems 7500 Fast Real-Time PCR System 
following the program: 2 min at 50°C, 10 min at 95°C, and 40 cycles repeating denaturation 
15 s at 95°C, and annealing for 1 min at 60°C. Duplicate reactions were used for each sample 
and 400ng of synthesized cDNA was used to amplify the target gene and 200 ng to amplify 
the control gene. 
Threshold cycle (Ct) values were determined using 7500 System Software V2.0.6 (Applied 
Biosystems) and data were further analyzed with Microsoft Office Excel 2013 (Microsoft 
Corporation). The data analysis was performed using the comparative Ct method (ΔCt) [405]. 
ΔCt values were used to measure gene expression, which was normalized using YWHAZ 
expression levels. The expression study was preliminary and because of low sample number it 
was not be possible to carry out statistical analysis. 
7.3.3.4. Typing ABCC6 gene variants  
Functionally relevant variants were considered to be those that were located in regulatory 
regions such as; splice sites and missense variants in the promoter region, exons 10, 14,15, 22, 
23, 25 and 27. The presence and location of mutations in the ABCC6 gene were procured in 
the DNA of all patients selected for the expression studies (13 individuals; 9 males, 4 females; 
mean age of surgery, 66 years; range, 47-76 years). 
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7.4. Results 
7.4.1. Sequencing 
7.4.1.1. ABCC6 variants 
The coding region of the ABCC6 gene was sequenced in a group of 12 DISH/CC probands 
and the variants identified are indicated in table 7-2. Thirty-one genetic variants were 
identified in the ABCC6 gene; 3 located in regulatory regions, 3 in splice sites, 6 missense 
variants, 5 synonymous, 13 intronic and 1 variant located in the 3’UTR (Table 7-2).  
Overall, three variants were found in the ABCC6 promoter region variant rs28529549, and 
rs565625561 were present in P8 and rs778876717 were present in P1 and P9. The MAF 
values for the variants were not available in Ensembl. In the Human Gene Mutation Database 
the rs28529549 variant is associated with PXE and has a protective effect [406]. The splice 
site variants rs55778939 in P1, rs9940089 in P1-9 and P11 and rs41278172 in P8 probably 
have no impact on splicing. Splice variant rs41278172 is rare (MAF 0.01), rs55778939 is 
relatively rare (MAF 0.02) and rs9940089 is a frequent variant (MAF 0.18) (Table 7-2). Of 
the 6 missense variants, three of them are rare, with a MAF of 0.01. Variants rs41278174 in 
P1 and P9 and rs613450537 and rs2606921 in P8 were extremely rare and had an unknown 
MAF as there was insufficient data to establish population frequency since it was identified in 
only 3 of 114594 alleles (ExAc_Aggregated_Populations), indicating that it was 
unquestionably very rare (MAF 0.00003023). The variant rs41278174 (R1064W, P1 and P8) 
causes the substitution of arginine by tryptophan at amino acid 1064 in the protein and causes 
a shift from large and basic arginine to large and aromatic tryptophan. 
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Table 7-2. ABCC6 variants identified in a group of 12 DISH/CC probands (P1-12) and information about their functional significance (assessed on 
December 2016).  The effect on splicing is indicated in Column SPL and absence of information stands for ‘no affect splicing’. 
Exon/   Intron 
modification 
Variant SNP 
Type of 
variant 
SPL MAF SIFT PolyPhen P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 
Promoter c.-219A>C rs28529549 RR ? ? NA NA 
       
ht 
    
Promoter c.-132C>T rs565625561 RR ? ? NA NA 
       
ht 
    
Promoter c.-127C>T rs778876717 RR ? ? NA NA ht 
       
hm 
   
intron3 c.345+26C>T rs56019914 Intronic  0.03 NA NA 
       
ht 
    
i3 c.346-6G>A rs55778939 Splicing  0.02 NA NA ht 
           
E4 
c.473C>T 
 (A158V) 
rs2606921 Missense as ? 0.22 0.003 
       
ht 
    
i4 c.474+13G>A rs111339199 Intronic  0.01 NA NA ht 
       
ht 
   
i8 c.998+99G>A rs150203830 Intronic  0.16 NA NA ht 
 
ht ht 
  
? ht 
 
hm ht ht 
i9 c.1176+243C>T rs2283503 Intronic  0.36 NA NA ht hm ht ? 
 
  
 
hm 
 
ht ht 
i9 c.1177-94T>C rs12935658 Intronic  0.32 NA NA 
   
ht hm hm hm ht 
    
i9 c.1177-89G>A rs12935089 Intronic  0.32 NA NA 
   
ht hm hm hm ht 
    
E10 
c.1233T>C 
 (N411N) 
rs9930886 Synonymous as 0.28 NA NA 
   
ht ht ht hm ht 
    
E10 
c.1245G>A 
(V415V) 
rs9940825 Synonymous as 0.23 NA NA 
   
ht ht ht hm ht 
    
i10 c.1338+7C>G rs9940089 Splicing  0.18 NA NA ht hm ht ht hm hm hm ht ht 
 
ht 
 
i10 c.1338+20C>T rs12929920 Intronic  0.27 NA NA ht hm ht ht hm ht hm ht ht 
 
ht 
 
i10 c.1338+62C>G rs58394656 Intronic  0.17 NA NA ht 
 
ht ht ht 
  
ht ht hm ht hm 
i11 c.1432-41A>G rs2239322 Intronic  0.32 NA NA ht ht hm 
     
hm 
 
ht 
 
i12 c.1635+48C>T rs55707615 Intronic  0.32 NA NA ht ht hm 
     
hm 
 
ht 
 
E14 
c.1841T>C  
(V614A) 
rs12931472 Missense  0.37 0.77 0 ht ht 
 
ht ht ht hm ht 
  
ht 
 
i14 c.1868-57G>A rs41278182 Intronic  0.30 NA NA ht ht hm 
     
hm 
 
ht 
 
E15 
c.1890C>G 
T630T 
rs8058696 Synonymous as 0.33 NA NA ht ht 
 
ht ht hm hm ht 
  
ht 
 
E15 
c.1896C>A 
(H632Q) 
rs8058694 Missense as 0.36 0.59 0.001 ht ht 
 
ht ht hm hm ht 
  
ht 
 
E19 
c.2490C>T 
(A830A) 
rs9924755 Synonymous as 0.15 NA NA ht 
   
ht hm 
    
ht 
 
E22 
c.2835C>T 
(P945P) 
rs2856585 Synonymous as 0.12 NA NA 
   
ht 
       
ht 
E22 
c.2836C>A 
(L946I) 
rs61340537 Missense as 0.01 0.42 0.013 
       
ht 
    
E23 
c.3190C>T 
(R1064W) 
rs41278174 Missense as 0.01 0 0.932 ht 
       
ht 
   
i24 c.3507-3C>T rs41278172 Splicing  0.01 NA NA 
       
ht 
    
E27 
c.3803G>A 
(R1268Q) 
rs2238472 Missense as 0.19 0.19 0.004 ht hm 
 
hm   ht ht ht 
  
ht 
i28 c.4042-30C>T rs2066738 Intronic  0.18 NA NA 
 
hm ht 
     
ht 
   
i30 c.4404-31A>G rs212097 Intronic as 0.28 NA NA ht ht 
 
hm ht 
 
ht hm ht hm 
 
hm 
3’UTR c.*17G>A rs3902401 3’UTR ? 0.07 NA NA 
       
ht 
   
ht 
Abbreviations: SNP - Single nucleotide polymorphism, SPL- splicing,  MAF – Minor Allele frequency, SIFT – Sorting Intolerant From Tolerant, P-proband, E-exon, i-
intron, RR-Regulatory region, as - altered splicing  NA - not applicable, ht - heterozygous, h - homozygous and ? - unknown genotype, as- altered splicing
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 According to the ensemble database this nucleotide position is totally conserved in mammals 
(Figure 7-1). This variant seems to have a fundamental relevance since its localization 
indicates a potential alteration of splicing and the algorithms SIFT score (0; deleterious) and 
PolyPhen (0.932; probably damaging) indicates a deleterious and a damaging effect on the 
protein (Table 7-2). 
The positions of variants in the topology model of MRP6 protein and the conservation of the 
related amino acids are shown in figure 7-1. One variant occurs in extracellular domain 
(p.A158V), three variants in the transmembrane domain (P945P, L946I and R1064W), while 
seven were located in the cytoplasmic region (N411N, V415V, V614A, T630T, H632Q, 
A830A and R1268Q). 
 
Figure 7-1. Predicted transmembrane protein topology of MRP6 (Protter) with locations of 
human variants and comparison with the amino acid in the equivalent position in other 
vertebrate species. In the protein structure the amino acids positions affected by a missense 
variant are highlighted in red and the synonymous variants are indicated in green. Ext: 
extracellular, CTD: cytoplasmatic domain and TMD: Transmembrane domain. 
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7.4.1.2. Case/control study 
In order to perform a case/control study we selected functionally relevant variants, namely 
those that were located in regulatory regions including splice sites and missense variants and 
assessed their distribution in two groups of patients with DISH/CC and AS and in a group of 
unaffected controls. The 12 SNPs identified were in HWE and the results are shown in table 
7-3. The missense variant rs12931472 in exon 14 was found in all AS females; 3 were 
heterozygous and 4 were homozygous (Supplementary table 7-1), however a fisher exact test 
did not give statistically significant p-value between AS females and controls females (Table 
7-3). However, a significant difference was found between AS and control females when a 
Cochran-Armitage trend test (p=0.03, CHISQ=4.62) and allelic test (p=0.04, CHISQ=4.09) 
was used (Table 7-4). The missense variant rs41278174 in exon 23 was not found in the AS 
group (Supplementary table 7-1). Using the Cochran-Armitage trend and allelic tests the 
rs41278174 variant was significantly less frequent in both DISH/CC and AS males relative to 
the control males, where it was more frequent (Table 7-4).  
 
 
 
  Chapter VII 
 
131 
 
Table 7-3. The results of the association study of genetic variants found in the ABCC6 gene in Azorean patients with DISH/CC and AS compared to 
the controls. The minor allele is represented in bold. 
SNP 
A
ll
el
es
 
MAF FISHER EXACT TEST 
DISH/CC CONTROLS AS DISH/CC vs Controls AS vs Controls 
All 
N=55 
F 
N=19 
M 
N=36 
All 
N=36 
F 
N=22 
M 
N=14 
All   
N=25 
F 
N=7 
M 
 N=18 
All F M All F M 
OR P OR P OR P OR P OR P OR P 
rs28529549 A/C 0.06 0.05 0.07 0.03 0 0.07 0.02 0 0.03 2.38 0.49 NA 0.21 0.97 1 0.71 1 NA 1 0.37 0.58 
rs565625561 C/T 0.03 0 0.04 0.01 0 0.04 0.02 0 0.03 1.99 1 NA 1 1.17 1 1.45 1 NA 1 0.77 1 
rs778876717 C/T 0.06 0.11 0.04 0.11 0.09 0.14 0.14 0.07 0.17 0.54 0.28 1.18 1 0.26 0.09 1.30 0.78 0.77 1 1.20 1 
rs55778939 G/A 0.08 0.05 0.10 0.06 0.05 0.07 0.04 0.07 0.03 1.52 0.57 1.17 1 1.40 1 0.71 1 1.62 1 0.37 0.58 
rs2606921 C/T 0.02 0 0.03 0.01 0 0.04 0.06 0 0.08 1.32 1 NA 1 0.77 1 4.53 0.30 NA 1 2.46 0.63 
rs9940089 C/G 0.29 0.29 0.29 0.32 0.32 0.32 0.22 0.29 0.19 0.87 0.74 0.87 0.81 0.87 0.81 0.60 0.31 0.86 1 0.51 0.26 
rs12931472 T/C 0.51 0.47 0.50 0.46 0.52 0.43 0.54 0.21 0.44 1.23 0.55 0.82 0.82 1.33 0.66 1.39 0.46 0.25 0.06 1.07 1 
rs8058694 C/A 0.48 0.50 0.47 0.40 0.43 0.36 0.48 0.64 0.42 1.38 0.36 1.32 0.66 1.61 0.37 1.37 0.46 2.37 0.22 1.29 0.80 
rs61340537 C/A 0.01 0 0.01 0.01 0.02 0 0.04 0 0.06 0.65 1 0 1 NA 1 2.96 0.57 0 1 NA 0.50 
rs41278174 C/T 0.04 0.08 0.01 0.06 0.02 0.11 0 0 0 0.64 0.71 3.69 0.33 0.12 0.07 0 0.14 0 1 0 0.08 
rs41278172 C/T 0.01 0 0.01 0.01 0.02 0 0.04 0 0.06 0.65 1 0 1 NA 1 2.96 0.57 0 2.92 NA 0.50 
rs2238472 G/A 0.22 0.24 0.21 0.21 0.20 0.21 0.24 0.43 0.17 1.06 1 1.21 0.79 0.96 1 1.20 0.82 2.92 0.16 0.73 0.75 
Abbreviations: SNP- Single nucleotide polymorphism, AS- Ankylosing Spondylitis, MAF- Minor allele frequency, OR- odds ratio, P- pvalue, N- number of individuals, 
NA- not applicable, vs: versus, F- Female, M- Male. 
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Table 7-4. Association study of the genetic variants in the ABCC6 gene in DISH/CC and AS patients compared to the controls. 
Abbreviations: SNP- Single nucleotide polymorphism, AS- Ankylosing Spondylitis, M-Males, F-females, T-trend, A- allelic, P- p-value, N- number of individuals.   
 
SNP 
A
ll
el
e 
(A
1
) 
A
ll
el
e 
(A
2
) DISH/CC (A1/A2) Controls (A1/A2) AS (A1/A2) 
T
E
S
T
 
DISH/CC vs Controls AS vs Controls 
All 
N=110 
M  
N=72 
F  
N=38 
All  
N=72 
M 
N=28 
F 
N=44 
All  
N=50 
M 
N=36 
F 
N=14 
All M F All M F 
CHISQ P CHISQ P CHISQ P CHISQ P CHISQ P CHISQ P 
rs28529549 C A 7/103 5/67 2/36 2/70 2/26 0/44 1/49 1/35 0/14 
T 1.26 0.26 0 0.97 2.44 0.12 0.08 0.78 0.71 0.40 NA NA 
A 1.19 0.28 0 0.97 2.37 0.12 0.07 0.79 0.67 0.41 NA NA 
rs565625561 T C 3/107 3/69 0/38 1/71 1/27 0/44 1/49 1/35 0/14 
T 0.37 0.54 0.02 0.89 NA NA 0.07 0.79 0.03 0.85 NA NA 
A 0.36 0.55 0.02 0.89 NA NA 0.07 0.79 0.03 0.86 NA NA 
rs778876717 T C 7/103 3/69 4/34 8/64 4/24 4/40 7/43 6/30 1/13 
T 1.43 0.23 3.43 0.06 0.05 0.82 0.27 0.61 0.08 0.77 0.06 0.81 
A 1.30 0.25 3.17 0.07 0.05 0.83 0.23 0.63 0.07 0.79 0.05 0.82 
rs55778939 A G 9/101 7/65 2/36 4/68 2/26 2/42 2/48 1/35 1/13 
T 0.42 0.52 0.14 0.71 0.02 0.88 0.16 0.69 0.71 0.40 0.15 0.69 
A 0.45 0.50 0.16 0.69 0.02 0.88 0.15 0.70 0.67 0.41 0.15 0.70 
rs2606921 T C 2/108 2/70 0/38 1/71 1/27 0/44 3/47 3/33 0/14 
T 0.05 0.82 0.05 0.83 NA NA 2.05 0.15 0.65 0.42 NA NA 
A 0.05 0.82 0.04 0.86 NA NA 1.98 0.16 0.61 0.44 NA NA 
rs9940089 C G 32/78 21/51 11/27 23/49 9/19 14/30 11/39 7/29 4/10 
T 0.15 0.70 0.08 0.78 0.06 0.80 1.23 0.27 1.35 0.24 0.04 0.84 
A 0.17 0.68 0.09 0.77 0.08 0.78 1.45 0.23 1.35 0.24 0.05 0.82 
rs12931472 T C 56/54 36/36 18/20 33/39 12/16 23/21 27/23 16/20 3/11 
T 0.46 0.50 0.40 0.53 0.22 0.64 0.89 0.35 0.02 0.89 4.62 0.03 
A 0.45 0.50 0.41 0.52 0.20 0.66 0.79 0.37 0.02 0.90 4.09 0.04 
rs8058694 A C 53/57 34/38 19/19 29/43 10/18 19/25 24/26 15/21 9/5 
T 1.07 0.30 1.06 0.30 0.37 0.54 0.74 0.39 0.27 0.61 1.83 0.18 
A 1.10 0.29 1.08 0.30 0.38 0.54 0.72 0.40 0.23 0.63 1.89 0.17 
rs61340537 A C 1/109 1/71 0/38 1/71 0/28 1/43 2/48 2/34 0/14 
T 0.09 0.76 0.40 0.53 0.89 0.35 0.86 0.35 1.66 0.20 0.33 0.57 
A 0.09 0.76 0.39 0.53 0.87 0.35 0.84 0.36 1.61 0.21 0.32 0.57 
rs41278174 T C 4/106 1/71 3/35 4/68 3/25 1/43 0/50 0/36 0/14 
T 0.40 0.53 4.76 0.03 1.46 0.23 2.97 0.08 4.26 0.04 0.33 0.57 
A 0.38 0.54 4.57 0.03 1.39 0.24 2.87 0.09 4.05 0.04 0.32 0.57 
rs41278172 T C 1/109 1/71 0/38 1/71 0/28 1/43 2/48 2/34 0/14 
T 0.09 0.76 0.40 0.53 0.89 0.35 0.86 0.35 4.66 0.20 0.33 0.57 
A 0.09 0.76 0.39 0.53 0.87 0.35 0.84 0.36 1.61 0.21 0.321 0.57 
rs2238472 A G 24/86 15/57 9/29 15/57 6/22 9/35 12/38 6/30 6/8 
T 0.02 0.88 0 0.95 0.12 0.73 0.17 0.69 0.24 0.62 2.75 0.10 
A 0.03 0.87 0 0.95 0.12 0.72 0.17 0.68 0.23 0.63 2.78 0.10 
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To compare the variant frequency between DISH/CC and AS we used a Fisher Exact 
Probability test (Table 7-5). 
Table 7-5. Frequency comparison of the genetic variants found in the coding exons of the ABCC6 gene 
between the DISH/CC and AS groups.  
SNP 
Allele  
(A1) 
Allele 
(A2) 
DISH/CC  (A1/A2) AS (A1/A2) 
p-value  
one tailed/two tailed 
All        
N=110 
M 
N=72 
F 
N=38 
All      
N=50 
M 
N=36 
F 
N=14 
All M F 
rs28529549 C A 7/103 5/67 2/36 1/49 1/35 0/14 0.22/0.44 0.34/0.66 0.53/1 
rs565625561 T C 3/107 3/69 0/38 1/49 1/35 0/14 0.62/1 0.59/1 1/1 
rs778876717 T C 7/103 3/69 4/34 7/43 6/30 1/13 0.10/0.13 0.03/0.05 0.59/1 
rs55778939 A G 9/101 7/65 2/36 2/48 1/35 1/13 0.27/0.50 0.18/0.26 0.61/1 
rs2606921 T C 2/108 2/70 0/38 3/47 3/33 0/14 0.18/0.33 1/1 0.21/0.33 
rs9940089 C G 32/78 21/51 11/27 11/39 7/29 4/10 0.23/0.44 0.20/0.35 0.63/1 
rs12931472 T C 56/54 36/36 18/20 27/23 16/20 3/11 0.42/0.74 0.37/0.68 0.08/0.11 
rs8058694 A C 53/57 34/38 19/19 24/26 15/21 9/5 0.56/1 0.37/0.68 0.27/0.53 
rs61340537 A C 1/109 1/71 0/38 2/48 2/34 0/14 0.23/0.23 0.67/1 1/1 
rs41278174 T C 4/106 1/71 3/35 0/50 0/36 0/14 0.22/0.31 0.66/1 0.21/0.31 
rs41278172 T C 1/109 1/71 0/38 2/48 2/34 0/14 0.23/0.23 0.26/0.55 1/1 
rs2238472 A G 24/86 15/57 9/29 12/38 6/30 6/8 0.45/0.84 0.41/0.80 0.16/0.30 
Abbreviations: SNP- Single nucleotide polymorphism, AS- Ankylosing Spondylitis, M-Males, F-females, T-
trend, A- allelic, OR- odds ratio, P- pvalue, N- number of individuals. 
 
The frequency of the variant rs778876717 was significantly different between the DISH/CC 
and AS cohorts, particularly in males and it was more frequent in AS males than in DISH/CC 
males (Table 7-5). The rs778876717variant is located in the promotor region and no 
frequency or population information exists for this variant.  
7.4.1.3 SNP frequencies 
The variant rs41278174 (R1064W) was found in ten individuals (in two probands, 4 
DISH/CC patients and 4 healthy controls). Since rs41278174 is extremely rare (Table 7-2) we 
procured for this variant in two representative populations of Terceira Island that contained 
124 and 385 individuals to verify if the frequency is also higher in these groups (Table 7-6). 
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Table 7-6. Frequency in population 1 and population 2 of Terceira Island of the ABCC6 gene 
variant (c.3190C>T/R1064W) in exon 23. 
Variant SNP 
Population 1 Population 2 
All 
(N=124) 
F 
(N=77) 
M 
(N=45) 
All 
(N=385) 
F 
(N=299) 
M 
(N=86) 
c.3190C>T 
R1064W 
rs41278174 
14 
11% 
11 
14% 
3 
7% 
19 
5% 
16 
5% 
3 
3% 
Abbreviations: SNP- Single nucleotide polymorphism, F-females, M-Males, N- number of individuals. 
 
The c.3190C>T/R1064W variant was found in 14 individuals in population 1 and in 19 
individuals in population 2, all of them were heterozygous. In addition, a further rare variant 
(rs60707953) was found in exon 23, which have a MAF of 0.01 in two individuals, one 
female and one male from the population 1. The male suffers from lower back pain and the 
female is healthy. The variant causes a substitution of a leucine by isoleucine at amino acid 
1097 in the protein. Both amino acids have similar physico-chemical properties and both 
residues are medium size and hydrophobic.  
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7.4.2. Expression 
It was only possible to assess the expression of the ABCC6 gene in 13 (9 males and 4 females; 
mean age 72 years; range 53-84) (Table 7-7 and supplementary figure 7.1) out of 53 RNA 
cartilage samples due to the poor quality of the RNA (Supplementary table 7-2).  
 
Table 7-7. Details of the 13 patients undergoing hip replacement from whom femoral head 
cartilage where obtained. The sample used as a control is highlighted in bold (THR-40). * Age 
(yr-years) at time of operation. The pathological anatomy of the affected tissue is also indicated. 
Samples Sex 
Age 
(yr)* 
Diagnosis Affected tissue 
THR-4 F 61(?) DISH (thoracic) Cartilaginous tissue 
THR-6 M 67 Coxoarthrosis (right) 
Cartilaginous tissue with degenerative 
alterations 
THR-13 M 76 DISH (cervical, lumbar and throracic), Coxoarthrosis Cartilaginous tissue 
THR-20 M 70 Coxoarthrosis (bilateral), hypertension 
Cartilaginous tissue with superficial 
fibrosis with papilliform contours 
THR-31 M 47 Coxoarthrosis (right) 
Fragment of cartilaginous tissue with 
focal fibrous cap 
THR-34 F 58 Coxoarthrosis (left) Synovial and cartilaginous fibrous tissue 
THR-35 M 75 Chondrocalcinosis (knees), Coxoarthrosis (bilateral) Cartilaginous tissue 
THR-36 F 59 Chondrocalcinosis (knees), Coxoarthrosis 
Cartilaginous tissue with degenerative 
aspects 
THR-40 F 64 Left femoral fracture No pathology 
THR-43 M 73 Osteoarthritis Cartilaginous tissue 
THR-47 M 64 Coxoarthrosis (left), lithiasis 
Cartilaginous tissue with superficial 
fibrosis forming papillary projections 
THR-49 M 76 Coxoarthrosis (right) 
Fragments of cartilaginous tissue with 
calcifications 
THR-51 M 63 Coxoarthrosis (right), Rheumatoid arthritis Cartilaginous tissue 
Abbreviations: F-females, M-Males, THR: Total hip replacement. 
Of the 13 samples selected for expression studies (9 males, 4 females; mean age at surgery, 66 
years; range, 47-76 years) there were two patients with DISH (confirmed with radiology), two 
patients with Knee chondrocalcinosis, 1 with lithiasis, 1 with osteoarthritis and 1 with 
rheumatoid arthritis (Table 7-7). These 5 groups of patients were compared with the control 
sample THR-40, since this individual did not present any disease pathology characterized by 
ectopic calcifications and the medical intervention was only due to a femoral fracture. Gene 
transcripts of the ABCC6 gene were detected in cartilage tissues. The ABCC6 gene was up 
regulated in all samples from diseased tissue relative to the control sample THR-40. The only 
exception was THR-6 patient in which ABCC6 transcript abundance was lower than the 
control sample (Figure 7-2). The samples with higher ABCC6 transcripts were THR-4, THR-
13, THR-35, THR-47 and THR-51.  
  Chapter VII 
 
137 
 
 
Figure 7-2. Relative expression of ABCC6 gene in cartilage tissue samples. The expression of the 
ABCC6 gene was determined in cDNA synthesized from cartilage tissues. The values were 
normalized in relation to the expression of the reference gene YWHAZ. The dashed line in the 
graph represents the value 1 of the control sample TRH40. 
 
Analyzing the samples by grouping them according to pathology revealed that the groups 
with coxoarthrosis, chondrocalcinosis and DISH, seemed to have a higher expression of the 
ABCC6 gene in relation to the normal control THR-40, but the DISH group is the group with 
more expression (Figure 7-3). 
 
Figure 7-3. Relative expression of the ABCC6 gene in normal (n = 1), coxoarthrosis (n = 8), DISH 
(n = 2) and CC (n = 2) individuals. Coxoarthrosis group include all the THR cohort with the 
exception of the normal individual THR-40 and the CC (THR-35, 36) and DISH patients (THR-
4, 13). 
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7.5. Discussion 
Both, DISH and AS are bone forming diseases that involve the axial skeleton and the 
peripheral entheses, resulting in bone proliferation in the spine and at the extraspinal entheseal 
sites in the later phases of their course. Since these conditions can coexist it has been 
suggested that their susceptibility genes may overlap. We performed a mutational analysis of 
the ABCC6 gene in a group of DISH/CC and AS patients in order to find a possible 
association between the gene and these diseases. In this study we identified 31 different 
variants along the 31 exons of ABCC6 gene. Analysis of the topology of these variants in the 
MRP6 protein (Figure 7-1) shows that the vast majority lie within the cytoplasmic domains. 
In PXE diseases the majority of disease causing variants are also located in the cytoplasmic 
region, particularly in the eighth intracellular loop encoded by exon 24, and the two 
nucleotide binding folds (NFB1 and NFB2) of MRP6, encoded by the exons 16-18 and 28-30, 
respectively [407]. As expected, in our group of patients that did not present PXE lesions, we 
did not find variants in these particular cytoplasmic regions. However in general it is thought 
that missense variants within the cytosolic domain of proteins, may affect their function by 
changing their substrate specificity or by disrupting the correct folding of the protein 
necessary for its function [308]. The variant rs12931472 of the ABCC6 gene is located in the 
sixth intracellular loop of the deduced protein, and is encoded by exon 14 and causes the 
substitution of amino acid 614 from a medium size and hydrophobic valine (V) to a small size 
and hydrophobic alanine (A). As shown in figure 7-1 this amino acid position is variable in 
other species, furthermore the altered amino acid (A) in the human variant is the normal 
amino acid in other vertebrates, such as chimpanzee, cow and dog. This variant is frequent in 
the human ABCC6 gene and it has a MAF value of 0.34(G) in all populations and in Peruvian 
population the presence of this variant can reach to 52%. In the present study the rs12931472 
variant was not associated with the occurrence of the DISH/CC or AS phenotypes; however a 
Cochran-Armitage trend and allelic tests adjusted for gender indicated that this variant is 
statistically more frequent in AS females than in control females. Despite the limited number 
of AS females (n=14) in the present study all of them had the rs12931472 variation in a 
heterozygous or homozygous state. The sexual divergence in ABCC6 variants ties in with the 
notion that gender specific differences occur between males and females with AS. AS females 
are more prone to cervical spine involvement, and males frequently complain about lumbar 
pain [408]. It is observed that female AS patients present higher fatigue scores, higher disease 
activity and more frequent peripheral involvement [409, 410]. Different haplotype 
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combinations in the ANKH gene have also been reported in males and females with AS. The 
authors found that in families with affected individuals of both sexes, two ANKH SNPs 
(rs28006 and rs25957) were associated with AS but only in affected women [248].  It is 
unlikely that the major genetic factors that account for these differences are X-linked because 
there is no linkage of AS susceptibility with X-chromosome markers [411]. The underlying 
pathogenic mechanism that result in gender-associated differences in terms of the 
manifestations of AS, is currently unknown. 
The missense variant rs41278174 identified in this study is rare (MAF 0.01) and is located on 
transmembrane domain; comparative analysis revealed that the modified amino acid is 
normally highly conserved between mammals (Figure 7-1) and although SIFT and PolyPhen 
indicate the mutation is deleterious it has never been linked to PXE or other disorder. The 
variant was found in two PXE families, however it was considered  non disease causing since 
it did not segregate with the disease phenotype [308]. We also evaluated the allele frequency 
of this rare variant in two groups of Azorean Terceira island individuals with 124 and 385 
individuals. The variant was detected in 33 individuals, indicating that this variant is not as 
rare in the island as in the general population from 1000 genomes project. The higher 
frequency of this variant in Terceira island (11% in population 1) can be explained by the 
consanguinity which tends to occur on small islands. Besides, this variant was not found in 
the AS group and it was significantly more frequent in male controls than in DISH/CC and 
AS males, which may suggest it has a protective effect against both diseases, but only in 
males. The protective effect of this variant on both diseases is difficult to explain and may 
suggest it affects pathological features shared by DISH and AS, such as the ossification of the 
axial skeleton. It is known that the transmembrane domain of MRP6 determines the substrate 
specificity of ABC transporters, and therefore it is likely that missense variants in this region 
change the substrate specificity of MRP6 causing substrate accumulation [412]. Mutations in 
the transmembrane domain can also affect the integration of the protein into the cell 
membrane and lead to a loss of function [308]. Probably the variant rs41278174 in males 
changes the specificity of MRP6 transporter, conferring a protective effect via an unknown 
mechanism. 
In the ABCC6 promoter we found the polymorphisms rs28529549, rs565625561 and 
rs778876717. Interestingly the rs28529549 (c.-219A>C) variant, according to Schulz et al 
[406], has a protective effect for PXE disease and is located in a transcriptional activator 
sequence of the ABCC6 promoter and occurs in the binding site of a transcriptional repressor, 
predominantly found in genes that participate in lipid metabolism. In fact, several studies 
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have described genetic mutations in the ABCC6 gene associated with variations in 
quantitative plasma lipoproteins [413], low High density lipoprotein (HDL) and/or coronary 
heart disease risk [414]. Alterations in lipoprotein composition with lowered plasma HDL 
cholesterol levels and hypertriglyceridemia were also found in plasma samples of PXE 
patients [406]. Furthermore, the Abcc6 knockout mice have HDL cholesterol plasma levels 
reduced by 25% [415], confirming the potential role of ABCC6 in lipid homeostasis [416]. 
The association between the polymorphism rs2238472 (p.R1268Q) in the exon 27 of the 
ABCC6 gene, found in our study in a great number of individuals (7 probands, 10 AS; 14 
controls and 14 DISH/CC individuals), with plasma lipoprotein levels has previously been 
reported [413]. The variant is pathogenic (HGMD mutation) for PXE disease only in 
compound heterozygous (associated with R1141X) and is harmless in homozygotes [417].  
Coxoarthrosis is characterized by focal areas of damage to the hip articular cartilage, 
associated with increased activity in the subchondral bone and marginal osteophyte formation 
[418], leading to hip replacement surgery in majority of cases. The most common reason for 
hip replacement is osteoarthritis, but other diseases such as rheumatoid arthritis [419], DISH 
[420] and CC [421, 422] can also be responsible for this outcome. In the present study in 
general the ABCC6 gene had expression in cartilage tissues and its expression was much 
higher in DISH/CC patients. As already mentioned, it is believed that the MRP6 mediates 
ectopic calcification via the circulation since ABCC6 is absent or minimally expressed in the 
calcified tissue resulting from the deficiency [423].  
Previous studies on ABCC6 associate BMP signaling with ABCC6 deficiency and it is this 
that promotes the osteochondrogenic transitions in susceptible cells [423]. One study revealed 
BMP2/SMADS/RUNX2 were up-regulated as were the Tgfb2/smad2/3 pathways at the 
mineralization sites in ABCC6 deficiency mice [424]. The ABCC6 deficient mice develops 
ectopic calcification similar to both the human PXE and mouse dystrophic cardiac 
calcification phenotypes, and in mice this ABCC6 deficiency stimulates BMP signaling by 
acting on the expression of multiple BMPs. The same authors verified an enhanced BMP 
signaling in liver, kidney and aortic tissues in the absence of ABCC6, leading the authors to 
hypothesize that deficiency of ABCC6, which is mainly expressed in liver, affects BMP 
signaling in other organs  [423]. It is believed that the change in BMP signaling involves 
matrix Gla protein (MGP), an extracellular glycoprotein that inhibits tissue mineralization by 
chelating calcium [425] and regulating local BMP signaling [426]. However, to be a 
calcification inhibitor, MGP has to be activated by γ-glutamyl carboxylation, a vitamin k 
dependent reaction. This protein is active in its carboxylated form (cMGP) and inactive in the 
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un-carboxylated form (ucMGP) [121]. In one study MGP was isolated from the liver of 
Abcc6-/- mice and was largely present as ucMGP and was inactive, and it was demonstrated 
that there is an association between ucMGP forms of MGP and ectopic mineralization [427]. 
Low levels of serum MGP have been reported in MRP6 deficiency and PXE patients have 
also lower serum concentration of MGP compared to controls, MGP is present within elastic 
fibers and is associated with calcification of dermal elastic fibers [428, 429]. MGP is 
expressed in various tissues and up regulated in bone and cartilage [430], it is believed that 
MGPs actions include the inhibition of mineralization by suppression of BMP2, which is a 
potent osteogenic factor [431]. Sarzi-Puttini et al reported higher serum MGP levels in DISH 
males and females, and the group suggested that MGP may be a marker of hyperostosis 
because it is produced in larger amounts by this patients [432]. It is possible that the higher 
concentration of ucMGP reported in DISH patient is most likely a consequence of the failure 
of the method to distinguish between the noncarboxylated and the γ- carboxylated forms of 
MGP. Other investigations have shown that BMP2 can regulate phosphate uptake [433], and 
that phosphate levels can regulate BMP2 expression [434], however it is not clear how 
pyrophosphate mediates other MRP6 actions. Although the physiological function of MRP6 
towards calcification is likely exerted via the systemic circulation of its substrate(s), the exact 
mechanism by which this protein affects the susceptibility to mineralization in distal tissues 
has yet to be defined. 
Our results suggest that ABCC6 gene plays a role in the ectopic calcification process in 
patients from the Azores and identifies possible alleles and reveals probable gender specificity 
in this interaction. The expression study of ABCC6 in cartilage suggests that differential 
expression of ABCC6 transcripts could play a role in the disease process. However, a much 
bigger sample size will be required to give robust statistical support to this hypothesis.  
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7.6. Supplementary material 
Supplementary table 7-1. Results of genetic variants found in the ABCC6 gene in Azorean 
patients with DISH/CC and AS compared to the controls. 
SNP 
G
en
o
ty
p
e 
DISH/CC SPA Controls 
All: N=55 All: N=25 All: N=36 
Female: N=19 Female: N=7 Female: N=22 
Male: N=36 Male: N=18 Male: N=14 
All 
N (%) 
Female 
N (%) 
Male 
N (%) 
All 
N (%) 
Female  
N (%) 
Male  
N (%) 
All 
N (%) 
Female 
N (%) 
Male  
N (%) 
rs28529549 
AA 48 (87) 17 (89) 31 (86) 24 (96) 7 (100) 17 (94) 34 (94) 22 (100) 12 (86) 
AC 7 (13) 2 (10) 5 (14) 1 (4) 0 (0) 1 (6) 2 (6) 0 (0) 2 (14) 
CC 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs565625561 
CC 52 (95) 19 (100) 33 (92) 24 (96) 7 (100) 17 (94) 35 (97) 22 (100) 13 (93) 
CT 3 (5) 0 (0) 3 (8) 1 (4) 0 (0) 1 (6) 1 (3) 0 (0) 1 (7) 
TT 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs778876717 
CC 48 (87) 15 (79) 33 (92) 18 (72) 6 (86) 12 (67) 28 (78) 18 (82) 10 (71) 
CT 7 (13) 4 (21) 3 (8) 7 (28) 1 (14) 6 (33) 8 (22) 4 (18) 4 (29) 
TT 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs55778939 
GG 47 (85) 17 (89) 30 (83) 23 (92) 6 (85) 17 (94) 32 (89) 20 (91) 12 (86) 
GA 7 (13) 2 (11) 5 (14) 2 (8) 1 (14) 1 (6) 4 (11) 2 (9) 2 (14) 
AA 1 (2) 0 (0) 1 (3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs2606921 
CC 53 (96) 19 (100) 34 (94) 22 (88) 7 (100) 15 (83) 35 (97) 22 (100) 13 (93) 
CT 2 (4) 0 (0) 2 (6) 3 (12) 0 (0) 3 (17) 1 (3) 0 (0) 1 (7) 
TT 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs9940089 
CC 5 (9) 10 (52) 18 (50) 1 (4) 4 (57) 11 (61) 6 (17) 12 (55) 7 (50) 
CA 22 (40) 7 (37) 15 (42) 9 (36) 2 (29) 7 (39) 11 (31) 6 (27) 5 (36) 
AA 28 (51) 2 (11) 3 (8) 15 (60) 1 (14) 0 (0) 19 (53) 4 (18) 2 (14) 
rs12931472 
TT 13 (24) 4 (21) 9 (25) 4 (16) 0 (0) 4 (22) 10 (28) 5 (23) 5 (36) 
TC 28 (51) 10 (53) 18 (50) 15 (60) 3 (43) 12 (67) 19 (53) 13 (59) 6 (43) 
CC 14 (25) 5 (26) 9 (25) 6 (24) 4 (57) 2 (11) 7 (19) 4 (18) 3 (21) 
rs8058694 
CC 15 (27) 5 (26) 10 (28) 6 (24) 1 (14) 5 (28) 13 (36) 7 (32) 6 (43) 
CA 27 (49) 9 (47) 18 (50) 14 (56) 3 (43) 11 (61) 17 (47) 11 (50) 6 (43) 
AA 13 (24) 5 (26) 8 (22) 5 (20) 3 (43) 2 (11) 6 (17) 4 (18) 2 (14) 
rs61340537 
CC 54 (98) 19 (100) 35 (97) 23 (92) 7 (100) 16 (89) 35 (97) 22 (100) 13 (93) 
CA 1 (2) 0 (0) 1 (3) 2 (8) 0 (0) 2 (11) 1 (3) 0 (0) 1 (7) 
AA 0 (0) 0 (0) 0 (0) 2 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs41278174 
CC 51 (93) 16 (84) 35 (97) 25 (100) 7 (100) 18 (100) 32 (89) 21 (95) 11 (79) 
CT 4 (7) 3 (16) 1 (3) 0 (0) 0 (0) 0 (0) 4 (11) 1 (4) 3 (21) 
TT 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs41278172 
CC 54 (98) 19 (100) 35 (97) 23 (92) 7 (100) 16 (89) 35 (97) 21 (95) 14 (100) 
CT 1 (2) 0 (0) 1 (3) 2 (8) 0 (0) 2 (11) 1 (3) 1 (4) 0 (0) 
TT 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
rs2238472 
GG 35 (64) 12 (63) 23 (64) 15 (60) 3 (43) 12 (67) 22 (61) 13 (59) 9 (64) 
GA 16 (29) 5 (26) 11 (31) 8 (32) 2 (29) 6 (33) 13 (36) 9 (41) 4 (29) 
AA 4 (7) 2 (11) 2 (6) 2 (8) 2 (29) 0 (0) 1 (3) 0 (0) 1 (7) 
Abbreviations: SNP- Single nucleotide polymorphism, N= number of individuals, A- adenine, C- cytosine, T-
Thymine, G- guanine. 
 
 
 
 
 
 
 
  Chapter VII 
 
143 
 
Supplementary table 7-2. RNA cartilage samples and measures of NanoVue and Agilent. The 
samples used in gene expression are highlighted in bold. 
Sample 
Nanovue spectrophotometer Agilent 
[] ng/µl Ratio RIN Ratio 28s/18s [] ng/µl 
THR-1 1580 1,838 2 0.0 1005 
THR-2 37 2,028 Too low 
THR-3 112 1,488 Too low 
THR-4 38 1,597 7.6 1.5 25 
THR-5 164 1,89 2.4 0.0 92 
THR-6 196 1,976 7.3 1.2 279 
THR-7 150 1,698 Too low 
THR-8 162 1,851 4.1 0.0 97 
THR-9 51 2,084 N/A 0.0 7 
THR-10 61 1,733 1.1 0.0 12 
THR-11 32 1,281 N/A 0.0 3 
THR-12 52 1,874 Too low 
THR-13 55 1,816 4,2 1.5 47 
THR-14 38 1,809 N/A 0.0 5 
THR-15 188 1,72 2.1 0.0 52 
THR-16 162 2,283 3 0.0 50 
THR-17 87 2,871 N/A 0.0 8 
THR-18 38 1,646 7 0.0 37,8 
THR-19 8.3 1,829 N/A 0.0 1 
THR-20 45 1,654 7.4 1.0 43 
THR-21 18 1,505 N/A 0.0 5 
THR-22 42 1,957 1 0.0 14 
THR-23 52 1,813 1.2 0.0 21 
THR-24 16 1,718 N/A 0.0 3 
THR-25 53 1,456 N/A 0.0 7 
THR-26 19 1,612 3 0.0 36 
THR-27 39 1,726 N/A 0.0 8 
THR-28 57 1,789 N/A 0.0 5 
THR-29 13 1,307 6 0.0 6 
THR-30 99 1,724 2.4 0.0 31 
THR-31 59 1,644 6.5 0.3 47 
THR-32 61 1,87 6.8 0.0 12 
THR-33 28 1,992 3.5 0.0 12 
THR-34 96 1,6 7.3 1.0 68 
THR-35 331 1,981 7.5 1.0 496 
THR-36 279 1,772 6.0 0.4 352 
THR-37 114 1,728 6.8 0.2 16 
THR-38 57 1,823 6.8 0.0 14 
THR-39 460 1.785 2.9 0.3 298 
THR-40 27 1,513 5.7 1.7 18 
THR-41 20 2,116 Too low 
THR-42 99 1,684 1.1 0.0 21 
THR-43 146 1,71 7.5 1.1 76 
THR-44 73 1,547 5.5 0.0 11 
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Sample 
Nanovue spectrophotometer Agilent 
[] ng/µl Ratio RIN Ratio 28s/18s [] ng/µl 
THR-45 54 1,476 Too low 
THR-46 42 1,907 7.3 0.0 14 
THR-47 264 1,976 7.9 1.1 401 
THR-48 15 1,393 N/A 0.0 1 
THR-49 15 1,851 7.3 1.0 14 
THR-50 264 2,091 2.8 0.0 168 
THR-51 47 1,987 7 0.7 70 
THR-52 163 1,7 Too low 
THR-53 71 11,708 2.1 0.0 40 
Abbreviations: THR- Total hip replacement patient, RIN- RNA integrity number. 
 
 
Supplementary figure 7-1. Conventional PCR amplification for β-actin gene (249 base pairs) on 
cDNA samples. Ethidium bromide stained 1.7% agarose gel. NTC- No template control, THR: 
Total hip replacement patient. 
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8. THE ORIGIN OF ABCC6 GENE IS POTENTIALLY LINKED 
WITH THE EMERGENCE OF A BONY SKELETON IN 
VERTEBRATES 
8.1 Abstract 
The ATP-binding cassette transporter ABCC6 gene encodes an ABC transporter protein 
(MRP6) expressed primarily in the human liver and kidneys. This gene has been shown to be 
involved in the regulation of tissue calcification in vertebrates. We aimed to study the 
evolution of the ABCC6 gene during the vertebrate radiation and characterize its potential role 
during the formation of the mineralized scale in the skin. 
The evolution of ABCC6 gene was performed using in silico comparative analysis and the 
PXE mutations were mapped in human MRP6 protein and compared with the respective 
amino acids positions in other species. The mRNA expression levels of abcc6 and abcc1 
(closely related family member) were assessed during scale formation by quantitative RT-
PCR on a sea bream skin/scale regeneration model. 
The abcc6 gene was only found in bony vertebrate genomes and evidence suggest that this 
gene was deleted from non-bony vertebrates, since no putative abcc6 genes were retrieved 
from the cartilaginous fish elephant shark and lamprey. In teleosts duplication of the abcc6 
gene occurred, but the gene duplicates only persisted in the genomes of some species, 
suggesting that lineage or species-specific gene deletion occurred across their radiation. Nine 
amino acid positions, common between the fish and the mutated human MRP6 protein were 
found which suggest that the amino acids that cause the disease in humans, could have an 
important role in the calcification process in fish. No difference in abcc6 and abcc1 transcript 
abundance was detected during skin regeneration and the formation of the mineralized scale 
(2-3 days).  
Our results provide evidence for parallel evolution of abcc6 gene with the acquisition of a 
bony skeleton and highlight its potential association with calcium regulation. However, in 
teleost skin abcc6 expression does not seem to be associated with scale 
formation/mineralization. 
Keywords: ABCC6, ABCC1, ABCC3, Fish, PXE, vertebrates, invertebrates, MRP6. 
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8.2. Introduction 
The ATP-binding cassette (ABC) proteins belong to a large and ancient family of active 
transporter proteins that are present in a broad spectrum of organisms from bacteria to 
vertebrates [435]. Members of this family play a pivotal role in cell physiology as they are 
involved in uni-or bidirectional transport [436] of a large variety of substrates in cells [435, 
437]. These active transporter proteins have been exploited for cellular delivery of drugs, 
including cancer chemotherapeutics and thus are of major pharmacological interest in human 
medicine. ABC transporters are typically composed of two transmembrane domains (TMD) 
and two nucleotide binding domains (NBD), also known as the ATP-binding cassette [435]. 
The NBDs, are the motor domains of ABC transporters and are characterized by the presence 
of a phosphate binding loop (Walker A), a magnesium binding site (Walker B), a switch 
region that contains a histidine loop targeted for hydrolysis, a Q-motif that interacts with the 
gamma phosphate of ATP via a water molecule and a conserved signature motif (LSGCQ) 
that is specific of the ABC transporters [438, 439]. The NBDs together bind and hydrolyze 
ATP, producing the driving force for the transport of molecules across the cell membrane 
against a concentration gradient. The TMD participates in molecular recognition and 
translocation [440], and two ATP molecules are necessary for the transport of one substrate 
molecule across the cell membrane [441]. The human ABC gene family contains an estimated 
49 members divided into seven subgroups (ABCA to ABCG), and deleterious mutations in 
these genes have been linked to several heritable human diseases . The ABCC (ABC 
subfamily C) subgroup (Table 8-1) are large proteins (1325-1582 amino acids in length) that 
include 8 members encoding multidrug resistance-associated proteins (MRP) and 3 members 
encoding ion channel proteins or regulators of potassium channels [435]. Evolutionary 
analysis has revealed that with the exception of the ABCC13 gene, two major ABCC 
subfamily clusters exist: one that contains ABCC1, 3, 2, 6, 8 and 9 and another that contains 
ABCC4, 7, 5, 11, 12 and 10 [435]. The ABCC6 gene encodes the multidrug resistance protein 
6 (MRP6) which has recently been shown to be involved in the regulation of tissue 
calcification in vertebrates [122]. Calcification is the physiological mechanism by which 
calcium salts are deposited in body tissues. Bone formation in vertebrates is the most common 
example of a normal calcification process. However, calcification disorders can also occur 
when calcium is abnormally deposited in soft tissues causing ectopic calcification [442]. 
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Table 8-1. Human ABCC genes and their functions, as listed in Ensembl and OMIM database 
(modified from Dean et al [400]). Thirteen genes are described and the chromosome location, 
number of exons and the corresponding protein are also indicated. The ABCC6 gene is 
highlighted in bold as it is the research topic of the present study. 
 
Gene 
Chr 
location 
Exons AA Protein Function 
ABCC1 16p13.1 31 1531 MRP1 drug-efflux pump 
ABCC2 10q24.2 32 1545 MRP2 Organic anion transporter 
ABCC3 17q21.33 31 1527 MRP3 Multidrug resistance 
ABCC4 13q32.1 31 1325 MRP4 Nucleoside transport 
ABCC5 3q27.1 30 1437 MRP5 Nucleoside transport 
ABCC6 16q13.11 31 1503 MRP6 Unknown function 
ABCC7 7q31.2 27 1480 CFTR Chloride ion channel 
ABCC8 11p15.1 39 1582 SUR1 Sulfonylurea receptor 
ABCC9 12p12.1 38 1549 SUR2 
Encodes the regulatory SUR2A subunit of the cardiac 
K+ (ATP) channel 
ABCC10 6p21.1 22 1492 MRP7 Drug resistance 
ABCC11 16q12.1 29 1382 MRP8 Drug resistance in breast cancer 
ABCC12 16q12.1 29 1359 ABCC12 Drug resistance 
ABCC13 21q11.2 Truncated protein ABCC13 Unknown function 
Abbreviations: AA- amino acid; Chr- chromosome, MRP- multidrug resistance protein, ATP- adenosine 
triphosphate. 
 
The ABCC6 gene has been associated with human calcification disorders such as human 
Pseudoxanthoma Elasticum (PXE; OMIM 264800), a heritable disorder characterized by 
calcification of elastic fibers in skin, arteries and the retina [125-127] and Generalized 
Arterial Calcification of Infancy (GACI; OMIM 614473), characterized by the calcification of 
the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation 
[96]. In humans, MRP6 transporter has a widespread tissue distribution and the protein is 
mostly detected in the basolateral membrane of hepatocytes, as well as in the proximal kidney 
tubules [123, 124]. Albeit with low expression, it is also found in the skin, retina and vessel 
walls [121, 125, 443]. Little is known about the molecules transported by MRP6 but these 
may be involved in stopping ectopic calcification, as in affected PXE patients MRP6 protein 
expression is depressed or absent [423].  MRP6 stimulates the release of adenosine 
triphosphate (ATP) from cells and the release of pyrophosphate (PPi) from the break-down of 
ATP, and is suggested to be involved in the control of calcium and other mineral deposition. 
Thus, the disease is not caused by the lack of functional MRP6 but rather by the absence of  
PPi provided to the circulation by an ABCC6- dependent mechanism [129]. 
In other vertebrates, homologues of the human ABCC6 are also present but its role in tissue 
calcification is poorly understood. Teleost fish are the largest and most successful group of 
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extant vertebrates and their genomes have evolved and adapted during their radiation. Studies 
in fish have largely focused on the study of vertebrate mineralization as they share many of 
the basic features of the formation of cartilage (chondrogenesis) and bone (osteogenesis) 
tissue [111-118]. Fish, as well as mammals develop ectopic calcifications; the zebrafish abcc6 
mutant develops ectopic calcifications around perichondral bone in the craniofacial and axial 
skeleton [113], and zebrafish enpp1 mutants develops ectopic calcification in a variety of soft 
tissues, including the skin, cartilage elements, the heart, intracranial space and the notochord 
sheet [114]. Zebrafish is the only teleost model system in which the abcc6 gene has been 
isolated and found to be associated with tissue mineralization [111] [113]. Mutations of the 
zebrafish abcc6 gene resulted in extensive hypermineralization of the axial skeleton, 
suggesting that functional conservation with the human exists and that it is also associated 
with tissue calcification in other vertebrates [113]. 
In order to better understand the potential association of abcc6 genes with vertebrate 
calcification and mineralization we studied the evolution of the abcc6 gene during the 
vertebrate radiation and characterized transcript expression during the process of scale 
regeneration in fish skin. In fish, scales are important skin appendages imbricated in the 
dermis that are a reservoir of minerals. When scales are lost, fish have the capacity to 
regenerate them and the formation of the new scale and scale pocket occurs immediately to 
protect the individual [444]. A sea bream skin regeneration model was available and it was 
observed that at 4 days after scale removal the skin had healed and a new scale had formed 
[444]. The potential involvement of abcc6 and abcc1 in the process of scale formation was 
studied by analyzing transcripts of skin and scale in the sea bream skin-scale regeneration 
model over 4 days of regeneration.  
8.3. Methods 
8.3.1. Database searches and sequence retrieval 
The genomes of several vertebrates and invertebrates (with publicly available data) were 
explored for orthologues of the human ABCC6 gene (ENSG00000091262) and the related 
family members, ABCC1 (ENSG00000103222) and ABCC3 (ENSG00000108846). A total of 
24 vertebrate genomes representative of different classes (Supplementary table 8-1), were 
searched using the BLAST algorithm or database annotations for orthologues of ABCC6, 
ABCC1 and ABCC3 genes. The majority was deposited and assembled in the Ensembl 
database (GRCh38.p2) (http://ensemblgenomes.org/, accessed April 2015). The retrieved 
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genomes included 7 mammals (Chimpanzee, Pan troglodytes; Mouse, Mus musculus; Dog, 
Canis lupus familiaris; Armadillo, Dasypus novemcinctus; Cow, Bos taurus; Opossum, 
Monodelphis domestica; Platypus, Ornithorhynchus anatinus); a bird, chicken (Gallus 
gallus); the reptile green anole lizard (Anolis carolinensis); the amphibian Xenopus (Xenopus 
tropicalis); the Sarcopterygii Coelacanth (Latimeria chalumnae); 10 teleost (Actinopterigii) 
and 1 Agnatha (marine lamprey, Petromyzon marinus). The teleost genomes explored were: 
Tilapia, Oreochromis niloticus; Platyfish, Xiphophorus maculates;  Cod, Gadus morhua; 
Stickleback, Gasterosteus aculeatus; Medaka, Oryzias latipes; Tetraodon, Tetraodon 
nigroviridis; Blind cave fish, Astyanax mexicanus; Zebrafish, Danio rerio; Spotted gar, 
Lepisosteus oculatus) and the sea bass, Dicentrarchus labrax assessed from the sea bass 
genome assembly [445]. To complement the characterization of the ABCC genes the genome 
of the elephant shark (Callorhinchus milii) a cartilaginous fish which diverged prior to the 
emergence of bony vertebrates, (Class Chondrichthyes) (http://ensembl.fugu-
sg.org/index.html, accessed April 2015) was studied along with the teleost European sea bass 
(Dicentrarchus labrax, http://seabass.mpipz.de/cgi-
bin/hgGateway?org=European+seabass&db=dicLab1). 
To trace the likely evolutionary origin of the ABCC6 genes the genomes of several 
invertebrates species were also analyzed by accessing the Ensembl Metazoa database 
(http://metazoa.ensembl.org/index.html, accessed April 2015). Invertebrate genomes analyzed 
(n = 11, supplementary table 8-2) included deuterostomes basal to the vertebrates, the tunicate 
Ciona (Ciona savigny) and the cephalochordate Amphioxus (Branchiostoma floridae) and the 
echinoderm, the Sea urchin (Strongylocentrotus purpuratus) and also the protostome genomes 
of the owl limpet (Lottia gigantea), the leech (Helobdella robusta), the fruit fly (Drosophila 
melanogaster), the Honeybee (Apis mellifera), the flour beetle (Tribolium castaneum), the 
malaria mosquito (Anopheles gambiae), the crustacean Daphnia (Daphnia pulex) and the 
nematode (Caenorhabditis elegans).  
The amino acid sequences of putative ABCC1, 3 and 6 candidates were retrieved by selecting 
those with the lowest e-value, similarity with the query proteins and then confirming putative 
identity by searching against the NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed April 
2015) protein database using the Blastp algorithm. We also searched the sequences of the 
others human ABCC transporters: ABCC2 (ENSG00000023839), ABCC4 
(ENSG00000125257), ABCC5 (ENSG00000114770), ABCC7 (ENSG00000001626), ABCC8 
(ENSG00000006071), ABCC9 (ENSG00000069431), ABCC10 (ENSG00000124574), 
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ABCC11 (ENSG00000121270), ABCC12 (ENSG00000140798) and ABCC13 
(ENSG00000243064) to better resolve the origin of the vertebrate ABCC6, 1 and 3 members. 
8.3.2. Multiple sequence alignments and sequence comparisons 
The deduced amino acid sequences of ABCC6, ABCC1 and ABCC3 genes from 35 species 
were aligned using ClustalW (http://www.genome.jp/tools/clustalw/, accessed April 2015) 
and were manually edited using GeneDoc 2.7 software, to remove sequence gaps and regions 
of poor aligned sequences. This software was also used to calculate the percentage of 
sequence identity/similarity between the homologue genes of the different species. The 
deduced mature sequence of the full-length human ABCC6 gene (ENSG00000091262) and 
the two pseudogenes ABCC6P1 (ENSG00000256340) and ABCC6P2 (ENSG00000255277) 
were also aligned using ClustalW (http://www.genome.jp/tools/clustalw/, accessed April 
2015) to identify differences between the sequences. 
The full-length human and vertebrate MRP6 deduced proteins were aligned using ClustalW 
and the amino acids that are normally changed in of the principal nucleotide mutations 
responsible for the manifestation of the PXE disease (http://www.hgmd.cf.ac.uk/; acceded 
May 2016) were mapped across the different species.  
8.3.3. Phylogenetic analysis 
Phylogenic trees were constructed using the deduced amino acid sequence alignment of the 
retrieved sequences (Supplementary table 8-1 and 8-2). We also added the sequences of the 
other human ABCC transporters: ABCC2, 4,5,7,8,9,10,11,12 and 13. The sequence alignment 
was edited in GeneDoc 2.7 software to eliminate gaps, and the edited final alignment with 
average sequence lengths of 1180-1200 was submitted to ProtTest 2.4 server software to 
select the best model to study protein evolution using the Selection Criterion of AIC (Akaike 
Information Criterion) [446]. The phylogenetic tree was established using the Maximum 
Likelihood (ML) method implemented in PhyML 3.0 software, available from the ATGC 
(http://www.atgc-montpellier.fr/phyml/, accessed April 2015) platform [447], using a 
JTT+I+G+F substitution model and the following parameters: gamma shape- 4 rate categories 
(G=1,109) and proportion of invariable sites (I=0.017). Sequence branch statistical support 
was assessed using 100 bootstrap replicates. The consensus phylogenetic tree was displayed 
and annotated with the FigTree4 program and was rooted using the protostome ABCC branch. 
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8.3.4. Gene organization and gene synteny 
Human ABCC6 and its two pseudogenes (ABCC6P1 and ABCC6P2) and the abcc6 gene from 
spotted gar was deduced using the Ensembl gene annotation tool. The gene structure and 
exon/intron sizes were compared between both species. 
To characterize the gene environment of the vertebrate ABCC6 gene we used as template the 
genome annotation of the Genomicus database 
(http://www.genomicus.biologie.ens.fr/genomicus-79.01/cgi-bin/search.pl, accessed August 
2015). The human gene environment was selected, and neighboring genes were identified in 
the following vertebrates (Opossum (Monodelphis domestica), Platypus (Ornithorhynchus 
anatinus), Chicken (Gallus gallus), Xenopus (Xenopus tropicalis), Coelacanth (Latimeria 
chalumnae), Spotted gar (Lepisosteus oculatus), Zebrafish (Danio rerio), Tetraodon 
(Tetraodon nigroviridis), Stickleback (Gasterosteus aculeatus), Medaka (Oryzias latipes) and 
the sea bass (Dicentrarchus labrax) using genome annotations available from the genome 
assemblies. The neighboring genes were characterized and identified based upon Ensembl 
database gene annotation and complemented with sequence homology searches 
(http://www.ensembl.org/Multi/Tools/Blast?db=core, accessed May 2015).  The Elephant 
shark (Callorhinchus milii) homologue genome region was also characterized using a similar 
strategy to that described above. The accession numbers used for linkage analysis are 
available in supplementary table 8-3. 
8.3.5 Transcriptome database searches 
To increase knowledge about the physiological importance of the ABCC genes, searches on 
vertebrate transcriptome data were also performed. The “in silico” distribution of the non-
mammalian ABCC6 was characterized and the transcriptome and EST (Expressed sequence 
tag) databases of the human, bird, reptile, amphibian and teleost were searched to construct a 
digital expression map to infer possible overlapping tissue expression of the ABCC6 gene 
with human. Searches were performed in lineage-specific NCBI EST databases human (taxid: 
9606); birds (taxid:8782); reptiles  (taxid:8504); amphibians (taxid:8292) and teleost fishes 
(taxid:32443) using the human, chicken, anole lizard, xenopus and zebrafish abcc6 sequences, 
respectively. The identity of the sequences retrieved was confirmed by homology with the 
human orthologues. Searches were also performed in other databases where expression data 
has been deposited: Geisha (http://geisha.arizona.edu/geisha/), Xenbase 
(http://www.xenbase.org/entry/), Expression Atlas Database 
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(https://www.ebi.ac.uk/gxa/home), GeneCards (http://www.genecards.org/), Ensembl 
(http://www.ensembl.org/index.html) and complemented with published data [113]. 
In addition, a sea bass scale and skin transcriptomes available “in house” was also searched 
for abcc6 and abcc1 transcripts (Pinto et al., unpublished). 
8.3.6 Polymerase chain reaction (PCR) and quantitative-PCR (qPCR) 
Based on the sea bass transcriptome data we further explored the potential physiological role 
of the abcc transcripts in fish skin and scale formation. abcc6 and abcc1 genes were studied in 
the skin/scale of sea bream (Sparus auratus) using a regenerating skin model over a 4 days 
period as previously described [444]. The experiments were carried out following 
international and national guidelines for animal care and experimentation, under a “Group-I” 
licence from the Portuguese Government Central Veterinary service to CCMAR and 
conducted by a certified investigator (DMP). 
Briefly, adult sea bream of the same age class (1 year) were used and at time zero scales were 
removed from the left flank of the body by gently stroking the skin with forceps to minimize 
damage of the dermis. Samples (N = 8/ time point) of intact skin (untouched right hand flank) 
and damaged skin (left hand flank) were collected during a time series after scale removal: 6 h 
(disruption of the dermis and scale pocket) and 24 h (reorganization of the epidermis to 
wound heal), 48h (emergence of dermal papilla that defines the localization of the new scale), 
72h (scale emergence) and 96h (scale mineralization). In this way, the same fish provided 
control and regenerating skin samples and they could be directly compared. Specific primers 
for the sea bream abcc6 and abcc1 were designed by searching the CCMAR sea bream 
transcriptome database with transcripts from various tissues [448]. The primers for abcc6 
were Sb_abcc6fwd ttagagacaagacccgcat and Sb_abcc6rev tggcaaaggtgtggatgaag and for 
abcc1 were Sb_abcc1fwd tatgagtcacctcaacaaagc and Sb_abcc1rev tccgttcatactggattacca. 
Preliminary expression analysis of abcc6 and abcc1 by PCR on sea bream cDNA (bone, skin, 
larva, scale) (available in the laboratory) was carried out using the following cycle: 95ºC, 3 
min; (95ºC 30 sec, 60ºC 30 sec, 72ºC 30 sec) cycled 40 times and a final extension of 72ºC, 5 
min. The amplified PCR products were sequenced to confirm their identity before testing for 
gene expression on the skin regeneration model. 
To investigate the potential involvement of abcc6 and abcc1 in sea bream skin regeneration a 
preliminary qPCR experiment was run using cDNA pools composed of RNA from both intact 
and damaged skin in 6 individuals for each time point. The qPCR was performed for a 10μl 
final reactions volume using the 1× SsoFast-Evagreen Supermix (Biorad) and 300 nM of 
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forward and reverse primers. Reactions were performed using the StepOnePlus thermocycler 
(Applied Biosystems, UK) following the program: 30 s at 95 °C, 45 cycles of 5 s at 95 °C and 
15 s at 60 °C. A final melting curve was carried out between 60 and 95 °C and produced a 
single product dissociation curve for each gene. Relative expression between the damaged 
and intact skin samples were compared using the delta Ct values normalized with the 
housekeeping gene rps18.  
8.4. Results 
8.4.1. Members of the ABCC6 in vertebrates and invertebrates 
Orthologues of the human abcc6 gene were identified in all the teleost and tetrapod genomes 
analyzed with the exception of two fishes: the cartilaginous fish elephant shark 
(Callorhinchus milii) and the lamprey (Petromyzon marinus). In some teleost species such as 
the stickleback (Gasterosteus aculeatus), blind cave fish (Astyanax mexicanus) and zebrafish 
(Danio rerio) more than one abcc6 gene was identified. In stickleback and blind cave fish two 
abcc6 genes were found and in the zebrafish three seem to exist (Figure 8-1). 
Multiple sequence alignment of the deduced amino acid sequence of the ABCC6 gene 
sequences revealed a relatively high conservation overall and several highly conserved 
regions (alignment of ABCC6 and ABCC1 genes of vertebrates available in supplementary 
figure 8.1). Comparison of the deduced mature protein sequence of the full-length MRP6 
transcripts in human with the orthologue in the chicken (Gallus gallus) indicated that the 
deduced proteins shared 52% amino acid identity and 69% similarity. Between the human and 
the lobe finned fish Coelacanth (Latimeria chalumnae) the MRP6 proteins shared 48% 
identity and 67% similarity and 42-47% identity and 61-65% similarity with the orthologues 
in the teleosts, stickleback (Gasterosteus aculeatus), European sea bass (Dicentrarchus 
labrax), tetraodon (Tetraodon nigroviridis), tilapia (Oreochromis niloticus), medaka (Oryzias 
latipes), platyfish, (Xiphophorus maculates), cod (Gadus morhua),zebrafish (Danio rerio), 
blind cave fish (Astyanax mexicanus) and spotted gar (Lepisosteus oculatus) (Supplementary 
table 8-4). ABCC6-related family members, the ABCC1 and ABCC3 genes, were also 
retrieved from the databases for evolutionary comparisons because, a) they are similar to 
ABCC6 and b) ABCC1 in the human genome is localized in proximity to the ABCC6 locus.  
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Figure 8-1. Dendrogram indicating the number of ABCC6 genes and the related ABCC1 and 
ABCC3 genes identified in the different vertebrate and invertebrate genomes. Circles with 
different colours represent members of the different gene families and uncoloured circles means 
the gene was not identified. The dendrogram was drawn having in consideration the 
evolutionary relationship of the different species and the two major genome duplication events 
(1R and 2R) that are proposed to have occurred early in the vertebrate radiation. The teleost 
specific genome duplication event (3R) is also indicated. Gene accession numbers are available in 
supplementary table 8-1 and 8-2. 
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Orthologues of the human ABCC1 and ABCC3 genes were also identified in almost all 
vertebrates with the exception of abcc1 in cod (Gadus morhua) and lamprey (Petromyzon 
marinus) genomes, and abcc3 in the sea bass (Dicentrarchus labrax) and the cartilaginous 
fish elephant shark (Callorhinchus milii) (Figure 8-1). It is unclear if the absence of the abcc1 
and abcc3 genes in several species is the result of their elimination from these species 
genomes or if they are the consequence of incomplete genome assemblies. Teleost duplicate 
genes were also found for abcc1 in platyfish (Xiphophorus maculatus) and for abcc3 in 
coelacanth (Latimeria chalumnae) and zebrafish (Danio rerio) (Figure 8-1). Searches in early 
deuterostomes and protostome genomes were also carried out to characterize the origin of the 
abcc6, 1 and 3 genes. Queries using the human MRP6 sequence identified putative abcc6-like 
genes in several invertebrate genomes and many species seem to possess multiple gene copies 
(Supplementary table 8-2). 
8.4.2 Sequence conservation of the amino acids altered in PXE disease 
A total of 139 mutation associated with PXE disease were retrieved from Human Gene 
Mutation database (HGMD) and the amino acids positions altered by mutation were mapped 
in the alignment and compared across the different vertebrate species. Mutations have been 
identified throughout the protein however the “hot spots” associated with PXE is more 
located within the cytoplasmatic region of human MRP6. Comparisons of the vertebrate 
homologue amino acid positions revealed that in general the mutations mapped in the 
alignment are well conserved across mammals (Supplementary figure 8-1). More than 50 
amino acid positions are 100% conserved across vertebrates (Supplementary figure 8-1), 
suggesting that these positions were under high selective conservative pressure during the 
vertebrate radiation. Interestingly, in some species, especially within fish, there are positions 
in which the amino acid in several vertebrates corresponds to the mutated amino acid in 
human MRP6. The amino acid positions, common between the fish and the mutated human 
MRP6 protein, map to the cytoplasmatic region (252; 415; 881; 1049; 1226 and 1268) and the 
transmembrane region (594; 946 and 950) and are represented in Figure 8-2.   
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Figure 8-2. Alignment of the MRP6 amino acid positions affected by 16 selected mutations 
previously associated with PXE disease in human and in other vertebrates in which amino acid 
that cause PXE in humans is the normal in other species. 
Comparisons of ABCC6 and ABCC1 revealed that the ABCC6 PXE point mutation are also 
generally highly conserved across this related family member, suggesting that they may also 
play a pivotal role in the maintenance of ABCC family function. 
8.4.3 Phylogeny of ABCC6  
Phylogenetic analysis was performed using the protein alignment of the deduced vertebrate 
MRP6, MRP1 and MRP3 mature proteins and their putative homologues in invertebrates 
(early deuterostomes and protostomes). The tree topology shows that ABCC6 and the two 
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other members are in three independent branches (with strong bootstrap support) and that the 
family members shared common ancestry prior to the vertebrate emergence (Figure 8-3). The 
tree suggests that ABCC3 members diverged earlier than ABCC1 and ABCC6 genes that seem 
to be the result of a more recent gene duplication. The invertebrate branch contains several 
ABCC-like genes that apparently share a common ancestor with the vertebrate genes but they 
form a separate clade and do not group with any of the vertebrate protein clusters. Several 
duplications of genes occurred in invertebrate species and also in some vertebrates, such as 
the teleosts. Based upon the sequence clustering in the tree, gene duplication of abcc6 seems 
to be the result of the teleost specific whole genome duplication event and in the zebrafish 
subsequent species-specific gene duplications also occurred. 
The tree topology, failed to cluster the coelacanth sequences ENSLACG00000022117 
(annotated as abcc1 in ensembl database) and ENSLACG00000001471 (annotated as abcc6 
in ensembl database) in the expected branch. According to the clustering in the phylogenetic 
tree the sequence ENSLACG00000022117 is an abcc6 gene, and the sequence 
ENSLACG00000001471 is an abcc1 gene. The absence of the abcc6 gene in lamprey 
(Petromyzon marinus) and cartilaginous fish elephant shark (Callorhinchus milli) suggests 
that abcc6 was potentially deleted in early vertebrates. The Xenopus (Xenopus tropicalis) 
abcc6 gene does not group as expected based on the consensus in relation to species 
evolution, suggesting that abcc6 in this specie suffered distinct selective pressures or there 
may be an errors in the genome or incomplete genome assemblies. The Coelacanth (Latimeria 
chalumnae) abcc3 gene did not group as expected since the putative coelacanth abcc3 
sequence (ENSLACG00000006619) was very incomplete.  
Addition of the other human ABCC transporters revealed that the early deuterostomes 
sequences identified shared common ancestry with vertebrate ABCC6, 1 and 3 members and 
that the protostome members retrieved from the insect and nematode genomes seem to have 
shared a common origin with the ABCC2 family early in the ancestral bilaterial genome 
(Figure 8-3). 
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Figure 8-3. Phylogenetic tree of the vertebrate and invertebrate ABCC6, 1 and 3 with the other 
human ABCC family members. The phylogenetic tree was built using the ML method with 
PhyML 3.0 software with 100 bootstrap replicates using JTT+I+G+F substitution model given 
by Protest and was rooted using the invertebrate ABCC-like branch. To facilitate interpretation, 
the three major vertebrate ABCC clades are boxed with different colours, and the detailed 
presentation of the invertebrates and the other human ABCC family members (ABCC2, 4, 5, 7, 
8, 9, 10, 11 and 12) have been collapsed. The original tree is available in supplementary figure 8-
2 and the accession numbers are given in the supplementary tables 8-1 and 8-2. 
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8.4.4. Gene structure and gene linkage across vertebrate 
The gene structure of the human ABCC6 genes (including the two ABCC6 pseudogenes 
ABCC6P1 and ABCC6P2) was compared with the fish spotted gar abcc6 gene (Figure 8-4). In 
human, the full ABCC6 gene structure is composed of 31 exons and spans 74,56kb in 
chromosome 16. The two pseudogenes are much smaller and map in close proximity to the 
full-length ABCC6 gene. ABCC6P1 is composed of 11 exons and ABCC6P2 is composed of 5 
exons which span 27,14Kb and 3,88 Kb, respectively (Figure 8-4). Exons 2, 3, 4 and 5 of 
ABCC6P2, ABCC6P1 and ABCC6 have almost the same sequence and only differ at exon 1. 
Exon 8, 9 and 10 of ABCC6P1 have the same coding potential as ABCC6 and the differences 
in the remaining exons may be a consequence of their divergence after gene duplication.  
 
 
Figure 8-4. Gene organization of the ABCC6 gene in human and spotted gar. The two incomplete 
human ABCC6 pseudogenes (ABCC6P1 and ABCC6P2) are also represented. Gene sizes are 
indicated and exons are represented by numbered boxes and the solid black line denotes the 
introns. 
 
No putative ABCC6 pseudogenes were found in other vertebrate genomes; they seem to be 
characteristics of the human genome. Comparison of the predicted in silico gene structure of 
the human and spotted gar (a slow evolving teleost genome, that has not suffered 
tetraploidization, 3R) revealed that they share the same exon number and most exons (21 
exactly) are of similar size (Supplementary table 8-5). Exon 15 and Exon 16 are the most 
divergent and they encode a region of low conservation within the cytoplasmic motif.  
Several conserved genes flank the vertebrate ABCC6 gene suggesting that evolution of this 
chromosome segment in vertebrates was under conservative pressures. The genes ABCC1; 
COQ7; ARL6IP1; RPS15A; NOMO3; XYLT1; MYH11; FOPNL and NDE1 were found in the 
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vicinity of the ABCC6 gene across many vertebrate genomes. Gene synteny analysis revealed 
that with the exception of the abcc6 gene in the Elephant shark (Callorhinchus milli) and 
ARL6IP1 in Platypus (Ornithorhynchus anatinus) and FOPNL in Coelacanth (Latimeria 
chalumnae) and Xenopus (Xenopus tropicalis) at least ten genes that are part of the human 
ABCC6 gene environment have been maintained across vertebrates (Figure 8-5). In the 
genomes of primates a conserved gene environment with the human and other vertebrates was 
also identified but no putative ABCC6 pseudogenes were found further suggesting that these 
were acquired during the radiation of the human. 
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Figure 8-5. Gene synteny analysis of the ABCC6 gene environment across vertebrates. The 
Human, Opossum, Platypus, Chicken, Xenopus, Coelacanth, Zebrafish, Stickleback, Spotted gar 
and Elephant shark homologue genome regions are represented. Arrowheads represent gene 
orientation in the genome. Members of the same family are indicated by the same color. The 
position of the genes in the genome fragments is indicated. 
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8.4.5 Expression analysis in non-mammals 
Searches on ESTs and several other databases for non-mammalian vertebrates revealed the 
tissue distribution of the ABCC6 transcripts (Table 8-2). A similar strategy was also applied 
for the sequence homologues ABCC1 and ABCC3 for comparisons. As in humans, expression 
of these transcripts seems to be widespread in different tissues including some with 
importance in calcium homeostasis. In the chicken, ABCC6 was found to be expressed in 
epiphyseal growth plate but also in the intestine and kidney, which are important organs that 
regulate calcium balance in vertebrates [442].  In reptiles, an EST was found in the kidney 
and in teleost fish abcc6 transcripts were found in the craniofacial bone elements, fins and 
intervertebral discs. ABCC1 and ABCC3 seem to have a more dispersed distribution than 
ABCC6 (Table 8-2). 
 
Table 8-2. ABCC6; ABCC1 and ABCC3 expression analysis in human, bird, reptile, amphibian 
and teleost. ESTs were obtained from NCBI EST databases. Searches were also performed in 
other databases: Geisha (http://geisha.arizona.edu/geisha/); Xenbase 
(http://www.xenbase.org/entry/); Expression Atlas (https://www.ebi.ac.uk/gxa/home), 
GeneCards (http://www.genecards.org/), Ensembl http://www.ensembl.org/index.html) and 
complemented with published data [113]. 
Tissue 
ABCC6 ABCC1 ABCC3 
Hsa Gga Aca Dre Hsa Gga Xtr Dre Hsa Gga Aca Xtr 
Adenocarcinoma cell line         X    
Adrenal gland     X    X    
Aorta     X        
Ascites     X        
Blood      X       
Brain     X X       
Bursa of fabricius      X       
Bursal lymphocyte      X       
Carcinoma, cell line         X    
Cerebrum X            
Cervix, tumor tissue         X    
Chondrocytes isolated from growth 
plate cartilage 
     X       
Chondrosarcoma lung metastasis cell 
lines 
    X    X    
Colon         X    
Connective tissue      X       
Cortex X            
Craniofacial bone elements    X         
Day 1 embryo        X     
Ductal carcinoma, cell line         X    
Dura mater     X        
EBV-transformed     X        
Embryonic stem cells, cell lines     X        
Embryonic tissue      X       
Epididymis     X        
Epiphyseal growth plate  X    X       
Epithelioid carcinoma     X        
Esophageal, tumor tissue         X    
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Tissue 
ABCC6 ABCC1 ABCC3 
Hsa Gga Aca Dre Hsa Gga Xtr Dre Hsa Gga Aca Xtr 
Esophagus muscle     X        
Fins    X         
Gallbladder X            
Gastroesophage     X        
Gonad  X    X       
Gonadal PGC     X X       
Head (Geisha)  X    X       
Heart      X X    X X 
Hepatocelular carcinoma, cell line X            
Human embryonic stem cells     X        
Intestine       X      
Invertebral disc    X         
Kidney X X X    X   X X X 
Large cell carcinoma         X    
Large intestine X            
Leukemia cell     X        
Leukocyte         X    
Liver X X    X       
Liver and Spleen         X    
Lung     X        
Lymph node     X        
Mitral valve     X        
Neuroblastoma     X    X    
Ovary  X   X X   X    
Pancreas X        X    
Paratiroid gland     X        
Peripheral Nervous system         X    
Pooled colon, kidney, stomach         X    
Pterygium         X    
Renal cell adenocarcinoma         X    
Retinoblastoma     X        
Skeletal muscle      X X      
Skin     X   X     
Small intestine  X           
Smooth muscle     X        
Spinal cord X            
Spleen     X X   X    
Splenocytes      X       
Stomach     X    X    
Testis     X   X     
Thalamus         X    
Thymus     X    X    
Thyroid     X        
Tongue     X        
Tongue, tumor tissue     X    X    
Trunks  X           
Uterus     X        
Vas deferens     X        
Whole embryo      X X X     
Whole larva        X     
Whole body        X     
Abbreviations: Hsa- Human, Gga- Chicken, Aca- Anole lizard, Dre- Zebrafish, Xtr- Xenopus. 
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8.4.6 Expression of abcc6 and abcc1 during sea bream scale formation 
According to the CT values (Supplementary table 8-6), both transcripts for abcc6 and abcc1 
are expressed in the sea bream skin and, abcc6 seems to be more expressed than abcc1 
(Supplementary table 8-6). Comparison of the Ct values between the regenerating and intact 
skin samples suggests that gene expression in both samples is similar and follows a similar 
trend, and there was no evidence for major changes in cycle number, indicating that abcc6 
and abcc1 genes not have a role in skin regeneration and scale formation in the teleost. The 
same results were observed in figure 8-6A and 8-6B in which both intact and regenerating 
skin samples, the genes shows also a similar distribution profile.   
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96h 0,53
 
Figure 8-6. Expression results of abcc6 and abcc1 in sea bream skin regeneration assay. A and B 
shows the profile of ΔCT values in abcc6 and abcc1; ΔCT values were obtained subtracting the 
Ct of each gene by the housekeeping control gene rps18. C and D represent the relative 
expression of abcc6 and abcc1 genes in regenerating skin relative to intact skin. 
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Comparisons of the relative expression levels between regenerating (ΔΔCt method) and intact 
sea bream skin (Figure 8-6C and 8-6D) revealed that expression of abcc6 and abcc1 between 
regenerating and intact skin was similar. 
8.5. Discussion 
In the present study the evolution of the vertebrate ABCC6 gene was studied and the potential 
role of this gene in fish skin scale regeneration was tested. Orthologues of the human ABCC6 
gene were explored in several vertebrate genomes and phylogenetic analysis revealed that 
human and other vertebrate ABCC6 genes shared common ancestry and that the abcc6 gene 
emerged early during the vertebrate radiation. The abcc6 gene was only found in bony 
vertebrates genomes and evidence suggests that this gene was deleted from non-bony 
vertebrate, as no putative abcc6 genes were retrieved from the cartilaginous fish elephant 
shark and the lamprey. The teleost duplication of the abcc6 gene occurred but the gene 
duplicates only persisted in the genomes of some species, suggesting that lineage or species-
specific gene deletion occurred during their radiation. In the mapping of the human PXE 
mutations we obtained nine amino acid positions, common between the fish and the mutated 
human MRP6 protein, located in cytoplasmatic and transmembrane regions. This could 
suggest that the amino acids that cause the disease in humans, may have an important role in 
the calcification process in fish. Expression analysis of abcc6 gene during the mineralization 
process in scales in the sea bream regeneration model suggested that this gene may not be 
involved in scale formation, even though it was highly expressed in fish skin. Our results 
provide evidence for parallel evolution of the abcc6 gene with the acquisition of a bony 
skeleton and highlights its potential association with calcium regulation, however the 
physiological role of the ABCC gene family in teleost skin remains to be determined. 
Orthologues of the human ABCC6 were found in the genomes of different vertebrates. The 
non-mammalian genes that shared high sequence and structure similarities with the human 
ABCC6 gene were retrieved from birds and fish. In tetrapods and in the majority of teleosts 
and also in the coelacanth and spotted gar, a single abcc6 gene was found, however in the 
stickleback and blind cave fish two paralogue genes persisted and in the zebrafish genome 
three were identified. During the vertebrate radiation, duplication and deletion events have 
greatly contributed to shape vertebrate genome content [449]. Early as the vertebrates 
emerged two whole round of genome tetraploidization occurred prior to the divergence of the 
jawless fish [450, 451]. In the teleosts, a subsequent genome duplication event occurred and 
this explains the presence of gene duplicates in teleost genomes relative to tetrapods [451]. 
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However, only some duplicates persisted and other were eliminated from the genome [452] 
potentially due functional redundancy [453]. The reason why duplicated abcc6 genes 
persisted in stickleback, blind cave fish and zebrafish and were deleted from the genomes of 
other analyzed teleost is unknown, and it remains to be established if both gene copies are 
functional.  
Although functional studies of the abcc6 genes in teleosts are scarce, in zebrafish some 
studies exist [111-113]. The zebrafish skeleton shows high similarity with human bones in 
terms of cells, matrix proteins, and molecular signaling pathways [454]. A study revealed 
that, in zebrafish embryos, the duplicate abcc6a is expressed in the kupffer’s vesicles and tail 
bud, while the second duplicate - abcc6b- is expressed in the enveloping layer and embryonic 
kidney proximal straight tubules [111]. In the same study, using morpholinos to “knock-
down” abcc6a and abcc6b the authors suggested that abcc6a is an essential gene for normal 
fish development [111]. 
It is known that the absence of the MRP6 activity observed in patients with PXE or Abcc6-/- 
observed in mice, cause ectopic mineralization [128, 415]. A study using zebrafish mutants 
revealed that disease causing abcc6 mutations, that do not directly affect the transport and or 
ATP catalytic activity, resulted primarily in lower stability and or cytoplasmatic retention of 
the mutant proteins [112]. Mackay and Schulte-Merker identified, by next generating 
sequencing, the causative mutation in the abcc6a gene in a zebrafish line with a recessive 
mineralization disorder. The identified mutation resulted in the substitution of L1429R in a 
highly conserved region of NBD-2 that contains the Walker B motif, which is essential for 
binding to ATP [455].  In another study, the authors verified that in zebrafish this variant 
causes hypermineralisation of the axial skeleton, resulting in mineralised structures in the 
intervertebral space. According to Ensembl database, this variant could also occur in the cow 
(L1426R; rs440576475), but no phenotype information was available. In humans, in the 
corresponding variant (L1425P; rs150230403) a proline substitution occurs instead of an 
arginine, and is not associated with PXE or any other disease. However the Sift and PolyPhen 
rating suggest that this variant has a deleterious and damaging effect on the protein. The 
immediately preceding variant I1424T in humans is associated with PXE. 
In our study, we show that abcc6 and the related abcc1 are expressed in teleost skin and we 
hypothesized that it could be involved in scale formation. However expression studies in a sea 
bream skin/scale regeneration model suggests that the gene expression varies across time but 
they were not significantly different from the control, and thus the potential role of abcc6 in 
skin remains undefined. In zebrafish the abcc6a gene is expressed and functions at the site of 
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mineralization, secreting ATP from cells increasing PPi locally, suggesting that the 
transporter ligand in fish is not liver derived as occurs in humans [113]. 
A strong link between the ABCC6 gene and reduced amounts of pyrophosphate has been 
established [129]. ABCC6 overexpression induces nucleotide release in vitro, which is rapidly 
converted by ENPP1 into PPi [129]. It has been reported that PPi secretion from the livers of 
Abcc6-/- mice was dramatically lower compared to wild type mice, and the authors suggested 
that MRP6 is an ATP efflux transporter [397]. ATP is converted into AMP and PPi and 
represents the main source of mineralization inhibitor PPi in plasma, which fully explains 
why the absence of ABCC6 results in the ectopic mineralization observed in patients with 
PXE [397]. 
Our preliminary expression analysis in a teleost skin regeneration mode revealed that the 
abcc6 gene may not be involved in early stages of scale formation. In fact it should be noted 
that mineralization in PXE and its mouse model Abcc6-/-, is not noted at birth, but develops 
later in life. Probably the abcc6 gene in fish skin acts as a potent inhibitor of pathological 
ectopic calcification through a PPi mechanism. Overall, the presence of the abcc6 gene in 
teleost fishes and its absence in cartilaginous and lamprey genomes suggest that this gene 
possibly emerged associated with the need for more sophisticated mechanisms of control of 
PPi in cells. Future studies aimed at understand the function of abcc6 in teleost skin will be 
required. 
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8.6 Supplementary Material 
Supplementary table 8-1. Accession numbers of the ABCC6, ABCC1 and ABCC3 genes retrieved from vertebrates. Sequences were retrieved from 
Ensembl Genomes (http://ensemblgenomes.org/, accessed April 2015) database. The Elephant shark (Callorhinchus milii) orthologues were obtained 
from (http://ensembl.fugu-sg.org/index.html, accessed April 2015) database. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: ni- not identified 
Vertebrates 
Specie name Common name Abbreviatures 
Accession number 
ABCC6 ABCC1 ABCC3 
Homo sapiens Human Hsa ENSG00000091262 ENSG00000103222 ENSG00000108846 
Pan troglodytes Chimpanzee Ptr ENSPTRG00000007815 ENSPTRG00000007812 ENSPTRG00000009406 
Mus musculus Mouse Mmu ENSMUSG00000030834 ENSMUSG00000023088 ENSMUSG00000020865 
Canis lupus familiaris Dog Cluf ENSCAFG00000018197 ENSCAFG00000018208 ENSCAFG00000017201 
Bos taurus Cow Bta ENSBTAG00000015191 ENSBTAG00000021090 ENSBTAG00000020070 
Dasypus novemcinctus Armadillo Dno ENSDNOG00000024923 ENSDNOG00000014990 ENSDNOG00000046300 
Monodelphis domestica Opossum Mdo ENSMODG00000005815 ENSMODG00000004194 ENSMODG00000020910 
Ornithorhynchus anatinus Platypus Oan ENSOANG00000005123 ENSOANG00000005124 ENSOANG00000013379 
Gallus gallus Chicken Gga ENSGALG00000006698 ENSGALG00000006646 ENSGALG00000007522 
Anolis carolinensis Anole Lizard Aca ENSACAG00000003478 ENSACAG00000005349 ENSACAG00000001396 
Xenopus tropicalis Xenopus Xtr ENSXETG00000026360 ENSXETG00000019661 ENSXETG00000012239 
Latimeria chalumnae Coelacanth Lch ENSLACG00000022117 ENSLACG00000001471 
ENSLACG000000007209 
ENSLACG00000006619 
Gasterosteus aculeatus Stickleback Gac 
1) ENSGACG00000019172 
ENSGACG00000000434 ENSGACG00000005901 
2) ENSGACG00000003037 
Dicentrarchus labrax See bass Dla 177430 195360 ni 
Oryzias latipes Medaka Ola ENSORLG00000013429 ENSORLG00000017141 ENSORLG00000020741 
Tetraodon nigroviridis Tetraodon Tni ENSTNIG00000012067 ENSTNIG00000005013 ENSTNIG00000004171 
Oreochromis niloticus Tilapia Oni ENSONIG00000018866 ENSONIG00000007824 ENSONIG00000019586 
Xiphophorus maculatus Platyfish Xma ENSXMAG00000004906 
1) ENSXMAG00000017319 
ENSXMAG00000012203 
2) ENSXMAG00000007738 
Gadus morhua Cod Gmo ENSGMOG00000005748 ni ENSGMG00000010029 
Danio rerio Zebrafish Dre 
1) ENSDARG00000016750 
 ENSDARG00000104719 
1) ENSDARG00000007243 
2) ENSDARG00000094901 
2) ENSDARG00000096662 
3) ENSDARG00000095820 
Astyanax mexicanus Blind cave fish Ame 
1) ENSAMXG00000004837 
ENSAMXG00000002943 ENSAMXG00000016253 
2) ENSAMXG00000003085 
Lepisosteus oculatus Spotted gar Loc ENSLOCG00000007152 ENSLOCG00000007196 ENSLOCG00000010918 
Callorhinchus milii Elephant shark Cmi ni SINCAMG00000015787 ni 
Petromyzon marinus Lamprey Pma ni ni ENSPMAG00000000892 
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Supplementary table 8-2. Accession numbers of the ABCC genes retrieved from invertebrates. 
Sequences were retrieved from Ensembl Metazoa database 
(http://metazoa.ensembl.org/index.html, accessed April 2015). 
Invertebrates 
Specie name Common name Abbreviation 
Accession  number 
abcc1/3/6 
Caenorhabditis elegans Roundworm Cel 
WBGene00003407 
WBGene00003408 
WBGene00003410 
WBGene00003413 
WBGene00003409 
WBGene00003414 
Daphnia pulex Water flea Dpu DAPPUDRAFT_347281 
Anopheles gambiae Malaria mosquito Aga 
AGAP009835 
AGAP008437 
AGAP027980 
AGAP028128 
Tribolium castaneum Red flour beetle Tca TC012253 
Apis mellifera Honeybee Amel GB53134 
Drosophila melanogaster Drosophila Dme FBgn0032456 
Helobdella robusta Leech Hro 
HelroG163344 
HelroG157076 
Lottia gigantea Owl limpet Lgi 
LotgiG107213 
LotgiG105097 
LotgiG110718 
LotgiG153611 
Strongylocentrotus purpuratus Sea urchin Spu 26395 
Ciona intestinalis Ciona Csa 
ENSCSAVG00000003792 
ENSCSAVG00000008135 
Branchiostoma floridae Anphioxus Bfl 
118638 
232174 
118636 
128060 
90918 
230771 
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Supplementary figure 8-1. Sequence alignments of the MRP1 and MRP6 proteins in vertebrates. 
Conserved amino acids in the sequence alignment are shaded in dark grey. The selected 139 
amino acids mutated in PXE disease analyzed in this study are coloured in red. Accession 
numbers are given in the supplementary table 8-1. Due to its size the alignment of all species 
(including invertebrates and the other ABCC family members) is not demonstrated but is 
available by request. 
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Supplementary figure 8-2. Phylogenetic tree of the vertebrate and invertebrate ABCC6, 1 and 3 with the other human ABCC family members. The 
phylogenetic tree was built using the ML method with PhyML 3.0 software with 100 bootstrap replicates using JTT+I+G+F substitution model given 
by Protest and was rooted using the invertebrate ABCC-like branch. To facilitate interpretation, the three major vertebrate ABCC clades are boxed 
with different colours. 
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Supplementary table 8-3. List of genes and their accession numbers used for linkage analysis. Data was retrieved from Ensembl Genomes genome 
database except the Elephant shark (Callorhinchus milii) orthologues that were obtained from (http://ensembl.fugu-sg.org/index.html, accessed 
August 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: ni- not identified, NDE1- Neurodevelopment protein 1, MYH11- Myosin heavy chain 11, FOPNL- FOP related protein, ABCC1,6- ATP binding cassette 
subfamily C member 1,6, NOMO3- Nodal modulator 3, XYLT1- Xylosyltransferase 1, RSPS15A- Ribosomal protein S15A, ARL6IP1- ADP ribosylation factor like protein 6 
interacting protein 1, COQ7- Coenzyme Q7. 
 
Specie/Gene NDE1 MYH11 FOPNL ABCC1 NOMO3 
Human ENSG00000072864 ENSG00000133392 ENSG00000133393 ENSG00000103222 ENSG00000103226 
Opossum ENSMODG00000004385 ENSMODG00000004360 ENSMODG00000004204 ENSMODG00000004194 ENSMODG00000005682 
Platypus ENSOANG00000005121 ENSOANG00000005134 ENSOANG00000005132 ENSOANG00000005124 ENSOANG00000005122 
Chicken ENSGALG00000006500 ENSGALG00000006520 ENSGALG00000006532 ENSGALG00000006646 ENSGALG00000006730 
Xenopus ENSXETG00000005528 ENSXETG00000019650 ni ENSXETG00000019661 ENSXETG00000019683 
Coelacanth ENSLACG00000006656 ENSLACG00000007990 ni ENSLACG00000022117 ENSLACG00000012305 
Zebrafish ENSDARG00000037900 ENSDARG00000009782 ENSDARG00000071198 ENSDARG00000059874 ENSDARG00000078592 
Stickleback ENSGACG00000019165 ENSGACG00000019168 ENSGACG00000019170 ENSGACG00000000434 ENSGACG00000019191 
See bass DLAgn_00177400 DLAgn_00177410 DLAgn_00177420 DLAgn_00195360 DLAgn_00177480 
Medaka ENSORLG00000013552 ENSORLG00000013536 ENSORLG00000013435 ENSORLG00000017141 ENSORLG00000013299 
Tetraodon ENSTNIG00000011286 ENSTNIG00000012065 ENSTNIG00000012066 ENSTNIG00000005013 ENSTNIG00000012072 
Spotted gar ENSLOCG00000007273 ENSLOCG00000009053 ENSLOCG00000007248 ENSLOCG00000007196 ENSLOCG00000006964 
Elephant Shark SINCAMG00000015553 SINCAMG00000015577 SINCAMG00000015784 SINCAMG00000015787 SINCAMG00000015915 
Specie/Gene ABCC6 XYLT1 RPS15A ARL6IP1 COQ7 
Human ENSG00000091262 ENSG00000103489 ENSG00000134419 ENSG00000170540 ENSG00000167186 
Opossum ENSMODG00000005815 ENSMODG00000005904 ENSMODG00000005920 ENSMODG00000005944 ENSMODG00000006166 
Platypus ENSOANG00000005123 ENSOANG00000009533 ENSOANG00000012228 ni ENSOANG00000003221 
Chicken ENSGALG00000006698 ENSGALG00000006757 ENSGALG00000006771 ENSGALG00000006780 ENSGALG00000006861 
Xenopus ENSXETG00000026360 ENSXETG00000019693 ENSXETG00000002942 ENSXETG00000002943 ENSXETG00000002946 
Coelacanth ENSLACG00000001471 ENSLACG00000008838 ENSLACG00000011476 ENSLACG00000010670 ENSLACG00000005333 
Zebrafish 
ENSDARG00000016750 
ENSDARG00000061248 ENSDARG00000010160 ENSDARG00000054578 ENSDARG00000062594 ENSDARG00000094901 
ENSDARG00000009582 
Stickleback 
ENSGACG00000003037 
ENSGACG00000019187 ENSGACG00000019181 ENSGACG00000014908 ENSGACG00000019175 
ENSGACG00000019172 
See bass DLAgn_00177430 DLAgn_00177470 DLAgn_00177460 DLAgn_00194490 DLAgn_00177440 
Medaka ENSORLG00000013429 ENSORLG00000013339 ENSORLG00000013347 ENSORLG00000001074 ENSORLG00000013378 
Tetraodon ENSTNIG00000012067 ENSTNIG00000012071 ENSTNIG00000012070 ENSTNIG00000011302 ENSTNIG00000012068 
Spotted gar ENSLOCG00000007152 ENSLOCG00000006998 ENSLOCG00000007017 ENSLOCG00000007049 ENSLOCG00000007132 
Elephant Shark ni SINCAMG00000015951 SINCAMG00000015952 SINCAMG00000015955 SINCAMG00000016019 
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Supplementary table 8-4. Percentage of amino acid sequence identity/similarity of the ABCC6 
and ABCC1 sequences in comparison with human sequence by GeneDoc program. 
Specie name Common name Abbreviation 
% Identity/Similarity               
with Hsa 
ABCC6 ABCC1 
Homo sapiens Human Hsa X X 
Pan troglodytes Chimpanzee Ptr 88/89 92/93 
Mus musculus Mouse Mmu 78/86 87/95 
Canis lupus familiaris Dog Cluf 80/89 91/96 
Bos taurus Cow Bta 83/90 90/95 
Dasypus novemcinctus Armadillo Dno 73/81 86/93 
Monodelphis domestica Opossum Mdo 57/70 83/91 
Ornithorhynchus 
anatinus 
Platypus Oan 59/74 71/78 
Gallus gallus Chicken Gga 52/69 77/89 
Anolis carolinensis Anole Lizard Aca 50/68 68/80 
Xenopus tropicalis Xenopus Xtr 40/60 69/82 
Latimeria chalumnae Coelacanth Lch 48/67 49/59 
Gasterosteus aculeatus Stickleback Gac 
44/64 
66/80 
43/60 
Dicentrarchus labrax See bass Dla 42/60 36/44 
Oryzias latipes Medaka Ola 45/63 64/80 
Tetraodon nigroviridis Tetraodon Tni 45/64 52/66 
Oreochromis niloticus Tilapia Oni 45/63 65/81 
Xiphophorus maculatus Platyfish Xma 45/64 
12/16 
24/29 
Gadus morhua Cod Gmo 43/62 XX 
Danio rerio Zebrafish Dre 
45/64 
68/81 44/62 
44/62 
Astyanax mexicanus Blind cave fish Ame 
46/64 
68/81 
44/62 
Lepisosteus oculatus Spotted gar Loc 47/65 68/81 
Callorhinchus milii Elephant shark Cmi X 56/71 
Petromyzon marinus Lamprey Pma X X 
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Supplementary table 8-5. Size of the exons and introns deduced from Ensembl for the Human 
and spotted gar ABCC6 orthologues genes. The sizes of human pseudogenes are also indicated. 
Bold represents the exons with the same size than human ABCC6 gene (accessed August 2015). 
 
Exons 
Human (Chr16) Spotted gar (LG13) 
ABCC6 ABCC6P1 ABCC6P2 abcc6 
E1 66 124 36 42 
I1 1567 1565 1565 4807 
E2 183 184 183 177 
I2 1701 1259 1259 354 
E3 126 116 116 126 
I3 139 325 325 2569 
E4 129 126 126 138 
I4 5104 139 139 3025 
E5 126 129 129 126 
I5 2077 5055 ni 1531 
E6 62 126 ni 62 
I6 3325 2070 ni 802 
E7 132 62 ni 132 
I7 5114 3338 ni 897 
E8 204 132 ni 201 
I8 1231 5166 ni 1105 
E9 178 204 ni 178 
I9 3818 1231 ni 126 
E10 162 178 ni 162 
I10 5098 4050 ni 335 
E11 93 1562 ni 93 
I11 2462 ni ni 989 
E12 204 ni ni 204 
I12 1189 ni ni 256 
E13 114 ni ni 147 
I13 1619 ni ni 304 
E14 88 ni ni 88 
I14 2089 ni ni 865 
E15 127 ni ni 70 
I15 215 ni ni 114 
E16 177 ni ni 127 
I16 3446 ni ni 308 
E17 177 ni ni 177 
I17 3446 ni ni 609 
E18 168 ni ni 168 
I18 1171 ni ni 423 
E19 175 ni ni 184 
I19 1465 ni ni 268 
E20 76 ni ni 82 
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Exons 
Human (Chr16) Spotted gar (LG13) 
ABCC6 ABCC6P1 ABCC6P2 abcc6 
I20 2506 ni ni 108 
E21 121 ni ni 118 
I21 3430 ni ni 237 
E22 208 ni ni 208 
I22 3712 ni ni 572 
E23 311 ni ni 311 
I23 2430 ni ni 438 
E24 200 ni ni 200 
I24 1428 ni ni 223 
E25 127 ni ni 127 
I25 1854 ni ni 282 
E26 102 ni ni 102 
I26 1672 ni ni 340 
E27 147 ni ni 147 
I27 2631 ni ni 349 
E28 159 ni ni 159 
I28 78 ni ni 403 
E29 167 ni ni 167 
I29 3855 ni ni 174 
E30 195 ni ni 195 
I30 336 ni ni 691 
E31 109 ni ni 109 
Abbreviations: Chr- chromosome. 
 
 
Supplementary table 8-6. CT values for the control gene rps18 and abcc6 and abcc1 genes in 
intact and regenerating skin at 0-96 hours. 
TIME 
Intact skin Regenerating skin 
Control abcc6 abcc1 Control abcc6 abcc1 
0h 25,96 28,65 31,71 -- -- -- 
6h 25,47 28,27 33,06 25,10 27,35 33,58 
24h 25,54 27,72 31,22 24,07 26,49 30,86 
48h 26,09 27,07 31,40 24,85 26,36 30,35 
72h 24,80 26,41 29,83 24,26 25,84 29,40 
96h 25,72 26,45 30,51 25,25 25,85 30,95 
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9. GENERAL DISCUSSION AND CONCLUSIONS 
This study was conducted in the Azores, a Portuguese archipelago located in the middle of the 
Atlantic Ocean, in a small island with only 56.467 inhabitants (Census, 2011). The high rate 
of consanguineous marriage and the high probability of common ancestry increases the 
possibility of finding diseases caused by a single gene. The coexistence of DISH with 
Chondrocalcinosis (CC) is very common on this island and seems to be an endemic 
manifestation. Previous studies, undertaken by our group, led to the identification and 
characterization of twelve families with early onset CC and/or DISH leading the group to 
suggest that both diseases, designated as DISH/CC phenotype, could share the same 
pathogenic mechanism [23]. These families may represent a familial type of pyrophosphate 
arthropathy with a phenotype that includes peripheral and axial enthesopathic calcifications. 
A similar phenotype has been described in several other studies in different populations [25, 
26]. The meticulous analysis of twelve pedigrees pointed toward a Mendelian disease with 
autosomal-dominant mode of inheritance [23]. Eight of the probands of these families were 
born in the same or nearby villages and this phenotype has higher in specific zones of the 
island, raising the possibility of an unknown environmental factor or a genetic founder effect. 
In fact, founder effects have been used to explain the presence of high-frequency Mendelian 
diseases in many isolated populations [456, 457]. Since isolated populations have proven 
particularly valuable for the purposes of mapping genes involved in rare Mendelian 
monogenic disorders, studying DISH/CC in this island population will increase the likelihood 
of identifying the causative mutation. For a number of years the group that hosted the present 
study has been looking for a possible major gene in the aethiopathogenesis of the DISH/CC 
phenotype. The involvement of the ANKH gene, the only monogenic disease causing gene yet 
known for chondrocalcinosis, has already been discarded by a previous study [110]. A whole 
genome linkage analysis followed by an “Identity-by-state/descent” was performed and two 
zones, in chromosomes 12 and 20, seemed relevant for further investigation. In line with these 
results, two genes were considered to be good candidate genes for DISH/CC; RSPO4 on 
chromosome 20, and LEMD3 on chromosome 12. Several gene variants were identified and 
nucleotide modifications located in the regulatory region of the RSPO4 gene were more 
frequent in controls than in the DISH/CC group (p-values; 0.03 and 0.05). RSPO4 mutations, 
especially those located in the highly conserved exons 2 and 3 of the gene encoding the 
furin/like cysteine/rich domain of R/spondin 4, causes autosomal-recessive anonychia [351]. 
The specific variant Gly67Arg causes anonychia by disrupting the Wnt/β-catenin signaling 
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pathway [458]. The effects on the protein of the two regulatory variants found in our study 
have not been defined. However, the variants are located in the regulatory region of the gene 
and so may alter the expression of the RSPO4 gene, although the modification in gene 
expression and why these variants are protective to DISH/CC is unknown. According to our 
results, neither RSPO4 nor LEMD3 are the main genetic causes for the development of the 
DISH/CC phenotype. These genes, in particular RSPO4 may, however, have a modest role 
which should be further investigated. 
To further identify candidate genes or variants associated with DISH/CC phenotype we 
performed Whole Exome Sequencing on four unrelated DISH/CC patients, followed by 
association studies of selected variants. Our focus on the “exome” was due to the common 
belief that the coding regions contain the most functionally relevant variants and because 
many coding mutations have been found to cause phenotypic effects [459]. For instance, 
missense mutations in ANKH gene causing gain or loss of function of ANK protein leads to 
the development of chondrocalcinosis (CCAL2; MIM 118600) [343-345] or 
Craniometaphyseal dysplasia (CMDD; MIM #123000) [109, 346], respectively. Other 
example is the coding mutations in the ACVR1 which cause a disruption of the glycine/serine-
rich domain of the activin A receptor 1 leading to the progressive ossification disease (FOP; 
MIM #135100) [460, 461]. Mutations in ABCC6 gene normally occur in cytoplasmatic 
regions of the protein [406], and cause a loss of function of the protein leading to the 
Pseudoxanthoma elasticum disease (PXE; MIM #264800) [126]. In fact the mutations that 
cause Mendelian diseases occur primarily in coding regions, and mutations that causes amino 
acids substitutions are the most frequent type of disease mutations (~60%) [462]. The 
candidate genes selected for the analysis in this study were those directly or indirectly related 
to mineralization or ossification, in which coding or splice-site mutations were found.  
BMP4 is a member of the BMP family and belongs to the transforming growth factor- β 
(TGF-β) superfamily, which is involved in osteoblast differentiation and bone formation 
[463]. One common missense variant in this gene, rs17563 T>C (p.V152A), was found in 
three out of four of the investigated patients (WES). After typing this variant in a group of 
DISH/CC patients and controls we observed that the C allele is statistically more frequent in 
the DISH/CC group than in controls. This variant is very frequent in all populations 
(MAF=0.37) which does not invalidate a role on the susceptibility to DISH/CC, since 
common variants associated with disease risk are not uncommon. In OPLL disease, for 
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instance, the majority of susceptibility variants associated are common variants [61] [33, 146] 
[61]. The rs17563 is one of the most functional SNP of BMP4 gene [464]. This SNP causes a 
change in the mRNA structure and the levels of BMP4 mRNA are significantly higher in T-
allele carriers when compared with C-allele carriers [381]. The T-allele has been associated 
with OPLL disease [160, 161], and mRNA and expression of BMP4 protein were 
significantly increased in OPLL cells derived from ossified spinal ligament when compared to 
non OPLL cells [382]. The rs17563 variant has been largely studied as associated with non-
syndromic cleft lip with or without palate (NSCL/P), however the results were inconsistent. 
For some the C allele is a risk factor for the disease [465, 466] and for others the C allele is 
protective [467]. To clarify this association a meta-analysis was performed and the authors 
conclude that the rs17563 variant could play a different role during the development of 
NSCL/P based on ethnicity diversity [464]. NSCL/P is a complex genetic disorder with a 
variable phenotype, largely attributed to the interactions of the environment and multiple 
genes, each potentially having certain effects [468]. In our case it is very difficult to state that 
this single variant is the responsible for the DISH/CC phenotype, but rather this variant could 
contribute to the DISH/CC phenotype by interacting with other moderate effect genes and/or 
with unknown enviromental factors. At this moment we do not know how the C variant 
contributes to the DISH/CC phenotype and thus there is a need for further research in this 
area. 
The main candidate gene investigated in this thesis was the ABCC6 gene, a member of the 
ATP-Binding Cassette family of transporters that has been extensively related to dermal 
ectopic calcification and has recently become a new member of the calcification regulators in 
mammals [122]. Loss-of-function mutations within the ABCC6 gene cause PXE and in some 
cases GACI, both heritable disorders related to soft tissue calcification. PXE and GACI are 
rare disorders and none of the patients investigated in this study were diagnosed with these 
conditions. The exact function of the protein encoded by this gene and the substrate(s) that it 
transport remain unknown [469], but evidences suggests that it may be involved in the 
metabolism of pyrophosphate. In PXE disease MRP6 deficiency leads to strong reduced 
plasma PPi levels that lead to a reduced PPi/Pi ratio and this favours pathological 
mineralization [397]. The same occurs in abcc6-/- mice, in which PPi levels were lower than 
in wild type mice [397]. It is now widely accepted that Pi and PPi levels are determinants for 
the development of rheumatic calcifying disorders. One missense rare variant in the ABCC6 
gene, rs41278174 C>T (p. R1064W), was present in one of the DISH/CC patients. A large 
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number of other variants were found in this gene, but no differences were identified between 
DISH/CC and controls. The rs41278174 variant is highly conserved between mammals, and 
according to the algorithms used (SIFT and PolyPhen) is deleterious and damaging to the 
protein. We observed that this variant had a higher frequency in the DNA samples of our 
island population and it was more frequent in male controls than in male patients with 
disorders that are characterized by ectopic calcification, such as DISH/CC and Ankylosing 
Spondylitis. This variant is located in the transmembrane domain of the MRP6 protein, which 
plays a role in the substrate specificity of ABC transporters [412]. Mutations in the 
transmembrane domain can also affect the integration of the protein into the cell membrane 
leading to a loss of function [308]. We hypothesize that the variant - rs41278174 - in males, 
may change the specificity of the MRP6 transporter, conferring a protective effect via an 
unknown mechanism.  
In humans, the ABCC6 gene has highest expression in the liver and kidneys and localizes to 
the plasma membrane [470]. However, several other studies show that ABCC6 is expressed in 
other tissues as well, albeit in much lower abundance, including the skin and the blood vessel 
walls, which are sites of pathology in PXE [125, 471, 472]. In fish, the abcc6a gene functions 
locally at the site of mineralization and in zebrafish the gene is also expressed in intervertebral 
disc regions, structures that are affected by hypermineralization caused by a specific mutation 
in abcc6a gene [113]. In this study, we found expression of ABCC6 in human cartilage tissues 
and the gene was also expressed in fish skin (normal and regenerating). In fish skin, no 
difference was found between normal skin and regenerating skin, and the function of this 
gene in fish skin remains an open question. The retention of the gene in the genome of the 
bony fishes but its loss from the genome of the cartilaginous fish, from which they derived, 
suggests that the gene has an important function. Furthermore, comparative genomics analysis 
indicated that the abbc6 gene emerged at the same time as bone vertebrates indicating it is 
most likely linked to specific innovations in the vertebrates.  
In human cartilage tissues we found very different levels of the ABCC6 transcript between 
patients. When grouped by disease we found that, in general, the level of expression was 
increased in coxoarthrosis, and was more evident in DISH and CC patients when compared 
with the only available control. In vitro, the overexpression of ABCC6 induces nucleotide 
release [129]. Although MRP6 does not directly transport ATP, it is thought that ATP is 
secreted via an MRP6 dependent mechanism. In the liver, ATP is converted into AMP and 
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PPi by ENPP1 and PPi is the main inhibitor of mineralization, in plasma [397]. The Pi:PPi 
ratio is a determinant factor that can lead to pathological mineralization or its inhibition [473]. 
In general, conditions which favour PPi increase promote CPP crystal formation, while 
decreases in PPi promotes hydroxyapatite crystal formation [474]. In line with this hypothesis 
we postulate that, in our patients, the PPi levels are higher, favouring CPP formation instead 
of hydroxyapatite crystals. In CC the deposited salts are normally composed of CPP, though 
other calcium salts can also be found including hydroxyapatite [256, 475]. In some cases, 
CPP can also occur in the spinal ligaments [257, 258], but it is usually difficult to distinguish 
from ossification [46]. In fact, in our patients the involvement of CPP deposition was already 
known, since CPP crystals were identified from knee effusions in 13 patients from the 12 
DISH/CC families previously characterized [24].  
Putting it all together, our results raise a question in relation to the monogenic or polygenic 
nature of the DISH/CC disease coupled with the possible involvement of environmental 
factors. The association of the rs17563 variant in the BMP4 gene, found in our study, has 
probably a minor effect on disease development. As suggested for OPLL [152], it seems that 
the association of different genes and variants are important and that it is unlikely that there is 
only one major gene responsible for the disease. Rather, it seems most likely that a number of 
variants in a variety of different genes may be associated with DISH, and therefore predispose 
for the development of the disease in patients. The former facts explain the failure in previous 
studies to identify causative genes, as the studies assumed a single gene inheritance pattern.  
The studies carried out and reported in this thesis have several limitations 1) DISH is 
currently lacking a validated set of diagnostic and classification criteria in order to better 
describe and establish homogeneous cohorts of patients. This is particularly important 
because DISH is characterized not only by the ossification of the anterior spinal ligaments but 
also by generalized symmetrical enthesopathic calcifications. Much has been debated about 
the importance of diagnostic and classification criteria for DISH, but no agreement has been 
reached so far [40]. In our opinion, a well validated set of classification criteria for DISH, is 
of extreme importance for genetic studies in order to have a homogeneous phenotype group 
for investigations; 2) the small sample size, especially the control group with only 36 
individuals gives very low statistical power of the study. The low sample number for the 
control group is linked to the need in the asymptomatic population to carry out radiographic 
examinations to identify those affected by the pathology; 3) All the filtering strategies 
Chapter IX 
196 
 
employed involved previous knowledge on the genes. The biggest limitation in this strategy is 
that genes that were not labeled yet or have unknown functions were not investigated in this 
study and may be relevant; 4) of course it cannot be assumed that any gene variant will 
necessarily have a negative impact on protein expression and function, but by focusing on the 
coding region we aimed to eliminate the synonymous and intronic variants. Normally the 
variants in the human genome with deleterious effects on the protein are the basis for the 
development of diseases, however variations that modify protein structure do not necessarily 
lead to a detectable human-disease phenotype, and a mutation that predispose an individual to 
a disease is not necessarily a deleterious variation. The synonymous variants are now widely 
acknowledged to cause changes in protein expression, conformation and function [476]. 
Sometimes the altered nucleotide is part of a splicing enhancer or suppressor and the change 
affects splicing or in other cases they do not affect splicing but the alternative codon could 
require an alternative transfer RNA that is in short supply, and this therefore changes the 
kinetics of translation [477]. For instance synonymous variants in the CFTR gene causes 
aberrant splicing in patients with Cystic Fibrosis [478] [479]. Thus, synonymous mutations 
within protein-coding regions may be associated with noncoding functions, acting pre-
transcriptionally at the DNA level or post-transcriptionally at the RNA level [480]. An 
example of this is found with the  dopamine receptor gene (DRD2) in which a synonymous 
variant is associated with schizophrenia and alcoholism by modulating receptor production 
through differences in messenger RNA (mRNA) folding and stability [481]. Also the intronic 
variants could be of interest. Transcript variants within an intron may regulate genes; through 
modifying alternative splicing of the mRNA or by changing the binding site of enhancers that 
act on the gene they are found in or could possibly enhance the expression of many genes. 
Disease associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-
variant expression in the brains in schizophrenia [482]; 5) the study population comprised 
only Azorean individuals and we cannot generalize our conclusion to other ethnic 
populations. Thus, the present findings need to be replicated and validated in a greater number 
of samples including other ethnic groups. The public health risk posed by the risk alleles is 
likely to show wide variation across populations simply as a function of its frequency, and 
this risk difference may be amplified by gene-gene and gene-environment interactions; 6) our 
expression studies were preliminary and with a reduced sample size.  
In the future further studies will be required to overcome the limitation of the present study 
this could include; 1) arranging groups according to the calcified tissue regions, since there is 
no exact classification criteria for DISH currently available, obviously this will greatly 
  Chapter IX 
 
197 
 
decrease the sample size, and thus more patients will be necessary; 2) look more closely at the 
unknown genes and to the synonymous and intronic variants obtained in the WES results in 
order to verify if there is a possible association with DISH/CC (extra filtering of the results); 
3) perform additional studies with an enlarged number of samples and expression studies to 
clarify the association of the BMP4 gene variant (rs17563) with our phenotype; 4) confirm if 
ABCC6 overexpression is related to the formation of CPP deposition in DISH and CC 
patients. Clearly in the future it will be important to extend the biobank and collect the 
necessary cartilage samples to ensure a bigger sample size that will generate more robust data. 
 
In conclusion, the findings of our study lead us to suggest that DISH/CC is polygenic, being 
influenced by the interaction of multiple small effect gene variants and possibly by unknown 
environmental factors. Exome sequencing combined with Sanger sequencing is confirmed by 
this study to be an efficient strategy to search for disease causing genes of both monogenic 
and polygenic diseases. Therefore, it seems most likely that DISH/CC phenotype has many 
potential different mutations in various genes in different chromosomes involved in its 
inheritance, pathology, and expression.  
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Abstract
Gitelman syndrome (GS) is a rare autossomal recessive inherited tubulopathy, characterized by defective tubular
reabsorption of magnesium and potassium, mostly caused by mutations in the SLC12A3 gene. The association of
GS with chondrocalcinosis (CC) has been described in the literature as a typical example of hypomagnesemia-
induced crystal deposition disease.
We are presenting one case where the genetic cause for GS was identified in a proband with secondary early
onset CC. A 60 years-old male patient with CC, hypomagnesemia and hypokalemia was identified in our hospital as
a result of clinical and laboratory assessments. The clinical diagnosis of GS was performed and SLC12A3 gene was
screened in the proband; variants detected were further searched in family members.
The proband was homozygous for the S615L mutation; additionally, only one from the seven family members
which were heterozygous presents CC. The presence of CC in two other individuals is most likely sporadic, in
agreement with their advanced age.
Keywords: Chondrocalcinosis; Calcium pyrophosphate dehydrate;
Genetic studies
Introduction
Gitelman Syndrome (GS, OMIM 263800; ORPHA358) is a rare
autossomal recessive tubulopathy, with a prevalence of approximately
1:40 000 in the Caucasian population. Onset is usually in adult life, but
cases with onset in childhood are also known [1]. GS is characterized
by hypomagnesemia, hypokalemia, metabolic alkalosis, hypocalciuria
and hyperreninemic hyperaldosteronism. The clinical spectrum is
wide and includes: cramps, myalgies, muscle weakness, tetania, and
paralysis [2]. GS is mostly caused by loss of function mutations in the
solute carrier family 12, member 3 (SLC12A3 gene) which consists of
26 exons and is located on the long arm of 16th chromosome [1]; this
gene encodes the thiazide-sensitive sodium-chloride cotransporter
(NCCT), expressed in the distal convoluted tubule of the kidney [3].
NCCT is a polypeptide which consists of 1021 amino acids. Its 2-D
structure is predicted to contain 12 transmembrane domains and
intracellular amino and carboxyterminal regions [3]. At present,
according to the Human Gene Mutation Database (http://
www.hgmd.cf.ac.uk/), more than 100 different variants have been
identified in patients with GS. They are missense, non-sense,
frameshift, and splice-site variations and are scattered throughout the
transporter protein with a possible clustering of variations in the
carboxy-terminal tail [4].
The association of GS with chondrocalcinosis (CC) has been
described in the literature as a typical example of hypomagnesemia-
induced crystal deposition disease [2]. CC is characterized by
deposition of crystals of calcium pyrophosphate dihydrate (CPPD) in
articular hyaline and fibro-cartilage [2]. Seventeen cases of GS
associated with CC due to CCPD have been published in the literature,
including 10 females and 7 males with a mean age of 51.4 ± 15.9 years
[2,5-15]. The role of hypomagnesemia in the development of CCPD is,
however, not fully understood [16]. Magnesium is an important
cofactor for alkaline pyrophosphatase, an enzyme that plays a key role
by converting inorganic pyrophosphate (PPi) to orthophosphate (Pi).
A reduction in the activity of this enzyme due to hypomagnesemia
could induce CCPD by raising extracellular levels of PPi. Both PPi and
calcium are crucial precursors for crystal nucleation. CCPD may be
found in other conditions associated with hypomagnesemia, such as
short bowel syndrome or in liver transplantation patients [16].
Case with Genetic Analysis
The proband, a 60 year-old caucasian male was first observed in the
Rheumatic Diseases Clinic - HSEIT when he was 48 years old; he was
born in Terceira island as well as both his parents. Symptoms started
when he was 33 years old, mainly affecting knees, ankles, wrists,
elbows and achilles tendons. In the proband, PPi crystals were
identified in the synovial fluid aspirated from a right knee effusion.
Since then he was under treatment with colchicine, NSAIDS
(Nonsteroidal anti-inflammatory drugs), and oral potassium and
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magnesium. Laboratory tests revealed normal leukocyte, erythrocyte
and platelet count.
Blood urea was 33 mg/dl, creatinine 0.9 mg/dl and glucose 177
mg/dl. Serum electrolyte concentrations were as follows: sodium 139
mEq/L, potassium 3.2 mEq/L, calcium 9.8 mg/dl, and magnesium 1.1
mg/dl (Table 1). In spite of the treatment with colchicine, patient still
maintain hypokalemia and hypomagnesemia, however he showed
some improvements. Using the diagnostic criteria of Bettinelli et al.
[17] a clinical diagnosis of GS was suspected, and a diagnosis of knee
CC was made after the identification of bilateral knee cartilage
calcification (Figure 1). SLC12A3 sequence analysis in the proband
revealed that he was homozygous for a missense substitution in exon
15, previously described as associated to GS [18]. This mutation
(CM014403), a C to T transition at position c.1869, changes the small
size and polar amino acid serine to a medium size and hydrophobic
leucine at position 615 (S615L), has a SIFT score of 0 and a Polyphen
value of 0.996, both values suggestive of a deleterious variation.
Individuals Sex Age Magnesium levelsa Potassium levelsb CC Pathogenic mutation S615L
III.2 M 60 1.1 3.2 + S615L/S615L
III.12 M 75 2.1 4.7 - S615L/WT
III.13 F 67 2.2 4.1 - WT/WT
III.16 M 75 2.0 4.6 + WT/WT
III.19 F 79 1.9 4.7 + S615L/WT
IV.1 M 35 2.3 3.7 - S615L/WT
IV.2 F 54 2.2 4.2 - S615L/WT
IV.4 M 46 1.9 4.0 - S615L/WT
IV.14 F 51 1.9 4.0 - WT/WT
IV.16 F 49 2.2 4.1 - WT/WT
IV.17 F 45 1.9 4.3 - WT/WT
IV.21 M 37 2.1 4.1 - S615L/WT
IV.22 F 36 2.0 3.7 - S615L/WT
V.1 F 25 2.0 4.7 - WT/WT
aNormal serum magnesium 1.5-2.5 mg/dL; bNormal serum potassium; 3.3-5.1 mmol/L; M:Male; F:Female; CC:Chondrocalcinosis; WT:Wild Type
Table 1: Characteristics and SLC12A3 gene variants identified in the proband and in thirteen individuals of his family pedigree. The proband is
indicated by bold.
Figure 1: X-rays of proband showing classical chondrocalcinosis in
knees.
Thirteen additional family members were investigated (5M: 8W;
[25-79]; mean age 51); blood tests and x-rays were obtained for all of
them (data not shown). The pedigree with investigated individuals is
shown in Figure 2. The biochemical data in these patients show
normal levels of serum magnesium ranging from 1.9 to 2.3 mg/dL and
normal levels of potassium ranging from 3.7-4.7 mmol/L (Table 1).
When the S615L mutation was searched in the thirteen relatives of
the proband, seven family members were found to be heterozygous, of
which only one presented CC. Furthermore six individuals were wild-
type homozygous; noteworthy, one of them (III.16) presented CC
(Table 1 and Figure 2).
Discussion
The GS patient described in this study has the S615L variation in
homozygosity, while the other cases of GS with this variation were
reported in compound heterozygotes [2]. In our study, seven
individuals heterozygous for the S615L did not have either
hypokalemia or hypomagnesemia, confirming that they were
asymptomatic carriers of this variation.
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Figure 2: Pedigree with 14 investigated individuals (6 males and 8
females). The CC affected individuals and the presence of the
mutation S615L are also indicated. The proband with GS is denoted
by the arrow.
Hypomagnesemia and hypocalciuria are found in most cases of GS,
however, some cases with mutations in the NCCT do not show these
conditions [19]. It is believed that hypomagnesemia causes CC by
increasing formation and reducing solubility of CCP crystals [16].
Excess of PPi is the main precursor for CPPD crystal nucleation.
Because the magnesium is a necessary cofactor for numerous enzymes,
such as pyrophosphatases, and considering the fact that it increases the
solubility of CPPD crystals, low levels of magnesium could induce
CPPD deposition disease by raising PPi and/or reducing the saturation
product of CPPD crystals [14]. The prevalence of CC increases with
age (10-15% for people between 65 and 75 years) and is hence called
sporadic in patients older than 60 years, whereas in younger
individuals there are several putative underlying disorders causing
CPPD deposition disease, such as hemochromatosis,
hyperparathyroidism, hypomagnesemia or hypophosphatemia [20].
The assumption that GS is caused by a defect in the NCCT
cotransporter in the renal distal tubule has been proven by the
identification of numerous variations in the SLC12A3 gene in patients
with GS [1,4,19,21]. In the present study the specific involvement of
this cotransporter in the etiology of this disorder is further
substantiated by the finding that the proband is homozygous for the
S615L variation. The S615L identified in this study was previously
described by Cruz and co-workers [18] in a study involved 36 kindreds
from the United States, Canada and England and later reported in a
study by Syrén et al. [22]. Although the SLC12A3 variations reported
in previous studies are distributed throughout the whole protein
[4,23], the study of Lemmink (1998) indicates that the carboxy-
terminal end represents a hot spot for variations [4]. S615L is located
at the intracellular C-terminal end of the SLC12A3 protein. It is
conceivable that structural alterations due to SLC12A3 variations in
the C-terminal domain interfere with phosphorylation of the NCCT
protein and as such with its regulation [4].
Evidence for an association between CC and GS comes from
uncontrolled case reports, case series and only one cross-sectional
study. As a result, its epidemiology remains unknown 16. There have
been few cases described with a definite diagnosis of CC due to GS. In
some patients with CPPD deposition disease secondary to
hypomagnesemia, the stabilization of magnesium and potassium levels
can reduce the deposition of CPPD crystals in the synovium and
synovial fluid, reducing the frequency of attacks of articular pain 14.
Conclusion
GS is a hereditary disease characterized by defective tubular
reabsorption of magnesium and potassium, mostly caused by
mutations in the SLC12A3 gene. Sometimes GS patients, as in our
case, might come with a CC diagnosis. We identified the genetic cause
for GS in a proband with secondary early onset CC. Further studies are
needed in order to enlighten the pathophysiology and prevalence of
CC in patients with GS.
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